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1 Enantioselective desymmetrization of a carboxylic acid 
 
1.1 Introduction 
 
1.1.1 Organocatalysis  
 
Organic chemists have employed small, organic molecules to facilitate 
enantioselective reactions since their advent in the 60s1 and 70s,2 and more so in their 
current renaissance beginning in the late 90s.3 The development of these chiral catalysts (in 
addition to chiral, transition metal-based catalysts4) correlates with the demand for chiral, 
nonracemic molecules, and more efficient manners for their synthesis.5 When contrasted 
with the enzymatic structures evolved by nature over the course of biological history, the 
transformations achieved by organocatalysts are truly remarkable. The advances in in 
oragnocatalysis have coincided with an ever-expanding catalog of small molecules at the 
disposal of the chemistry community. These can be roughly organized into four types: 6 
Lewis acids,7 Lewis bases,8 Brønsted acids,9 and Brønsted bases.10 Organocatalysts have 
multiplied within these types based upon successful and well-established scaffolds: i.e. 
phosphoric acids,11 thioureas,12 cinchona alkaloids and quaternary ammonium salts,13 
                                      
1 a)Pracejus, H. Ann. 1960, 634, 23. b)Pracejus, H. Ann. 1960, 634, 9. 
2 a)Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1615.b) Eder, U.; Sauer, G.; Wiechert, R. Angew. Chem. Int. 
Ed. 1971, 10, 496. 
3 Dalko, P. I.; Moisan, L. Angew. Chem. Int. Ed. 2004, 43, 5138. 
4 a) Knowles, W. S.; Sabacky, M. J.; Vineyard, B. D. J. Chem. Soc., Chem. Commun. 1972, 10. b) Noyori, R.; 
Ohkuma, T.; Kitamura, M.; Takaya, H.; Sayo, N.; Kumobayashi, H.; Akutagawa, S. J. Am. Chem. Soc. 1987, 109, 
5856. c) Katsuki, T.; Sharpless, K. B. J. Am. Chem. Soc. 1980, 102, 5974. 
5 a) Dalko, P. I.; Moisan, L. Angew. Chem. Int. Ed. 2001, 40, 3726. b) Dondoni, A.; Massi, A. Angew Chem Int Ed 
Engl 2008, 47, 4638. 
6 Seayad, J.; List, B. Org. Biomol. Chem. 2005, 3, 719. 
7 Denmark, S. E.; Beutner, G. L.; Wynn, T.; Eastgate, M. D. J. Am. Chem. Soc. 2005, 127, 3774. 
8 a) Denmark, S. E.; Beutner, G. L. Angew Chem Int Ed Engl 2008, 47, 1560. b) Sakakura, A.; Ukai, A.; Ishihara, K. 
Nature 2007, 445, 900. 
9 Kampen, D.; Reisinger, C. M.; List, B. In Asymmetric Organocatalysis; List, B., Ed.; Springer Berlin Heidelberg: 
Berlin, Heidelberg, 2009, p 1. 
10 a) Palomo, C.; Oiarbide, M.; Lopez, R. Chem. Soc. Rev. 2009, 38, 632. b) Zamfir, A.; Schenker, S.; Freund, M.; 
Tsogoeva, S. M. Org. Biomol. Chem. 2010, 8, 5262. 
11 Terada, M. Chem Commun (Camb) 2008, 4097. 
12 Connon, S. J. Chem Commun (Camb) 2008, 2499. 
13 Marcelli, T.; Hiemstra, H. Synthesis 2010, 2010, 1229. 
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phosphines,14 N-heterocyclic carbenes,15 strong acids,16 and guanidines.17 These scaffolds are 
being applied to a growing range of functions as: phase transfer catalysts,18 nucleophilic 
catalysts,19 covalent catalysts,20 frustrated pair catalysts,21 ion pairing catalysts,22 anion 
binding catalysts,23 hydrogen bonding catalysts,24 and organocatalytic photoredox catalysts25 
to select a few examples. 
 
1.1.2 Chiral Proton Catalysis 
 
Within this realm of organocatalysis, a relatively simple bifunctional catalyst 1,  was 
discovered by coordination of a bis(amidine) (BAM) ligand to one equivalent of triflic acid 
(Figure 1).26 This “chiral proton” was capable of activating aryl imine electrophiles 2 
through  hydrogen bonding, as well as activating acidic nitroalkanes 3 by the second 
aminoquinoline base through deprotonation, acting as a bifunctional catalyst. Control over 
these two reactive partners was key to achieving both high enantioselectivity and 
diastereoselectivity of 4. However, due to the relatively low catalyst activity, only highly 
electron deficient aryl imines could be used, and solvent amounts of nitroalkane (~50 
equivalents) were required to achieve acceptable results. 
 
 
Figure 1: Early enantioselective aza-Henry reaction.26 
                                      
14 Methot, J. L.; Roush, W. R. Adv. Synth. Catal. 2004, 346, 1035. 
15 Enders, D.; Niemeier, O.; Henseler, A. Chem. Rev. 2007, 107, 5606. 
16 a) Akiyama, T.; Mori, K. Chem Rev 2015, 115, 9277. b) Rueping, M.; Nachtsheim, B. J.; Ieawsuwan, W.; Atodiresei, 
I. Angew Chem Int Ed Engl 2011, 50, 6706. 
17 a) Coles, M. P. Chem Commun (Camb) 2009, 3659. b) Leow, D.; Tan, C. H. Chem.--Asian J. 2009, 4, 488. 
18 Shirakawa, S.; Maruoka, K. Angew Chem Int Ed Engl 2013, 52, 4312. 
19 a) Fu, G. C. Acc. Chem. Res. 2000, 33, 412. b) Taylor, J. E.; Bull, S. D.; Williams, J. M. Chem. Soc. Rev. 2012, 41, 
2109. 
20 Bertelsen, S.; Jorgensen, K. A. Chem. Soc. Rev. 2009, 38, 2178. 
21 Stephan, D. W. Science 2016, 354. 
22 Mahlau, M.; List, B. Angew Chem Int Ed Engl 2013, 52, 518. 
23 Zhang, Z.; Schreiner, P. R. Chem. Soc. Rev. 2009, 38, 1187. 
24 Doyle, A. G.; Jacobsen, E. N. Chem. Rev. 2007, 107, 5713. 
25 Romero, N. A.; Nicewicz, D. A. Chem. Rev. 2016, 116, 10075. 
26 Nugent, B. M.; Yoder, R. A.; Johnston, J. N. J. Am. Chem. Soc. 2004, 126, 3418. 
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The ability to fine-tune this catalyst framework is exemplified by its catalysis of 
nitroacetate (5) additions into imines (6) (Figure 2a).27 When the previously developed 
quinoline BAM 1 was employed, moderate yield and stereoselectivity was observed. Upon 
further exploration of the catalyst structure, non C2 symmetric BAM 7 was discovered to 
deliver the product in excellent enantioselectivity and high yield of the anti diastereomer 8 
(up to 12:1 dr in select examples). Replacing a quinoline with a 6-anthracenyl pyridine 
drastically altered the steric environment of the catalyst pocket. Combined with the impact 
of the large ester, these are believed to be responsible for the reversal of diastereoselectivity. 
In order to facilitate the addition of more highly substituted nitroacetates 9, catalyst 10 
was enlisted, bearing a 4-methoxy relative to the quinoline nitrogen (Figure 2b).28 This more 
basic catalyst improved reactivity and selectivity significantly, yet the syn-diastereomer 11 
was preferred. This difference has since been capitalized upon to produce the anti-
diastereomer in high selectivity with another novel catalyst,29 and the origins for the 
diastereodivergence has been illuminated by computational methods.30 
 
 
Figure 2: Enantioselective aza-Henry reactions catalyzed by electronically and sterically 
tuned BAM catalysts. 
 With this knowledge of catalyst modulation in hand, the prior limitations of the aza-
Henry methodology of simple nitroalkanes was revisited (Figure 3, compare to Figure 1).31 
                                      
27 Singh, A.; Yoder, R. A.; Shen, B.; Johnston, J. N. J. Am. Chem. Soc. 2007, 129, 3466. 
28 Singh, A.; Johnston, J. N. J. Am. Chem. Soc. 2008, 130, 5866. 
29 Sprague, D. J.; Singh, A.; Johnston, J. N. Chem. Sci. 2018, doi: 10.1039/C7SC05176J  
30 Struble, T. J.; Johnston, J. N. Submitted.  
31 Davis, T. A.; Wilt, J. C.; Johnston, J. N. J. Am. Chem. Soc. 2010, 132, 2880. 
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Several catalysts with higher basicity were screened under more practical reaction conditions 
(1.5 equivalents of nitroethane, a full range of electron rich and poor imines). It was observed 
that catalyst  1 performed poorly, with lowered enantioselectivity (87% ee) and poor yield 
(29%). More basic catalysts with methoxy (12) or pyrrolidyl (13) at the 4-quinoline position 
increased selectivity, but more importantly conversion, significantly. PBAM•HOTf (13) 
was hence discovered to benefit not only from utilizing a “chiral proton” to activate imine 
electrophiles, but also benefit from increased basicity for nucleophile activation. 
Optimization of the catalyst to acid ratio led to the conclusion that the (PBAM)2(HOTf)3 
state was best, with yields up to 99% and selectivities up to 95% and >20:1 dr. This 
methodology and bifunctional catalyst have since enabled successful application to other 
aza-Henry variants, using aryl nitromethane pronucleophiles,32 silyl imine electrophiles,33 
bromonitromethane pronucleophiles (for production of non-natural, alkyl amino amides),34 
and fluronitroalkane pronucleophiles.35 
 
 
Figure 3: More Brønsted basic (acid) catalysts increase reactivity and selectivity. 
 
1.1.3 Catalytic asymmetric halofunctionalizations of alkenes 
 
                                      
32 Davis, T. A.; Johnston, J. N. Chem. Sci. 2011, 2, 1076. Vara, B. A.; Mayasundari, A.; Tellis, J. C.; Danneman, M. 
W.; Arredondo, V.; Davis, T. A.; Min, J.; Finch, K.; Guy, R. K.; Johnston, J. N. J. Org. Chem. 2014, 79, 6913. 
33 Makley, D. M.; Johnston, J. N. Org. Lett. 2014, 16, 3146. 
34 a) Schwieter, K. E.; Johnston, J. N. ACS Catalysis 2015, 5, 6559. b) Lim, V.; Tsukanov, S. V.; Doody, A.; Johnston, 
J. N. Org. Synth. 2016, 93, 88. 
35 Vara, B. A.; Johnston, J. N. J. Am. Chem. Soc. 2016, 138, 13794. 
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 While bifunctional BAM catalysis was being used to control azomethine 
functionalities, it was discovered to also have utility in alkene functionalizations: namely, 
halofunctionalizations. Using a newly developed catalyst, StilbPBAM•HNTf2 (14), the 
intramolecular iodolactonization36 of 1,1-disubstituted alkenes could be achieved in very 
good yield and enantioselectivity, and will be further discussed in the ensuing discussion.37  
There have been a variety of strategies reported by the synthetic community to 
accomplish asymmetric halocyclizations.38 Most of these methods could arguably be 
categorized under Lewis base, Lewis acid, Brønsted base, or Brønsted acid catalysis (or a 
multifunctional combination of these), along with more specific categories such as chiral 
anion binding and phase transfer catalysis. Some of the earliest examples of selective  
 
Figure 4: Iodolactionizations utilizing chiral auxiliaries.  
                                      
36 van Tamelen, E. E.; Shamma, M. J. Am. Chem. Soc. 1954, 76, 2315. 
37 Dobish, M. C.; Johnston, J. N. J. Am. Chem. Soc. 2012, 134, 6068. 
38 Enantioselective halocyclization reviews: a) Tan, C.; Zhou, L.; Yeung, Y.-Y. Synlett 2011, 1335. b) Hennecke, U. 
Chem. - Asian J. 2012, 7, 456. c) Denmark, S. E.; Kuester, W. E.; Burk, M. T. Angew. Chem. Int. Ed. 2012, 51, 
10938. d) Fujioka, H.; Murai, K. Heterocycles 2013, 87, 763. e) Cheng, Y.; Yu, W.; Yeung, Y.-Y. Org. Biomol. Chem. 
2014, 12, 2333. f) Mukherjee, S. Catalytic Enantioselective Halocyclizations beyond Lactones: Emerging Routes to 
Enantioenriched Nitrogenous Heterocycles. g) Hennecke, U.; Wilking, M. Synlett 2014, 25, 1633. 
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halocyclizations required the use of chiral auxiliaries, as demonstrated by the Fuji group in 
1990 (Figure 4A and B)39 and the Shibuya group in 1992 (Figure 4C).40 Fuji and coworkers 
employed a chiral amide substrate bearing a C2-symmetric pyrrolidine auxiliary to 
accomplish diastereoselective iodolactonizations of simple dienes 15 and 16 in good yield 
and good enantioselectivity. Shibuya and coworkers used chiral camphor sultam-derived 
imide 17 to produce similar products in decent enantioselectivity and moderate 
diastereoselectivity.  
Taguchi and coworkers reported the earliest example of catalytic enantioselective 
halocyclizations using chiral Lewis acid catalysts (Figure 5). A stoichiometric amount of 
chiral titanium complex 18 was used to first achieve a diastereo- and enantioselective 
iodolactonization of diene 19 (58:1 dr, 64% ee) (Figure 5A).41 A 20 mol % loading of 18 was 
used for an iodocarbocyclization of alkene 20 in high enantioselectivity (94% ee). X-Ray 
crystallography of the titanium complex bound to acetylacetone enabled the development 
of a hypothesis for the origins of enantioselectivity.42 Binding of the malonate moiety to 
titanium and deprotonation by the alkoxide ligand generates a chiral enolate complex. The 
alkene electrophile can be ordered by the chiral ligands into an energetically favored chair, 
leading to the major enantiomer. 
 
 
Figure 5: A) Enantioselective iodolactonization and B) iodocarbocyclization by a chiral 
titanium catalyst.  
                                      
39 Kaoru, F.; Manabu, N.; Yoshimitsu, N.; Takeo, K. Tetrahedron Lett. 1990, 31, 3175. 
40 Yokomatsu, T.; Iwasawa, H.; Shibuya, S. Tetrahedron Lett. 1992, 33, 6999. 
41 Kitagawa, O.; Hanano, T.; Tanabe, K.; Shiro, M.; Taguchi, T. J. Chem. Soc., Chem. Commun. 1992, 0, 1005. 
42 Inoue, T.; Kitagawa, O.; Ochiai, O.; Shiro, M.; Taguchi, T. Tetrahedron Lett. 1995, 36, 9333. 
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Following Taguchi’s work, several groups made progress in establishing selectivity 
based on chiral Lewis base binding to halogen electrophiles. One of the earliest examples of 
chiral Lewis base catalysis was reported by the Grossman group, from the University of 
Kentucky, in 1998 (Figure 6A).43 Based on the hypothesis that Taguchi’s earlier work 
proceeds via a covalently bound, chiral titanium enolate, Grossman’s work is the earliest 
example of enantioselectivity in a halocyclization by noncovalent, or reagent, control. Using 
two equivalents of dihydroquinidine 21 and one equivalent of iodine, a hypothesized chiral 
source of halonium is generated, delivering products 22 in ‘promising’ initial selectivities 
(15% ee). The Brown group applied a different Lewis base, 2-menthyl pyridine 23, to 
generate a preformed, chiral bromonium source (Figure 6B).44 Pentenoic acid 24 was 
converted to bromo lactone 25 in 5% enantiomeric excess. Soon after, the Wirth group 
reported a significant advance in this stragetgy (Figure 6C).45 Chiral amines were screened 
as ligands for iodine, with the surprisingly simple 26 found to facilitate this lactonization 
in relatively high enantioselectivity (45%). However, this result only stands for 1,1  
 
Figure 6: The earliest enantioselective catalyzed halolactonizations. 
disubstituted aryl alkenes 27. Alkyl substituted alkenes, similar to those used in Grossman’s 
and Brown’s work, produced racemic products. It should be that there is debate about the 
                                      
43 Grossman, R. B.; Trupp, R. J. Can. J. Chem. 1998, 76, 1233. 
44 Cui, X.-L.; Brown*, R. S. J. Org. Chem. 2000, 65, 5653. 
45 Haas, J.; Piguel, S.; Wirth, T. Org. Lett. 2002, 4, 297. 
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mechanism of this class of reaction, with recent findings providing evidence for Brønsted 
base mechanisms being operative instead of Lewis base.46 
A remarkable extension of this Lewis base strategy was realized by Ishihara and 
coworkers in 2007 (Figure 7A).47 Phosphoramidite 28 was used as a stoichiometric chiral 
promoter to facilitate an iodopolycyclization reminiscent of squalene synthase. Polycyclic 
iodides 29 are produced from polyenes 30 in modest yield and excellent selectivities (94:6 
dr, 99% ee). Although substoichiometric Lewis base activation of halogens still remains a 
challenge, selenophosphoramide catalysts have been recently used to accomplish  
 
Figure 7: A) Enantioselective polycyclization, B) sulfenyletherification, and C) 
carbosulfenylation by chiral Lewis bases.  
enantioselective sulfenylcyclizations of alkenes. Using selenophosphoramide 31, Denmark 
and coworkers could achieve a selective sulfenyletherification with good selectivity (92% ee) 
(Figure 7B).48 This work could be extended to the carbosulfenylation of alkenes with related 
catalyst 32 (Figure 7C).49  These selenophosphoramides are proposed to bind to and deliver 
                                      
46 Denmark, S. E.; Ryabchuk, P.; Burk, M. T.; Gilbert, B. B. J. Org. Chem. 2016, 81, 10411. 
47 Sakakura, A.; Ukai, A.; Ishihara, K. Nature 2007, 445, 900. 
48 Denmark, S. E.; Kornfilt, D. J. P.; Vogler, T. J. Am. Chem. Soc. 2011, 133, 15308. 
49 Denmark, S. E.; Jaunet, A. J. Am. Chem. Soc. 2013, 135, 6419. 
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sulfenium to the alkene, selectively forming a thiiranium ion which is captured by the 
nucleophile intramolecularly.  
Chiral ion pairing catalysis, also known as “asymmetric counteranion-directed 
catalysis” (ACDC50), has emerged as a powerful tool in asymmetric synthesis by Brønsted 
acids.16,51 This catalysis frequently uses chiral phosphoric acids, chiral carboxylic acids, and 
chiral N-triflyl phosphoramides52 to achieve a variety of enantioselective reactions, such as 
spiroacetalizations,53 hydroaminations,54 and halocyclizations. One of the earliest 
applications used a chiral BINOL-based phosphate salt 33 to catalyze an enantioselective 
iodoetherification (Figure 8).55 Hennecke and coworkers propose the formation of an 
iodonium-chiral phosphate ion pair as the origin of enantioselectivity. By employing 
symmetric alkene substrate 34, they were able to avoid the necessity of forming the 
iodonium enantioselectively, as other groups had been previously focused on. Rather, the 
phosphate counterion must control which alcohol cyclizes onto the meso-iodonium ion in 
order to succeed. Interestingly, the corresponding phosphoric acids were unable to achieve 
significant levels of enantioselectivity. Upon generation of the chiral ion pair, sodium 
pyrrolidinone is generated, and this is likely basic enough to activate the alcohol nucleophile 
for cyclization. However, a mechanism for how enantioselectivity is achieved is not 
addressed in detail. Interestingly, when 33 was applied to the bis(carboxylic acid) version 
of substrate 34, only racemic iodolactone product was generated. Results from the 
phosphoric acid of 33 are not reported.  
 
 
Figure 8: Chiral ion pairing applied to halocyclizations by enantioselective 
desymmetrization. 
                                      
50 Mahlau, M.; List, B. Angew Chem Int Ed Engl 2013, 52, 518. 
51 a) Parmar, D.; Sugiono, E.; Raja, S.; Rueping, M. Chem. Rev. 2014, 114, 9047. b) Min, C.; Seidel, D. Chem. Soc. 
Rev. 2017, 5889. 
52 Kampen, D.; Reisinger, C. M.; List, B. In Asymmetric Organocatalysis; List, B., Ed.; Springer Berlin Heidelberg: 
Berlin, Heidelberg, 2009, p 1. 
53 Coric, I.; List, B. Nature 2012, 483, 315. 
54 Ackermann, L.; Althammer, A. Synlett 2008, 2008, 995. 
55 Hennecke, U.; Müller, C. H.; Fröhlich, R. Org. Lett. 2011, 13, 860. 
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The Toste group also made significant advances in the area of chiral ion pairing 
catalysis (chiral anion phase-transfer catalysis) (Figure 9).56 This work stands upon the 
realization that insoluble halogen sources can advantageously inhibit the racemic 
background reaction from occurring. Only when the tetrafluoroborate counterion is 
exchanged for a chiral phosphate counterion can reaction with the substrate occur. As such, 
this methodology has been successfully applied to the cyclization of amides with a range of 
halogen sources. The fluorocyclization of amides 35 is accomplished using highly insoluble 
Selectfluor as the halogen source, and a derivative of TRIP, 36, as the catalyst (Figure 
9A).56a 36 is deprotonated in situ and then can undergo salt metathesis with Selectfluor to 
generate a soluble halogen source possessing at least one phosphate counterion. A non-linear 
effect was observed, indicating that two phosphate counterions may be present in the 
enantiodetermining step. Fluorocyclizations were achieved in good yields and high 
selectivities (96% ee, >20:1 dr). This methodology significantly advanced the stereoselective 
construction of carbon-fluorine bonds, and it’s utility was further demonstrated by extension 
to other halogen cyclizations. Using highly insoluble, tricationic halonium reagents 37 and 
38, the highly enantioselective bromo- and iodo- cyclizations of amides 39 could be 
performed under nearly identical conditions by phosphoric acid 40 (Figure 9B).56b  
 
 
Figure 9: A) Fluoro-, B) bromo-, and iodocyclizations of amides by chiral ion pairing. 
                                      
56 a) Rauniyar, V.; Lackner, A. D.; Hamilton, G. L.; Toste, F. D. Science 2011, 334, 1681. b) Wang, Y.-M.; Wu, J.; 
Hoong, C.; Rauniyar, V.; Toste, D. F. J. Am. Chem. Soc. 2012, 134. 
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Haloaminations and haloetherification have also been achieved using chiral ion 
pairing catalysis. The Shi group and the Denmark group simultaneously reported 
bromocyclizations of similar alkenes (41 and 42) using similar methodology (Figure 10). 
The Shi group was able to achieve both bromo –aminations and –etherifications of 
unactivated alkenes in high enantioselectivity (products 43a  and 44b, 90% ee and 81% ee, 
respectively) (Figure 10A).57 However, styrenyl substrates gave poor exo:endo selectivity, 
and (E) alkenes reacted in lower enantioselectivities. This work is hypothesized to generate 
a halonium/phosphate ion pair, but phosphoric acid catalyst 45 is hypothesized to 
simultaneously activate nucleophile and electrophile (although the calcium salt has been 
mistakenly used in the past58). Denmark’s work is remarkably similar, save for the addition 
of a catalytic Lewis base, triphenylphosphine sulfide, to facilitate bromonium transfer from 
succinimide to the alkene (Figure 10B).59 Consequently, this methodology is capable of 
functionalizing styrenyl alkenes efficiently. When (Z)-42 is used, bromofuran 46 is produced 
in high levels of exo- and enantioselectivity (95:5 exo:endo, and 82% ee). (E)-42 also yields 
the exo-product 46 in good enantioselectivity, but an equal amount of endo-product is 
produced racemically.  
 
 
Figure 10: A) Haloamination and B) haloetherification of alkenes by chiral ion pairing. 
Arguably the most common strategy for enantioselective halofunctionalizations of 
alkenes is bifunctional catalysis. Oftentimes these catalysts have an acidic, hydrogen bond 
donating functionality combined with basic functionality (acting as either a Brønsted base 
or Lewis base). Most proposed mechanisms focus overwhelmingly on catalyst activation and 
control of the halogen source, however several recent studies have brought renewed emphasis 
                                      
57 Huang, D.; Wang, H.; Xue, F.; Guan, H.; Li, L.; Peng, X.; Shi, Y. Org. Lett. 2011, 13, 6350. 
58 Hatano, M.; Moriyama, K.; Maki, T.; Ishihara, K. Angew. Chem. 2010, 122, 3911. 
59 Denmark, S. E.; Burk, M. T. Org. Lett. 2012, 14, 256. 
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on the role of catalyst nucleophile activation.46,60 One of the earliest examples of an 
organocatalyst achieving high selectivity in a halofunctionalization was reported by the 
Jacobsen group in 2010 (Figure 11A).61 Using bifunctional 47 as a catalyst, the 
iodolactonization of 1,1 disubstituted alkenes 48 to lactones 49 was performed in high yields 
and selectivities. A unique, phthalimide iodonium source 50 provided the highest 
enantioselectivity (94% ee), and a catalytic amount of iodine was mandatory for reactivity 
(3% yield without I2). An extensive catalytic cycle is proposed in which a key catalytic 
intermediate (51, Figure 11B) serves to deliver iodine to the alkene in an enantioselective 
fashion, and the authors classify this mode as chiral ion pairing catalysis. They propose that 
urea 47 reacts with N-iodophthalimide to generate 51. 52Then the hydrogen bonded 
phthalimide anion purportedly activates the carboxylic acid nucleophile as the tertiary 
amine moiety delivers iodine to the alkene. The main support for this proposal is based on 
the impact of different halogen-source structures on the stereoselectivity of the reaction, 
indicating its involvement in the enantiodetermining step. A simpler, and experimentally 
consistent, mechanistic proposal wherein the Brønsted base (tertiary amine) moiety 
activates the carboxylic acid nucleophile and the Brønsted acidic thiourea activates the 
phthalimide electrophile is not discussed as a possibility, however.  
 
 
Figure 11: A) Jacobsen’s enantioselective iodolactonization using a bifunctional catalyst; 
B) proposed ion binding activation mode.  
                                      
60 Ashtekar, K. D.; Vetticatt, M.; Yousefi, R.; Jackson, J. E.; Borhan, B. J. Am. Chem. Soc. 2016, 138, 8114. 
61 Veitch, G. E.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2010, 49, 7332. 
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The Yeung group soon after reported an example of Lewis base/Brønsted base 
bifunctional catalysis for the enantioselective bromolactonization of pentenoic acids (Figure 
12A).62 Using a cinchonine scaffold with an appended thiocarbamate, bifunctional catalyst 
53 was found to impact the reaction in good yield and selectivity (90% ee). Under the 
premise that an additional hydrogen bond donor may help, several weak acid additives were 
tested, and p-nitrobenzenesulfonamide was found to increase enantioselectivity from 87% to 
90%. The authors also mention the possible formation of NsNHBr from p-
nitrobenzenesulfonamide, which could serve as the active brominating agent. The catalyst 
thiocarbamate functionality is proposed to activate and position NBS through hydrogen 
bonding and sulfur-bromine coordination (54, Figure 12B). Simultaneous deprotonation of 
carboxylic acid 55 by the catalyst quinuclidine would position the substrate for 
enantioselective formation of bromolactone 56. 
 
Figure 12: A) Yeung’s Lewis base/Brønsted base catalyzed bromolactonization; B) 
proposed Lewis base/Brønsted base catalytic activation mode.  
An organocatalyst (57) which partners an acidic phenol and a basic amidine was 
developed by Martin and coworkers for an enantioselective bromolactonization (Figure 
13A).63 As in previous methodologies, higher selectivity was observed for Z-olefins (58) 
versus E-olefins. This catalytic system could even desymmetrize prochiral substrate 59 to 
the 4-exo lactone 60, albeit in low enantioselectivity (46%) (Figure 13B). These conditions 
were also amenable to iodolactonizations with only minor adjustments.64 The authors 
propose that the amidine stabilizes a bromonium ion by Lewis base interaction and that 
the phenol hydrogen bonds to the carboxylic acid (or carboxylate) to orient the substrate 
(Figure 13C). This proposal must assume that the brominating agent, TBCO, reacts with 
                                      
62 Zhou, L.; Tan, C.; Jiang, X.; Chen, F.; Yeung, Y.-Y. J. Am. Chem. Soc. 2010, 132, 15474. 
63 Paull, D. H.; Fang, C.; Donald, J. R.; Pansick, A. D.; Martin, S. F. J. Am. Chem. Soc. 2012, 134, 11128. 
64 Fang, C.; Paull, D. H.; Hethcox, J. C.; Shugrue, C. R.; Martin, S. F. Org. Lett. 2012, 14, 6290. 
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the substrate initially to form zwitterionic bromonium-carboxylate species 61, which then 
is coordinated by the catalyst. A plausible, yet unmentioned, alternative would involve 
amidine activation of the substrate carboxylic acid as a Brønsted base, and catalyst phenol 
activation of TBCO as a Brønsted acid. However, an early focus on Lewis base control of 
halogenation influenced the proposed mechanism.  
 
Figure 13: A) Martin’s bifunctionally catalyzed bromolactonization, B) enantioselective 
desymmetrization, and C) proposed Lewis base/Brønsted acid catalytic activation mode. 
Another example of bifunctional catalysis was developed by the Borhan group, and 
they reported the enantioselective chlorolactonization of 1,1-disubstituted pentenoic acids 
(62,  Figure 14)65 by the previously developed organocatalyst, (DHQD)2PHAL.66 Production 
of 63 was optimized to high yields and high enantioselectivities (81% and 89%, respectively), 
finding that one equivalent of benzoic acid was required to reach 89% ee. This additive is 
hypothesized to protonate a catalyst quinidine, forming a hydrogen bond donor to activate 
                                      
65 Whitehead, D. C.; Yousefi, R.; Jaganathan, A.; Borhan, B. J. Am. Chem. Soc. 2010, 132, 3298. 
66 a) Jacobsen, E. N.; Marko, I.; Mungall, W. S.; Schroeder, G.; Sharpless, K. B. J. Am. Chem. Soc. 1988, 110, 1968. b) 
Li, G.; Chang, H.-T.; Sharpless, K. B. Angew. Chem. Int. Ed. 1996, 35, 451. c) Becker, H.; Sharpless, K. B. Angew. 
Chem. Int. Ed. 1996, 35, 448. 
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the hydantoin chloronium source, and NMR studies revealed a binding interaction between 
catalyst and dichlorohydantoin. The remaining quinidine serves as a Brønsted base to 
deprotonate the carboxylic acid nucleophile. Interestingly, a screen of chloronium sources 
revealed the larger diphenylhydantoin (89% ee) to perform better than smaller halogen 
sources, such as dimethylhydantoin (84% ee). A matched/mismatched case was discovered 
between chiral chlorohydantoin structures and catalyst, as (S)-5-isopropyl-1,3-
dichlorohydantoin was found to be more reactive and more selective (78% yield, 83% ee) 
than its (R) counterpart (44% yield, 69% ee). This further corroborated the hypothesized 
interaction between catalyst and oxidant in the enantiodetermining step. This work has 
been further developed to the asymmetric chlorocyclization of amides,67 intermolecular 
haloetherifications,68 and dihalogenation of alkenes.69 
 
 
 Figure 14: Enantioselective chlorolactonization using bifunctional catalysis. 
A desire to further understand the origin of enantioselectivity in this methodology 
inspired a series of mechanistic investigations. The Borhan group sought to understand the 
nature of chloronium delivery in their prior work (Figure 15A): enantioselective formation 
of a bridged chloronium ion 64 followed by stereospecific (anti) nucleophilic addition, or 
formation of planar carbocation 65 followed by catalyst controlled addition of the 
carboxylate nucleophile. In order to provide a record of the path of attack without 
structurally altering the 1,1-disubstituted alkene substrates, E-deuterated alkene 66 was 
prepared (Figure 15B).70 This enabled the observation of chlorine facial selectivity, bridged 
chloronium or carbocation formation, and relative stereochemical orientation between 
chlorine and carboxylate. Cyclization of 67 was highly diastereoselective, yielding 89% of 
                                      
67 Jaganathan, A.; Garzan, A.; Whitehead, D. C.; Staples, R. J.; Borhan, B. Angew. Chem. Int. Ed. 2011, 50, 2593. 
68 Soltanzadeh, B.; Jaganathan, A.; Staples, R. J.; Borhan, B. Angew. Chem. Int. Ed. 2015, 54, 9517. 
69 Soltanzadeh, B.; Jaganathan, A.; Yi, Y.; Yi, H.; Staples, R. J.; Borhan, B. J. Am. Chem. Soc. 2017, 139, 2132. 
70 Yousefi, R.; Ashtekar, K. D.; Whitehead, D. C.; Jackson, J. E.; Borhan, B. J. Am. Chem. Soc. 2013, 135, 14524. 
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5R,6R-68, which surprisingly arose from a net syn addition of chlorine and carboxylate 
across the alkene. This result eliminated the possibility of a bridged chloronium intermediate  
 
Figure 15: A) Two possible pathways for enantioselective chlorolactonizations; B) 
mechanistic investigations into alkene facial control and nucleophile addition in 
chlorolactonizations; C) segregating nucleophile and electrophile control. 
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and supported a carbocation intermediate.71 The second most abundant diastereomer, 
5S,6R-69 (8%), has the same configuration at the chlorine center, indicating a total of 96% 
of the starting alkene was electrophilically attacked by chloronium at the pro-R face. The 
highly stereoselective delivery of chlorine linked the catalyst to this step. Additionally, the 
preference for the syn diastereomer implicated a second catalyst role in nucleophilic addition 
to the carbocation intermediate.  
In order to individually investigate the two catalyst roles, a tert-butyl ester substrate 
analog was tested in the chlorolactonization reaction, to prevent catalyst binding to the 
nucleophile. The product was produced in 20% ee, indicating a catalyst influence over 
nucleophile addition in the typical lactonization. When deuterated tert-butyl ester 70 was 
subjected, a broader distribution of stereoisomers was obtained (Figure 15C). The preferred 
relative stereoselectivity was reversed, with the anti diastereomer now favored. Although 
enantioselectivity was low due to poor nucleophile control, high R-facial selectivity (87%) 
was still observed for chloronium delivery (28% 5R,6R-68 plus 59% 5S,6R-69). Therefore, 
the authors concluded that both chlorination of the alkene and cyclization to the lactone 
product are both under distinct influences from (DHQD)2PHAL. A quantitative study of 
the reactivity of halogenating agents with various Lewis bases was subsequently conducted, 
yielding the halenium affinity (HalAI) scale.72 This report addresses the frequent invocation 
of bridged halonium species in mechanism proposals. Based upon calculations on styrenyl 
substrates for a variety of halonium sources (B3LYP/6-31g*/LanL2DZ), the open 
carbocation form was always found to be more stable and have a low barrier to rotation. 
This is consistent with previous findings of a highly selective, syn chlorolactonization 
(Figure 15A). The HalA method also claims that traditional imide-based halonium sources 
(NIS, DBDMH, etc) cannot effectively transfer halonium to an olefin, as the resultant imide 
anion is a better nucleophile than the olefin. Activation of the olefin and/or activation of 
the halonium source is required.  
 This led the Borhan group to investigate the nucleophilic addition portion of 
halocyclizations, arriving at the concept of Nucleophile Assisted Alkene Activation (NAAA) 
(Figure 16B).60 The activation of olefins by neighboring nucleophiles has long been 
hypothesized as the cause for the ease of intramolecular halocyclizations relative to 
intermolecular halocyclizations.73 Increasing electron density of the carboxylic acid 
functionality of 71 was observed to shift the alkene protons and carbons by NMR in a 
                                      
71 A prior study had found that bromonium and chloronium ions of 1,2 disubstituted alkenes were configurationally 
stable: Denmark, S. E.; Burk, M. T.; Hoover, A. J. J. Am. Chem. Soc. 2010, 132, 1232. 
72 Ashtekar, K. D.; Marzijarani, N. S.; Jaganathan, A.; Holmes, D.; Jackson, J. E.; Borhan, B. J. Am. Chem. Soc. 2014, 
136, 13355. 
73 a) Staninets, V. I. S., E. A. Russ. Chem. Rev. 1971, 40. b) Williams, D. L. H.; Bienvenue-Goetz, E.; Dubois, J. E. J. 
Chem. Soc. B 1969, 517.  
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manner consistent with a pre-polarized complex (Figure 16C). The authors find that 
addition of chloronium from chlorohydantoin (174 kcal/mol) to an olefin (165 kcal/mol) 
should be too endothermic to occur. The rate of chlorolactonization by an AdE2 mechanism 
depends on the electron-richness of the nucleophile,46,73a with ammonium salt 72 having an 
almost 20 kcal/mol lower barrier to reaction than the carboxylic acid 71 (B3LYP/6-
31g*/SM8-CHCl3) (Figure 16C). Calculated potential pathways found that carboxylic acid 
interaction with the olefin is the only substrate conformation capable of weakening the N-
Cl bond toward chlorolactonization. Without NAAA, calculations minimize to a simple Van 
der Waals complex between substrate and halogen donor. Kinetic isotope effect studies on 
18O labeled carboxylic acid 71 revealed a significant effect (K 16O/18O = 1.026), implying 
involvement in the rate determining step. The authors conclude that conditions in which 
stabilized, bridging halonium ions are known to be generated do not translate to 
synthetically useful conditions, and that nucleophile interaction with an olefin enables 
reaction with commonly used halogen sources. 
 
 
Figure 16: A) Traditional stepwise electrophilic addition to olefins; B) nucleophile 
assisted alkene activation in addition to olefins; C) base activation of the nucleophile 
lowers the activation energy for chlorolactonizations. 
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The eloquent and instructive mechanistic work by Borhan and coworkers leads one 
to wonder about the effectiveness of simple, chiral Brønsted bases.74 Examples of solely 
Brønsted base catalysis in halocyclizations are perhaps the least common, however, this 
could be partially due to inadvertent categorization as Lewis base catalysis. This was 
recently investigated by Denmark and coworkers. Their attempt to use Lewis bases to 
catalyze the chlorolactonization of challenging 1,2-substituted alkenes eventually led to the 
conclusion that Brønsted base catalysis was actually operative.46 The TBDMS ester of their  
 
Figure 17: Mechanistic investigation into a previously proposed Lewis base catalyzed 
chlorolactonization: A) cyclization of a silyl ester, B) lactonization of an ammonium 
carboxylate, and C) 1HNMR studies of the vinylic protons in various reaction conditions. 
test substrate (73) could not undergo lactonization with or without quinuclidine present 
(Figure 17A). However, the ammonium carboxylate 74 easily reacted even without a 
catalyst present (Figure 17B), and the N-chloroquinuclidine was never observed by 1HNMR 
when it was reacted with quinuclidine catalyst. In solution, quinuclidinium carboxylate 75 
shows shifted alkene protons relative to its carboxylic acid counterpart (Figure 17C). 
                                      
74 Palomo, C.; Oiarbide, M.; Lopez, R. Chem. Soc. Rev. 2009, 38, 632. 
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Subsequent addition of DCDMH does not further alter the chemical shift of the alkene 
protons significantly. Brønsted acid activation of DCDMH by the conjugate acid of 
quinuclidine may be operative in addition to the nucleophilic alkene activation. The authors 
state that “what was initially interpreted as Lewis base catalysis is, in fact, Brønsted 
base/Brønsted acid catalysis.” Experimental evidence was also found for the configurational 
instability of benzylic chloriranium ions, suggesting benzylic carbocation formation is 
favored.  
The Hennecke group reported the first enantioselective halolactonization of alkynes 
in the desymmetrization of diynoic acids such as 76 (Figure 18).7576 This substrate could 
undergo 5-exo bromolactonization to 77 by the dimeric Brønsted base, (DHQD)2PHAL, in 
good yield and 72% ee. The authors hypothesize that the base catalyst is able to activate 
the carboxylic acid to cyclize onto one alkyne selectively. Binding to the carboxylic acid 
was tested by submitting the potassium carboxylate salt of 76 to the reaction, and only 
racemic product was generated. This indirectly indicates that deprotonation of the substrate 
by the catalyst is vital for binding and selectivity.  
 
Figure 18: Bromolactonization of diynoic acids and catalyst screens based on 
dihydroquinidine.  
                                      
75 Wilking, M.; Mück-Lichtenfeld, C.; Daniliuc, C. G.; Hennecke, U. J. Am. Chem. Soc. 2013, 135, 8133. 
76 See also an earlier example of hydro-carboxylation of alkynes: Yoshida, S.; Fukui, K.; Kikuchi, S.; Yamada, T. J. Am. 
Chem. Soc. 2010, 132, 4072. 
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Additional catalyst screens were undertaken to better understand the roles this 
catalyst plays.77 Dihydroquinidine itself could not induce enantioselectivity, indicating the 
phthalazine’s importance. Monomeric dihydroquinidine alkaloids 78 were screened, with 
78a rescuing some enantioselectivity by inclusion of the phthalazine moiety. More electron 
donating substituents were found to be optimal (78a - 78c), and bulky alkoxy substituents 
delivered the product in better yield (99%) and selectivity (88%) than (DHQD)2PHAL (78d 
and 78e). Therefore, the second alkaloid may be mainly serving to help create a catalytic 
pocket around the pthalazine and first quinuclidine ring. NMR titration studies confirm 
that these catalysts bind tightly to carboxylic acid 76 in a one to one ratio. A similar proton 
shift of the alkynyl protons is observed by 1H NMR due to nucleophile-assisted alkene 
activation. No evidence is presented for any Lewis base activation of bromine, but the 
authors do not rule that out as a possible second catalytic function. 
 
Figure 19: Brønsted base catalysis by: A) trisimidazolines in an enantioselective 
bromolactonization, B) (DHQD)2PHAL in the 5-exo chlorocyclization of amides, and C) 
the 6-endo chlorocyclization of amides. 
                                      
77 Wilking, M.; Daniliuc, C. G.; Hennecke, U. Chem. Eur. J. 2016, 22, 18601. 
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The Fujioka group has developed highly effective and unique tris(imidazoline) 
catalysts (79) for the Brønsted base catalyzed bromolactonization (Figure 19A).78 
Interestingly, the bis- and mono- imidazoline catalyst analogs demonstrated similar 
reactivity but much lower enantioselectivities (28% and 6%, respectively). This work was 
extended to cyclization of symmetric bis(carboxylic acids), as well.79  
The Borhan group was able to apply prior methodology to the enantioselective 
chlorocyclization of allylic acylamides (80, Figure 19B).80 The polar protic solvent, 
trifluoroethanol, was surprisingly found to be the optimal solvent for enantioselectivity, 
while chloroform only provided product in 57% ee. Additionally, no benzoic acid additive 
was required in this case, despite having a similar alkene and the same chlorine source. 
Granted, benzoic acid only had a minimal effect in the bromolactonization chemistry. The 
catalyst is likely acting as a Brønsted base for activation of the amide. These conditions 
were impressively amenable to trans-alkene 81, providing 6-endo products 82 in good yield 
and excellent enantioselectivities (99%) (Figure 19C). Further still, this same methodology 
was used to effect an intramolecular, enantioselective haloetherification81 and an 
enantioselective dichlorination.82 
 
 
Figure 20: Application of bifunctional BAM catalysis to an iodocyclization.  
 
                                      
78 Murai, K.; Matsushita, T.; Nakamura, A.; Fukushima, S.; Shimura, M.; Fujioka, H. Angew. Chem. Int. Ed. 2010, 49, 
9174. 
79 Murai, K.; Nakajima, J.; Nakamura, A.; Hyogo, N.; Fujioka, H. Chem. - Asian J. 2014, 9, 3511. 
80 Jaganathan, A.; Garzan, A.; Whitehead, D. C.; Staples, R. J.; Borhan, B. Angew. Chem. Int. Ed. 2011, 50, 2593. 
81 Soltanzadeh, B.; Jaganathan, A.; Staples, R. J.; Borhan, B. Angew. Chem. Int. Ed. 2015, 54, 9517. 
82 Soltanzadeh, B.; Jaganathan, A.; Yi, Y.; Yi, H.; Staples, R. J.; Borhan, B. J. Am. Chem. Soc. 2017, 139, 2132. 
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 This overall journey by the synthetic community from a focus on catalytic control 
of the electrophile towards a greater understanding of nucleophilic control is also reflected 
in the development of halocyclizations in the Johnston group. Using the previously 
developed PBAM•HOTf (13, Figure 3), the intramolecular iodolactonization36 of 1,1 
disubstituted alkenes could be achieved in promising yield and enantioselectivity (Figure 
20).37 A range of sulfonic, triflamidic, and triflimidic acid salts of PBAM were screened, and 
triflimidic acid was found to give the best results (90% yield, 84% ee). In general, more 
acidic and sterically encumbered acids performed better. The free base of PBAM had 
comparable reactivity yet much lower enantioselectivity (19% ee), indicating that one 
protonated amidine was necessary for selectivity. At this point, other catalyst chiral 
backbones were tested. A stilbene diamine derived catalyst was found to provide better 
selectivity, with triflic acid salt of StilbPBAM (14) delivering the product in high yield and 
increased selectivity (95% yield, 87% ee). Again, changing to the larger and more acidic 
acid additive, HNTf2, proved optimal. StilbPBAM•HNTf2 facilitated the iodolactionization 
in 89% yield and 95% ee. This methodology could be applied to a range of aryl and alkyl 
1,1-disubstituted alkenes, and found that lower selectivities were observed for alkyl, electron 
rich aryl, and unsubstituted alkene substrates.  
The cause of StilbPBAM’s greater selectivity relative to PBAM remains uncertain, 
although it is hypothesized that its smaller dihedral angle83 and it’s two phenyl groups may 
restrict substrate conformation to a greater extent than PBAM upon binding. The acidic 
additive HNTf2, that increases the enantioselection relative to the free base, is hypothesized 
to orchestrate the reaction by hydrogen bond donation to the succinimide electrophile 
(Figure 21A). This bifunctional activation hypothesis builds on the paradigm developed 
during investigations of chiral proton catalysis in prior aza-Henry investigations. It implies 
a catalyst role in enantioselective delivery of iodine to the alkene, accompanied by a 
stereospecific lactonization step. Another important feature of this hypothesis is the strength 
of the triflimide/amidinium ion pair, which may be separated during binding to the carbonyl 
of N-iodosuccinimide. Alternatively, recent highly selective results with the free base of 
BAM catalysts (vida infra) in related systems indicate the amidinium/counterion moiety 
may modify the steric environment of the catalyst structure in a beneficial manner specific 
to certain cyclizations (Figure 21B). This alternative implies that amidine deprotonation 
and binding to the carboxylic acid positions the substrate in a chair-like conformation with 
one alkene face toward the carboxylate and one open to electrophilic activation. The 
amidinium/triflimide ion pair could be more tightly associated, serving as a steric “wall,” 
and only allowing N-iodosuccinimide approach from one face. Each of these two hypotheses 
                                      
83 Kim, H.; Yen, C.; Preston, P.; Chin, J. Org. Lett. 2006, 8, 5239. 
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appear reasonable for BAM catalysis, and the hierarchy of these two functions will be the 
subject of further discussion in this chapter.  
 
Figure 21: Two faces of bifunctional activation: electrophilic and nucleophilic control 
hypotheses based on counterion displacement, and counterion block, respectively. 
Studies of halocyclizations led to the application of StilbPBAM•HNTf2 to the first 
organocatalytic, enantioselective capture of CO2 (Figure 22A).84 Using homoallylic alcohols 
such as 83, enriched iodocarbonates (84) could be produced in good yield (91%) and 
selectivity (95% ee). Catalyst-substrate complex 85 is believed to sufficiently stabilize the 
carbonic acid intermediate to enable the unfavorable addition of an alcohol into carbon 
dioxide.  
A similar capture of CO2 has been developed for homoallylic amines, 86 (Figure 
22B).85 Several challenges arise in this methodology. Upon addition of CO2 to the reaction, 
fast reaction with amine substrate generates carbamic acid. Further reaction with another 
equivalent of amine substrate produces a stable ammonium/carbamate salt dimer. 
Additionally, amines are more basic than any substrate used previously with BAM catalysis. 
Being more basic than an amidine, the amine substrate likely deprotonates the acidic 
triflimidic acid from the catalyst. A more basic catalyst, 7MeOStilbPBAM•HNTf2 (87) was 
required to activate the ammonium substrate salt generated in the conditions, and 
successfully produced enantioenriched carbonates (86% yield, 92% ee). The ability of the 
catalyst to corral the variety of possible intermediates, adducts, and dimers into a major 
product and stereoisomer is notable.  
The concept of intermolecular generation of a sufficiently acidic nucleophile by 
capture of CO2 by alcohols and amines inspired the search for CO2 surrogates. The capture 
of tosyl isocyanate by an allylic amine (88) would generate an acidic imide capable of N- 
                                      
84 Vara, B. A.; Struble, T. J.; Wang, W.; Dobish, M. C.; Johnston, J. N. J. Am. Chem. Soc. 2015, 137, 7302. 
85 Yousefi, R.; Struble, T. J.; Johnston, J. N. Unpublished results. 
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or O- cyclization, and stereoselectively forming a C-N bond was rare and attractive. Upon 
catalyst screening, the more basic 6,7(MeO)2StilbPBAM (89, Figure 22) was found to be 
most effective in the free base form, favoring N-cyclization to produce enantioenriched ureas 
(90, 91% ee, 82% yield, Figure 22C).86 The reversal of previously observed alkene facial 
selectivity was notable as well. The same conditions were remarkably general, and they 
were applied to both cis- and trans- 1,2 disubstituted alkenes. trans-1,2-Disubstituted 
alkenes 91 underwent 6-exo, N-cyclization in good yield and excellent enantioselectivies 
(92, 60% and 94%, respectively, Figure 22D), and cis-1,2 disubstituted alkenes reverted 
back to a 5-exo cyclization (93% yield, 93% ee). 
  
Figure 22: Enantioselective halocyclizations by the Johnston group.  
The success of free base BAM catalysis in this methodology (Figure 22C and D) was 
surprising. It should be noted that both N-iodosuccinimide and N-iodopyrrolidinone 
performed well in this reaction, but  N-iodopyrrolidinone was employed because it converted 
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the starting material more quickly. This amide iodine source is less electrophilic than the 
imide source, NIS. It would have been previously hypothesized that additional Brønsted 
acidic activation, not less, would be required for use of N-iodopyrrolidinone. Yet use of the 
triflimidic acid salt of 6,7(OMe)2StilbPBAM•HNTf2 was inferior to the freebase. It appears 
at this time that the acidic role of BAM salts may have been over-generalized, since 
predicting when it will be beneficial does not follow working hypotheses. 
A significant, and somewhat fortuitous, advancement in the understanding of how 
the Brønsted basic function of BAM catalysts operate began with the discovery of the 
halocyclizations of phosphoramidic acids. An unanticipated benefit from the use of these 
unique substrates was the configurational stability of chiral phosphorous atoms. In the 
iodocyclization of phosphoramidic acids (93), StilbPBAM•HNTf2 was found to be most 
effective for the 5-exo cyclization (Figure 23A), providing the products in good yield (94, 
85%), excellent enantioselectivity (96%), and high diastereoselectivity (>20:1).87 Essentially, 
the alkene facial selectivity (as is common with 1,1-disubstituted alkenes) and the selectivity 
at the phosphorous atom were both very high. When examining how this selectivity at 
phosphorous arises, it became apparent that upon deprotonation of the phosphoramidic 
acid, a prochiral anion (95) is generated. Which oxygen of the phosphoramidate cyclizes 
onto the alkene determines the configuration at phosphorous. Therefore, the catalyst could 
be selecting for one oxygen over the other. Alternatively, perhaps selective generation of a 
chiral iodonium provides the necessary conformation to get a highly diastereoselective 
cyclization.  
 
Figure 23: Enantioselective iodocyclization of phosphorous-based acids. 
                                      
87 Toda, Y.; Pink, M.; Johnston, J. N. J. Am. Chem. Soc. 2014, 136, 14734. 
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To further investigate, the cyclization of trans-alkene substrates 96 was undertaken 
(Figure 23B).88 With six stereoisomers now possible, optimized conditions afforded the 5-
endo cyclization product in decent yield but poor diastereoselectivity (97, 1.5:1), with each 
diastereomer having high enantioselectivity (90% and 89%). The absolute and relative 
stereochemistry of these two diastereomers was not known. Presuming that a trans 
relationship between the phenyl and iodine will exist, the source of the poor 
diastereoselectivity could either be poor alkene facial selectivity or poor nucleophile 
selectivity. To investigate, reductive deiodination was performed, and the diastereomers 
were separated into trans -d1 and cis 98-d2 (Figure 24). Phenyl Grignard addition to each 
diastereomer ablated the phosphorous stereocenters, leaving only chiral alcohol 99 behind. 
Upon optical rotation analysis, it was determined that trans -d1 produced (S)- 99 and cis 
98-d2 produced (R)-99. Therefore, the alkene stereocenter was the source of poor selectivity. 
The major diastereomer had configurations of (2S,4R,5R) and the minor (2S,4S,5S), with 
the stereocenter at phosphorous being conserved. From these results, it appears that the 
priority of stereoselectivity by BAM catalysis relies first on nucleophile control before alkene 
facial selectivity.  
These findings of high degrees of nucleophile control in BAM catalysis were quite 
surprising, and led to the investigation of nucleophile control in much more common 
substrates: carboxylic acids. 
 
Figure 24: Derivatization of 97 diastereomers to find the source of poor 
diastereoselectivity. 
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1.1.4 Activation of carboxylic acids in synthesis and nature 
 
Studies of chiral phosphoric acid activation mechanisms89 have resulted in a better 
understanding of their roles in both electrophile and nucleophile activation, and this 
knowledge has enabled their frequent use and derivatization in chemical synthesis.10 
Carboxylic acids are commonly used as catalysts90,51b and as substrates, however, studies on 
their mechanism have been relatively sparse.91,92 
List and coworkers have begun developing a catalytic activation mode for carboxylic 
acids by chiral phosphoric acids. Recognizing that bulky BINOL based phosphoric acids 
(TRIP, 45) cannot readily homodimerize, they hypothesized that small carboxylic acids 
could form heterodimers with them instead (Figure 25A).91a Their hypothesis was supported 
by the elucidation of a cocrystal structure of TRIP bound to acetic acid in the solid state. 
In solution, diffusion-ordered spectroscopy (DOSY) studies confirmed an increase in volume 
when the species were heterodimerized. A strong binding constant (Ka = 1948 M-1) between 
acetic acid and TRIP (100) was revealed by NMR titration studies, which is close to the 
binding constant of a carboxylic acid and quinidine (Ka = 1.9e4 M-1).93 The authors propose 
that this heterodimer could in fact raise the HOMO energy of the carboxylic acid by 
hydrogen bonding to the “basic” P=O functionality. However, an equally important 
interaction between the carboxyl C=O and the phosphoric acid OH could be argued to 
decrease the nucleophilicity of the carboxylic acid. The selectivity between carboxylate or 
phosphate addition to electrophiles is likely due to the greater steric hindrance about the 
phosphate. Ultimately, the fact that a stronger acid can activate a weaker acid towards 
nucleophilic addition is quite interesting. The asymmetric ring opening of meso-aziridines 
101 was accomplished in excellent yields and selectivities (99% ee, Figure 25B). As is 
depicted in Figure 25A, the dimer is proposed to protonate the aziridine and add carboxylate 
in a concerted fashion. The thermodynamically favorable heterodimer also acts to protect 
                                      
89 a) Champagne, P. A.; Houk, K. N. J. Am. Chem. Soc. 2016, 138, 12356. b) Duarte, F.; Paton, R. S. J. Am. Chem. 
Soc. 2017. c) Yang, C.; Xue, X. S.; Jin, J. L.; Li, X.; Cheng, J. P. J. Org. Chem. 2013, 78, 7076. d) Yang, C.; Xue, X. 
S.; Li, X.; Cheng, J. P. J. Org. Chem. 2014, 79, 4340. e) Simon, L.; Goodman, J. M. J. Am. Chem. Soc. 2008, 130, 
8741. f) Simon, L.; Goodman, J. M. J. Org. Chem. 2011, 76, 1775. 
90 a) Hashimoto, T.; Maruoka, K. J. Am. Chem. Soc. 2007, 129, 10054. b) Hashimoto, T.; Hirose, M.; Maruoka, K. J. 
Am. Chem. Soc. 2008, 130, 7556. c) Hashimoto, T.; Maruoka, K. Synthesis 2008, 2008, 3703. d) Hashimoto, T.; 
Uchiyama, N.; Maruoka, K. J. Am. Chem. Soc. 2008, 130, 14380. e) Hashimoto, T.; Kimura, H.; Maruoka, K. Angew. 
Chem., Int. Ed. 2010, 49, 6844. f) Hashimoto, T.; Nakatsu, H.; Takiguchi, Y.; Maruoka, K. J. Am. Chem. Soc. 2013, 
135, 16010. g) Hashimoto, T.; Gálvez, A. O.; Maruoka, K. J. Am. Chem. Soc. 2013, 135, 17667. 
91 a) Monaco, M. R.; Poladura, B.; Diaz de Los Bernardos, M.; Leutzsch, M.; Goddard, R.; List, B. Angew. Chem. Int. 
Ed. 2014, 53, 7063. b) Monaco, M. R.; Fazzi, D.; Tsuji, N.; Leutzsch, M.; Liao, S.; Thiel, W.; List, B. J. Am. Chem. 
Soc. 2016, 138, 14740. 
92 Hashimoto, T.; Kimura, H.; Nakatsu, H.; Maruoka, K. J. Org. Chem. 2011, 76, 6030. 
93 Lah, J.; Maier, N. M.; Lindner, W.; Vesnaver, G. J. Phys. Chem. B 2001, 105, 1670. 
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the catalyst from degradation, by preventing protonation and phosphate addition to 
electrophiles.  
 
Figure 25: Brønsted acid activation of carboxylic acids. 
Calculations of the stabilization free energies were performed on 1) a complex 
between TRIP and pyridine, and 2) a trimeric complex between TRIP, pyridine, and acetic 
acid (B3LYP/cc-pVTZ).91b The first complex was found to be 12 kcal/mol less stable than 
the second, trimeric complex. Within these computed structures, the heterodimer also 
displayed increased acidity compared to TRIP, as evidenced by the protonation of pyridine 
by the heterodimer, whereas full protonation of the pyridine is not observed by TRIP alone. 
The frontier molecular orbitals of the carboxylic acid were also found to be altered when 
heterodimerized with TRIP. The LUMO increased in energy by 0.08 eV, and the HOMO 
inceased by 0.25 eV, showing a greater increase in nucleophilicity than electrophilicity. 
Work conducted by a separate laboratory has found that an increase of negative charge on 
the phosphate oxygen has also been shown to stabilize transient positive charged 
intermediates in several transformations, and in ring openings of epoxides, this may 
contribute to the regioselectivity of nucleophilic attack.91,94 They also were able to minimize 
transition state structures where TRIP was simultaneously activating a nucleophile and 
electrophile.94a The increased understanding of this activation mode has allowed the reaction 
to applied to the enantioselective opening of meso-epoxides and the kinetic resolution of 
aziridines, epoxides, and chiral carboxylic acids.91  
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The carboxylic acid activation mode was used by the Tan group to achieve the first 
highly general three-component Passerini reaction (Figure 26A).95 They sought to apply 
List’s heterodimerization strategy between chiral phosphoric acid 102 and a carboxylic acid 
to simultaneously activate an aldehyde and isocyanide. The proposed mode of activation is 
depicted in Figure 26B, and is supported by studies of complexes in solution by 31P NMR. 
When the aldehyde was added to just catalyst 102, no significant shift of the phosphorous 
peak was observed. However, when either carboxylic acid or isocyanide was added, dramatic 
shifts were detected (0.85 and 1.03 ppm, respectively). When both acid and isocyanide were 
added to the catalyst, a larger shift of 1.54 ppm was observed. Ultimately, this carboxylic 
acid activation mode was able to control aldehyde facial selectivity as well as isocyanide 
addition. This reaction has a wide substrate scope, with aromatic and alkyl aldehydes, alkyl 
and aromatic carboxylic acids, and various isocyanides all providing products 103 in good 
yield and excellent enantioselectivities. 
 
 
Figure 26: Enantioselective Passerini reaction enabled by carboxylic acid activation. 
 The Maruoka group has heavily investigated the applications of carboxylic acids as 
“Brønsted acid-assisted Brønsted acid” catalysts.90 In one such investigation, an axially 
dicarboxylic acid catalyst, 104, was found to facilitate a highly enantioselective Mannich 
reaction of an imine with diazoacetates (Figure 27).92 Internal hydrogen bonding between 
the carboxylic acids serves two purposes: to generate a large dihedral angle of the binaphthyl 
junction by forming a 9-membered ring (93º versus 55º in TRIP), and to increase the acidity 
of one carboxylic acid by assistance from the second acid. These mechanistic characteristics 
as well as a proposed transition state are derived from a cocatalyst structure of 104 and 
pyridine.  
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Figure 27: Mauroka’s chiral dicarboxylic acid catalyst. 
 The use of carboxylic acids by enzymes is pervasive in nature, in large part due to 
the prevalence of amino acids in biological processes. In fact, a key step in the evolution of 
modern biology was the ability of ribozymes (RNA enzymes) to harness amino acids for 
peptide bond synthesis.96 The majority of enzyme catalyzed transformations of carboxylates 
is their deprotonation and phosphorylation, generating an active ester primed for 
nucleophilic acyl substitution, an example is in the conversion of glutamic acid to glutamine 
by glutamine synthetase (Figure 28A).97 Based on crystal structure data, multiple hydrogen 
bonds to nearby arginines and ionic bonding to magnesium position the substrate 
carboxylates and readies one for phosphorylation. An intriguing example, although not of 
carboxylate control but of carbamate control, is found in the enzyme dethiobiotin 
synthetase, which is the penultimate enzyme of the biotin biosynthetic pathway.98 
Diaminononanoic acid (105) is converted into dethiobiotin (106) by an ATP dependent 
carboxylase, dethiobiotin synthetase (Figure 28B). One of the amine substrates reacts with 
carbon dioxide to generate a carbamate intermediate, which is activated by ATP before 
subsequent cyclization. According to crystal structure data, this carbamate intermediate 
makes four hydrogen bonds. Significantly, one oxygen is accepting two neutral hydrogen 
bonds, and the other oxygen is accepting only one charge-assisted hydrogen bond. The 
authors note that the singly bound oxygen atom “is almost perfectly aligned for nucleophilic 
attack on the phosphorus atom.” This unique oxygen atom selectivity, combined with 
                                      
96 Polacek, N.; Mankin, A. S. Crit. Rev. Biochem. Mol. Biol. 2005, 40, 285. 
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previous enantioselective cyclizations of phosphoric acids (Figure 23), led to the search for 
a system to challenge BAM catalysis to selectively react one oxygen of a carboxylic acid.  
	
 
Figure 28: A) Enzymatic control of a carboxylate, and B) dethiobiotin synthetase 
selectively functionalizes one of the two oxygens in a carbamate.  
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1.2 Development of an enantioselective lactonization of symmetric 
carboxylic acids, and mechanistic evidence of Brønsted base catalysis 
 
1.2.1 Mechanistic proposal for enantioselection in cyclopentene carboxylic acids 
 
With the desymmetrization of prochiral phosphoric acid derivatives accomplished, 
the desymmetrization of prochiral carboxylic acids 107 by bisamidine methodology was 
investigated (Figure 29A).99 Cyclopentene carboxylic acids would offer a unique challenge 
to an organocatalyst for a stereoselective halocyclization. Since the molecule is symmetric 
through the carboxylic acid, a very subtle desymmetrization would be required for 
enantioselectivity. As shown in Figure 29B, upon deprotonation by a chiral Brønsted base 
(B:), chiral carboxylate (108) is generated. The enantiomer of product (109) produced is 
determined by which oxygen of the carboxylate adds to the alkene. Essentially, a catalyst 
must differentiate the carboxylate oxygens for enantioselectivity to be achieved. During the 
course of optimization, a secondary parameter for which a chiral catalyst must account was  
 
Figure 29: A) Iodocyclization of cyclopentene carboxylic acids, B) depiction of required 
oxygen atom selectivity for enantioselectivity, and C) added necessity of conformational 
restraint for success. 
                                      
99 Knowe, M. T.; Danneman, M. W.; Sun, S.; Pink, M.; Johnston, J. N. J. Am. Chem. Soc. 2018, 140, 1998. 
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discovered (Figure 29C). Two major orientations of the alkene relative to the carboxylate 
can be envisioned (108 and110). In 108, cyclization of the “left-hand” oxygen would lead 
to e1-109. Alternatively, if that same oxygen reacts with the alkene in the reversed 
conformation, then e2-109 would be the major enantiomer produced. In summary, oxygen 
differentiation and alkene conformation must be accounted for simultaneously. 
 
1.2.2 Initial investigation into reaction optimization 
 
The background reaction of 107 with NIS was determined to be minimal, delivering 
less than 5% yield due to poor conversion (Table 1, entry 1). Using 10 mol % of previously 
developed 14•HNTf2,37 iodolactone 109 was not able to be isolated (Table 1, entry 2). 
Increasing the reaction temperature from -20 ºC to 25 ºC allowed the production of an 
isolable amount of product, albeit in 16% ee (Table 1, entry 3). Changing to the free base 
form (14) produced 109 in 25% yield and 48% ee (Table 1, entry 4). The free base of the 
cyclohexane diamine-derived 13 performed much worse, producing racemic product in low 
yield (Table 1, entry 5). Returning to catalyst 14 at colder temperature increased to 62% 
ee (Table 1, entry 6).100 These results contradicted the electrophilic control hypothesis at 
the time (Figure 21A), but was a promising beginning nonetheless. 
 
Table 1: Exploratory experiments in the iodocyclization of 107. 
  
entry catalyst temp. (ºC) yield (%)a ee (%) 
1 none -20 <5 – 
2 14•HNTf2 -20 <5 – 
3 14•HNTf2 25 trace 16 
4 14  25 25 48 
5 13 (PBAM) 25 9 <5 
6 14 -20 50 62 
a Yield determined by 1HNMR analysis relative to an internal standard 
(CH2Br2). 
 
The impact of other solvents was then examined. Aprotic solvents typically have the 
most success in BAM catalysis, as they are unable to disrupt hydrogen bonding between 
catalyst and substrate. Toluene has traditionally been the optimal solvent for BAM 
catalysis, as it has a low freezing point, solubilizes BAM catalysts well, and is aprotic. It 
                                      
100 Absolute configuration determined by X-ray crystallography.  
Ph CO2H
O
O
I
Ph
10 mol % catalyst
NIS
toluene
-20 ºC
48 h
107 109
 35 
provided the product in promising yield and selectivity (Table 2, entry 1). Structurally 
similar xylenes showed diminished selectivity and yield (Table 2, entry 2). Dichloromethane 
has previously been found to increase reactivity in other lactonization systems,101 although 
this was not the case here (Table 2, entry 3). Polar variations of toluene, trifluoro-toluene 
(Table 2, entry 4) and anisole (Table 2, entry 5) were drastically inferior. Increasing the 
reaction concentration from 0.05 M to 0.2 M did increase conversion and yield, however the 
enantioselectivity suffered (Table 2, entry 6). Thus, toluene was the solvent of choice 
moving forward.  
Table 2: Screening of solvent conditions 
 
entry solvent conc. (M) conv. (%)a yield (%) ee (%) 
1 toluene 0.05 79 50 62 
2 xylenes 0.05 82 27 47 
3 CH2Cl2 0.05 70 15 11 
4 CF3Ph 0.05 69 13 7 
5 anisole 0.05 52 3 <5 
6 toluene 0.2 91 58 46 
a Conversion and yield determined by 1HNMR analysis relative to an internal 
standard (CH2Br2). 
 
Next, an examination of halogenating agents was undertaken. N-Iodosuccinimide had 
already been determined to provide decent yield and selectivity (50% and 62%, respectively; 
Table 3, entry 1). Bromonium sources were also screened, with neither N-bromosuccinimide 
nor dibromodimethylhydantoin producing product 111 with enantioselection (Table 3, 
entries 2 and 3). N-Chlorosuccinimide was even less reactive and did not yield enough 
product (112) to measure enantioselectivity (Table 3, entry 4). As a result, other iodionium 
sources had to be evaluated. Diiododimethylhydantoin gave slightly worse results relative 
to NIS (Table 3, entries 5 and 1). Unlike Jacobsen’s methodology, the addition of a catalytic 
amount of elemental iodine to NIS did not enhance the selectivity either (34% yield, 38% 
ee; Table 3, entry 6).61 An iodine source that showed promising results in an enantioselective 
7-exo iodolactonization, (diacetoxyiodo)benzene and potassium iodide, was not electrophilic 
enough to convert the starting material at room temperature (Table 3, entry 8). Finally, 
the slightly larger and more electrophilic iodonium source, N-iodophthalimide, was tested 
and found to have an increased reaction rate and enantioselectivity after just 24 hours (36% 
                                      
101 Johnston et al., unpublished work. 
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yield, 69% ee; Table 3, entry 9). This easily prepared and handled iodonium source was 
found to be ideal for this lactonization.102  
 
Table 3: Enantioselective halolactonizations: Evaluation of halogen sources. 
 
Entry X+ source 
Conv. 
(%)a 
Yield 
(%) 
ee 
(%) 
1 NIS 79 50 62 
2 NBS 34 7 <5 
3 DBDMH 56 <5 – 
4 NCS 14 <5 – 
5 DIDMH 49 41 52 
6 NIS/10 % I2 85 34 38 
7 I2/KI 13 8% – 
8b PIDA/KI 0 – – 
9c N-iodophthalimide 42 36 69 
a Conversion and yield determined by 1H NMR analysis 
relative to an internal standard (CH2Br2). b Reaction 
temperature = 25 ºC. c Reaction time = 24 h. 
 
Since it appeared that none of the other reaction conditions tested had a significant 
impact on enantioselectivity, catalyst structure was examined next. Since the change from 
cyclohexane diamine backbone to stilbene diamine was so drastic (Table 1, entries 4 and 
5), other chiral diamine backbones were tested (Table 4). When ortho-methyl substituents 
were installed on the phenyl rings of stilbene diamine, the reaction was not drastically 
impacted, resulting in a slightly increased rate and decreased enantiomeric excess (33% and 
57%, respectively; Table 4, entry 2, 113). Changing from phenyl rings to 1-naphthyl rings 
proved to be too sterically encumbered, with 114 leading to much lower yield (9%) and 
further diminished selectivity (43%, Table 4, entry 3). The less conformationally flexible 
anthracenyl diamine catalyst, 115, showed poor reactivity and selectivity (Table 4, entry 
4). The binaphthyl diamine catalyst 116 had moderate reactivity but produced essentially 
racemic product (Table 4, entry 5). 
  
                                      
102 Artaryan, A.; Mardyukov, A.; Kulbitski, K.; Avigdori, I.; Nisnevich, G. A.; Schreiner, P. R.; Gandelman, M. J. Org. 
Chem. 2017, 82, 7093. 
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Table 4: Effect of catalyst diamine backbone structure on yield and selectivity. 
 
a Conversion and yield determined by 1H NMR analysis relative to an internal standard (CH2Br2). 
 
 Continuing forward with stilbene diamine as the chiral backbone, the electronics of 
the appended quinoline rings were examined next. Catalysts 14b-14e were prepared and 
tested in the iodolactonization reaction (Table 5). The least electron-rich 14b performed 
better than 4-MeO bearing 14c (17% ee vs. no product, Table 5, entries 1 and 2). More 
electron-rich catalysts, 14d and 14e, did not outperform 14a either (Table 5, entries 4 and 
5). Adding a 7-MeO substituent decreased the enantioselectivity to 21%, whereas adding 
methoxy substituents at the catalyst 6- and 7-positions rescued some of the selectivity (45% 
ee). No clear significance can be drawn from these results, except that pyrrolidine appears 
necessary, and a substituent at the catalyst 6-position may be able to increase selectivity 
slightly. The catalyst activity may be more controlled by quinoline steric changes. 
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Table 5: Impact of catalyst’s quinoline electronic character on enantioselectivity. 
 
a Conversion and yield determined by 1H NMR analysis relative to an internal standard (CH2Br2). 
 
 A series of catalysts substituted around the quinoline rings were then synthesized 
and used in the reaction (Table 6). A 3-methyl substituent on the catalyst hampered 
reactivity and selectivity (14f, Table 6, entry 1). Methyl substitutions at the 5- and 7-
position entirely inhibited reactivity, possibly due to the A1,3 strain of the 5-methyl 
substituent forcing the pyrrolidine nitrogen out of conjugation with the quinoline ring, 
effectively decreasing basicity of the catalyst (14g, Table 6, entry 2,). Additionally, 
substituents at the 7-position did not perform well previously (see Table 5, entry 4).  
Table 6: Steric effects of quinoline substituents on the reaction outcome. 
 
a Conversion and yield determined by 1H NMR analysis relative to an internal standard (CH2Br2). 
Installation of an 8-methyl substituent (14h) allowed for some product formation, though 
it was nearly racemic (Table 6, entry 3,). Surprisingly, a tert-butyl group at the quinoline 
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6-position (14i) showed improved performance over StilbPBAM (14a), increasing 
enantiomeric excess from 62% to 68% (Table 6, entry 4,). This 6-position appeared to be 
very far from the reactive site, and its role was unclear until a later time. When combined 
with the optimized iodine source, N-iodophthalimide, catalyst 14i further increased 
selectivity to 75% ee. The similar 6-phenyl catalyst, 14j, performed equally well (74% ee, 
Table 6, entry 5).  
Table 7: Commercially available organocatalysts in the desymmetrization of 107. 
 
a Conversion and yield determined by 1H NMR analysis relative to an internal standard (CH2Br2). 
 Other organocatalysts that have previously had success in halocyclizations were 
screened for comparative analysis. Commercially available (DHQD)2PHAL and 
(DHQD)2AQN were both tested, but neither one was able to convert the starting material 
(Table 7, entries 1 and 2). Cinchonidine was also unable to catalyze the reaction (Table 7, 
entry 3). Quinidine was only able to catalyze the reaction when run at room temperature, 
yielding a small amount of racemic product (Table 7, entry 4). Finally, Takemoto’s 
bifunctional thiourea catalyst also failed to promote the reaction.  
A range of 2,2’-substituted chiral phosphoric acid catalysts were examined, due to 
their previous success in activation of carboxylic acids (Table 8).91 Unfortunately, the bulky 
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tri-iso-propyl phenyl catalyst (45, TRIP) was unable to catalyze the reaction at -50 ºC or 
even at 25 ºC (Table 8, entries 1 and 2). The 9-anthracenyl and 9-phenanthrene catalysts, 
117 and 118, also did not catalyze the reaction (Table 8, entries 3 and 4). Interestingly, 
the 4-MeO-2,6-dimethyl-phenyl substituted catalyst 119 was capable of producing enough 
iodolactone product for HPLC analysis (Table 8, entry 5), but the product was racemic. 
VAPOL hydrogen phosphate (120) was also unable to catalyze the reaction (Table 8, entry 
6). 
Table 8: Attempts to employ commercially available phosphoric acid catalysts.  
 
a Conversion and yield determined by 1H NMR analysis relative to an internal standard (CH2Br2). 
 
With only minor improvements made through steric modification of the catalyst, 
alterations to the N-iodophthalimide iodine source were again examined (Table 9). 
Electron-poor variations, such as a 5-fluoro and 5-nitro derivatives performed worse (58% 
and 35% ee, respectively; Table 9, entries 2 and 3) compared to N-iodophthalimide. 5-
Methyl-N-iodophthalimide actually showed an increase in rate but with diminished 
enantiomeric excess (69%, Table 9, entry 4). More significant changes were explored, but 
N-iodoisatin and N-iodosaccharin were unable to afford the product (Table 9, entries 5 
and 6). N-Iodopyrrolidinone was also unable to improve upon the already optimized 
results (Table 9, entry 7). Additional options to examine seemed to be exhausted, so 
insight into the catalyst and substrate interactions was sought in order to inspire new 
hypotheses. 
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Table 9: Screening iodine sources based on N-iodophthalimide 
 
a Conversion and yield determined by 1H NMR analysis relative to an internal standard (CH2Br2). 
 
1.2.3 X-Ray crystallographic analysis of a catalyst•substrate (14•107) complex 
 
After exhausting these variables to optimize enantioselection without compromising 
the yield, attempts were made to cocrystallize the substrate and catalyst in order to obtain 
an X-ray structure. A 1:1 ratio of substrate 107 and catalyst 14 were dissolved in 
dichloromethane, a layer of hexanes was gently added on top, and the two were allowed to 
slowly diffuse in a sealed vial. A single crystal was formed and the structure was solved by 
Maren Pink (Indiana University Molecular Structure Center) (Figure 30). The structure 
obtained revealed a new mode of binding that had not been hypothesized previously. 
Immediately obvious is the presence of three hydrogen bonds between the carboxylate and 
the catalyst. The two hydrogen bonds from one amidine is consistent with previous 
hypotheses, however the extra hydrogen bond donor is unexpectedly positioned by the twist 
of the second amidine. The catalyst must be realizing a moderate level of enantioselectivity 
by donating two hydrogen bonds to one oxygen (N1-H1—O1 and  N2-H2—O1, Table 10, 
entries 1 and 2) and only one hydrogen bond to the other one oxygen (N3-H3—O2, Table 
10, entry 3). The singly bound oxygen may be more nucleophilic than the doubly bound 
oxygen, leading to its enhanced reactivity, however this is a difficult hypothesis to test. In 
this crystallized conformation, cyclization of the singly bound oxygen would lead to the 
major enantiomer of the product. It must be stated that a solid-state conformation does not 
necessarily depict the conformation in solution, and all conclusions derived from a crystal 
structure need additional evidence for substantiation. Nevertheless, this unexpected binding 
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pattern gave physical evidence as to how BAM catalysis could achieve oxygen differentiation 
of the carboxylic acid (see Figure 29B). This crystal structure also provided a basis to 
further improve the enantioselectivity. 
 
Figure 30: X-Ray co-crystal structure of substrate 107 bound to catalyst 14 (some 
hydrogens omitted for clarity).  
Table 10: Hydrogen bond distances and angles. 
 
 
entry bond N-H (Å) O-H (Å) N-O (Å) N-H-O (º) 
1 N1-H1—O1 0.89 2.04 2.904 163 
2 N2-H2—O1 0.85 1.96 2.812 175 
3 N3-H3—O2 0.94 1.71 2.647 174 
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 Based on the absolute configuration of the product, the mechanism of product 
formation could be proposed (Figure 31A). In order to form the major enantiomer, the 
singly bound oxygen will cyclize onto the alkene which is oxidized by iodonium. The cause 
of the poor enantioselectivity remained hidden, though. Assuming good selectivity for 
differentiation of oxygen atoms, a possible explanation for moderate enantioselection was 
that the alkene conformation was not as restricted as it appeared in the crystal structure. 
As was alluded to before, the substrate could bind to the catalyst with the alkene forward 
(as shown in Figure 31A) or with the phenyl forward and the alkene behind (illustrated in 
Figure 29C). To address this, the catalyst structure was examined for areas that may  
  
Figure 31: A) Proposed mechanism for formation of the major enantiomer, and B) 
possible cause of poor enantioselectivity by catalyst 14, and potential catalyst 
modifications to improve selectivity. 
influence the conformation of the substrate. Fortunately, due to the third hydrogen bonding 
N-H, one quinoline is twisted with the 4-pyrrolidyl substituent pointing near the substrate 
(Figure 31B). This substituent may exert a small influence but may not be large enough to 
effectively discriminate between the two possible alkene conformations, leading to only 
moderate enantioselectivity. From this observation, larger pyrrolidine surrogates were then 
installed and tested. 
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1.2.4 Hypothesis driven catalyst structure optimization 
 
The catalyst-substrate cocyrstal was used as a rational guide to test catalyst 
derivatives for improved selectivity in this iodolactonization reaction (Table 11). These 
investigations were initially undertaken on the more readily accessible 4-Cl precursor to 
catalyst 14a, as opposed to the more precious 4-Cl, 6-tBu precursor to the optimal 14i. 
Larger heterocyclic rings were surveyed, with piperidine and azepine being installed at the 
4-position. Piperidine-containing catalyst 121 demonstrated poorer reactivity and 
selectivity than its pyrrolidine counterpart, 14a (Table 11, entries 1 and 2). 122, with a 4-
azepine group, had similar reactivity issues but higher enantioselectivity than expected (51% 
ee, Table 11, entry 3). Larger rings did not appear beneficial to the reaction, so groups with 
more flexibility were examined next. Acyclic, dialkyl amines (diethyl amine, dibenzyl amine) 
were attempted to be installed at the catalyst 4-position. These amines were not nucleophilic 
enough, however, to accomplish the desired SNAr reaction and yield the desired catalysts. 
By chance, p-anisidine was installed in the 4-position. Catalyst 123 was anticipated to have 
lower reactivity than 14a, because of the weaker electron donating ability of an aniline 
nitrogen compared to a pyrrolidine nitrogen. Surprisingly, this catalyst performed much 
better than ever expected (Table 11, entry 4). The enantiomeric excess was 49%, slightly 
lower than the pyrrolidine based catalyst. However, the yield of product over the course of  
Table 11: Catalysts with larger substituents at the quinoline 4-position. 
 
a Conversion and yield determined by 1H NMR analysis relative to an internal standard (CH2Br2). 
one day was almost double that produced by 14a over two days. The cause of this drastic 
increase in reaction rate still remains unclear. One would expect a less basic catalyst to be 
a worse activator of a carboxylic acid, yet this is not the case. This increased rate also 
opened the possibility for future tests at lower temperatures. Additionally, a wide range of 
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anilines were commercially available for further examination, in hopes of finding an aniline 
substituent to deliver high selectivity with increased rate.  
Using the readily accessible 4-Cl StilbBAM precursor, 124,37 a small library of 
aniline-substituted catalysts could be quickly produced (Figure 32). Trifluoroacetic acid was 
required to enhance the electrophilicity of the 4-Cl quinoline, and upon heating in a sealed 
vessel the products were generated. After base washing, the catalysts were tested without 
further purification. Changing from p-anisidine to o-anisidine maintained selectivity and 
lowered the reactivity (123a to 123b; Table 12, entries 1 and 2). Decreasing in electron 
richness, aniline catalyst 123c did not react quite as well, but the selectivity increased to 
61% ee (Table 12, entry 3). This added selectivity was comparable to the pyrrolidine 
substituted catalyst (61% versus 62% ee, see Table 11, entry 1), and the yield was still 
significantly higher (64%). Less electron rich p-CF3- and 3,5(CF3)2-aniline derivatives were 
also tested (123d and 123e, respectively). The yields continued to drop as the electron 
density of the aniline was lowered (62% and 41% yield, Table 12,  entries 4 and 5). 
Selectivity for 123d remained high (59% ee, Table 12, entry 4), but for the most electron 
poor 123e, enantiomeric excess dropped to 20% (Table 12, entry 5). A trend from this data 
is not obvious, however it appears that extremely electron rich or deficient substituents are 
not helpful, and that p-substituted anilines may be sterically beneficial.  The sterically 
demanding 9-anthracenyl amine substituent was also tested (Table 12, entry 6), providing 
comparable results to the undecorated aniline 123c in entry 3 (Table 12). This catalyst was 
problematic to synthesize and prone to decomposition, so it was not pursued further. The 
triflimidic acid salt, 123•HNTf2, was found to have similar reactivity and lower 
enantioselectivity (56% and 43%, respectively, Table 12, entry 7).  The enhanced rate of  
  
Figure 32: Synthesis of aniline-based catalysts. 
these aniline catalysts provoked the synthesis of methylated catalyst, 123h. The extra N-
H donor from the aniline may play a role in substrate binding that allows for higher yield 
and selectivity. The yield and enantiomeric excess were significantly lowered with this 
catalyst (Table 12, entry 8). Removal of the N-H donor or the added steric element was 
detrimental to the reaction.  
 With the p-anisidine substituents (123a) and aniline (123c) providing the best 
results, these were combined with previously impactful catalyst changes, namely 
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substitution at the quinoline 6-position (Table 6). Adding a phenyl substituent at the 6-
position (catalyst 125a, Table 13, entry 1) increased the enantiomeric excess from 49% to 
62% (compare Table 12, entry 1). This effect was even greater when combined with the 
aniline (125b), seeing the selectivity rise to 78% from 61% and the yield rise from 64% to 
87% (Table 13, entry 2). With such high reactivity being achieved, catalyst 125b was next 
tested at -40 ºC for 48 h, and the selectivity increased to 83% ee (Table 13, entry 3). At 
these same conditions, a 6-tert-butyl substituted catalyst, 126a, provided a slight boost in 
enantiomeric excess (Table 13, entry 4). This catalyst was combined with the optimal iodine 
source, N-iodophthalimide, to further increase selectivity to 87% ee (Table 13, entry 5). For 
comparison, 6-tert-butyl StilbPBAM (14i) could only yield 34% of the product in 68% ee 
(Table 13, entry 6). Overall, a substitution at the 6-position of the quinoline had a 
cooperative effect with the 4-aniline substituent, increasing the selectivity. The increased  
Table 12: Results from screening aniline derivatives at the catalyst 4-position. 
 
a Conversion and yield determined by 1H NMR analysis relative to an internal standard (CH2Br2). 
reaction rate from the aniline group allowed the reaction to be run for reasonable lengths 
at colder temperatures to further increase selectivity without sacrifice to conversion.  
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Table 13: Combination of 4-aniline and quinoline 6-substitutions. 
 
a Conversion and yield determined by 1H NMR analysis relative to an internal standard (CH2Br2). 
These catalysts performed well even at -50 ºC, breaking the 90% enantiomeric excess 
threshold (Table 14, entry 1). Since substituents at the para position of the aniline appeared 
to impact the reaction, a small study of p-anilines was performed to find the right balance 
of electronics and sterics. A large, tert-butyl substituted aniline was installed in catalyst 
126b, however the selectivity dropped to 85% ee (Table 14, entry 2). p-Fluoro aniline was 
then examined, since it is more electron rich than aniline and has no added steric influence,  
Table 14: Impact of para aniline substituents on reaction outcome. 
 
a Conversion and yield determined by 1H NMR analysis relative to an internal standard (CH2Br2). b Reaction stirred in a 2-5 mL 
round bottomed vial for 24 h. 
and the yield and selectivity rose (126c, 72% yield, 92% ee, Table 14, entry 3). Then p-
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have more steric bulk. We were excited to see that it showed an increase in yield (79%) and 
enantiomeric excess (93%, Table 14, entry 4). After a screen of reaction vessels, a round-
bottomed microwave vial provided faster conversion compared to the previously used, flat-
bottomed storage vials. The more efficient stirring in a microwave vial yielded the product 
in 83% after 24 hours, and the enantiomeric excess increased to 94% as well (Table 14, 
entry 5). 
 
1.2.5 X-Ray crystallographic analysis of a catalyst•substrate (126d•14a) complex 
  
The X-ray co-crystal structure of the cyclopentene carboxylic acid substrate bound 
to StilbPBAM (14a) provided a rationale for how moderate enantioselectivity was being 
achieved by oxygen atom differentiation of the carboxylate (Figure 30). It also provided a 
foundation on which to build hypotheses for the improvement of enantioselectivity. Most 
clear of these was that the alkene conformation of the substrate appeared to be too flexible 
(Figure 29C and Figure 31B). The 4-position of the catalyst seemed conveniently oriented 
near the substrate, and it could be easily modified to build a library of catalysts for 
screening. Led by this hypothesis, aniline substituents were found to provide the highest 
reactivity. Combined with a 6-substituent on the quinoline and fine-tuning of the aniline 
structure, optimized catalyst 126d was developed. It is able to desymmetrize carboxylic 
acid 107 in 83% yield and 94% ee (Table 14, entry 5). 
These optimized results were consistent with the hypothesis that led to catalyst 
126d. A second co-crystal structure of substrate 107 and catalyst 126d would further test 
this hypothesis. This catalyst and substrate were combined in a 1:1 ratio, and 
recrystallization conditions were tested. A single co-crystal of sufficient quality was obtained 
when the complex was dissolved in dichloromethane and heptanes was gently layered on 
top to allow slow diffusion (Figure 33). A surprisingly similar structure of this complex to 
that of the suboptimal catalyst and substrate was revealed (compare Figure 30). The 
substrate orientation relative to the catalyst is the same between the two co-crystal 
structures. The dihedral angles of the catalyst backbones in both structures were nearly 
identical (166º and 167º). An analogous hydrogen bonding network (two hydrogen bonds 
to one oxygen and one hydrogen bond to the other oxygen) is present, indicating a similar 
mechanism of carboxylate desymmetrization is still operative. In fact, all of the hydrogen 
bond distances and angles are remarkably similar (Table 15, compare to Table 10). The 
major differences arise from the added 4-aniline and 6-tert-butyl functionalities. The tert-
butyl may serve to limit the rotational freedom of the 4-subtituent, forcing it closer to the 
substrate pocket. The aniline is clearly much closer to the substrate than the pyrrolidine 
was in Figure 30. The substrate alkene also appears to be rotated away from the steric 
influence of the aniline. The role of the aniline N-H is not clear in this crystal structure, if 
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it is somehow serving to accelerate the reaction. It should be noted that this N-H does 
participate in hydrogen bonding with another catalyst-substrate structure, binding to the 
free quinoline nitrogen of another unit. This additional hydrogen bonding between unit cells 
is not possible, and is therefore not observed, in the cocrystal structure of 14a•107.  
  
 
Figure 33: X-Ray co-crystal structure of 107 bound to catalyst 126d (some hydrogen 
atoms omitted for clarity). 
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Table 15: Hydrogen bond distances and angles. 
 
 
entry bond N-H (Å) O-H (Å) N-O (Å) N-H-O (º) 
1 N1-H1—O1 0.90 2.07 2.919 157 
2 N2-H2—O1 0.97 1.82 2.786 173 
3 N3-H3—O2 0.96 1.76 2.703 167 
 
 
Figure 34: Front view of co-crystals of 126d•107 (cyan) and 14a	•107 (grey) overlayed. 
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 To more effectively compare and contrast the two catalyst-substrate co-crystal 
structures, they were overlayed and aligned along the three nitrogen atoms of the hydrogen 
bond network (front view, Figure 34; top view, Figure 35; side view, Figure 36). The front 
and side views show the remarkable similarity between these two separate co-crystal 
structures (Figure 34 and Figure 36). The top view makes the relative positional differences 
of the substrates bound to their respective hydrogen bond networks especially evident, with 
the aniline catalyst appearing to “push” the substrate away. It is hypothesized that this 
added influence, which twists the substrate just a few extra degrees, was essentially 
responsible for increasing enantiomeric excess from the 60’s to the 90’s. The energy 
difference between substrate binding with alkene forward and binding with the alkene 
behind was likely increased by the aniline substituent of 126d. Density functional theory 
calculations have been undertaken to investigate this hypothesis.  
 
Figure 35: Top view of co-crystals of 126d•107 (cyan) and 14a	•107 (grey) overlayed. 
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Figure 36: Side view of co-crystals of 126d•107 (cyan) and 14a	•107 (grey) overlayed. 
In summary, the hypothesis derived from the initial co-crystal structure enabled the 
development of optimized catalyst, (R,R) 126d, from catalyst 14a (Figure 37). Including 
additional optimization of iodine sources, temperature, and reaction container, the reaction 
was optimized to 86% yield and 94% ee. The optimized catalyst was also co-crystallized, 
and its structure supports the original hypothesis of the origins of enantioselectivity in this 
application of BAM catalysis. The broader implications of this work toward other BAM 
catalyzed reactions is still being realized.  
 
 
Figure 37: Summary of reaction optimization by catalyst developement. 
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1.2.6 Analysis of the scope and limitations of the desymmetrization of a carboxylic acid 
 
With an optimized reaction system in hand, exploration of its substrate scope was 
carried out. A summary of the synthesis of most substrates is in Figure 38. For the synthesis 
of aryl-cyclopentenecarboxylic acids, a range of commercially available aryl-acetate esters 
were treated with sodium hydride before bis-alkylation by cis-1,4-dichloro-2-butene (Figure 
38A). The second, intermolecular alkylation step can either occur by an SNi mechanism to 
create the desired 5-membered ring, or it can cyclize via an SNi’ mechanism to generate a 
cyclopropane byproduct. This undesired cyclopropane is generally formed in about 10%, 
and recrystallization of the final carboxylic acid was typically able to remove it. Synthesis 
of alkyl substrates were straightforward (Figure 38B). Commercially available 3-
cyclopentenecarboxylic acid could be doubly deprotonated by LDA, addition of an alkyl 
halide electrophile and acidic workup furnished the desired alkyl-cyclopentenecarboxylic 
acids. Ester substrates were synthesized from LDA deprotonation of 3-
cyclopentenecarboxylic esters before quenching by carbon dioxide (Figure 38C).  
 
 
Figure 38: Synthesis of A) aryl-, B) alkyl-, and C) ester-cyclopentene carboxylic acid 
substrates. 
 Synthesis of more exotic symmetric carboxylic acid substrates is reported in Figure 
39. In an effort to test the viability of this methodology on other ring sizes, phenylacetic 
acid was doubly alkylated by 4-bromo-1-butene in 14% yield over two steps (Figure 39A). 
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Diene 127 was then subjected to ring closing metathesis, producing cycloheptene 128 in 
nearly quantitative yield. A substrate with two symmetric alkenes was also desired. Benzoic 
acid was subjected to Birch reduction followed by addition of benzyl bromide to generate 
cyclohexadienecarboxylic acid 129 in good yield (Figure 39B). An attempt was made to 
explore alkene substitution with tetrasubstituted alkene substrate 130 (Figure 39C), 
however neither the Grubbs II nor the Stewart-Grubbs103 catalysts could not promote the 
ring closing methathesis of these hindered alkenes.  
 
 
Figure 39: A) synthesis of a phenyl-cycloheptene carboxylic acid substrate; B) synthesis 
of a symmetric, cyclohexadiene carboxylic acid substrate; C) attempt to synthesize a 
tetrasubstituted cyclopentene carboxylic acid. 
                                      
103 Stewart, I. C.; Douglas, C. J.; Grubbs, R. H. Org. Lett. 2008, 10, 441. 
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Overall, the substrate scope revealed a wide tolerance of substituents. Aryl 
substituents generally performed the best, perhaps due to the reaction optimization on 
phenyl-cyclopentenecarboxylic acid 107a. This phenyl substrate could be used on a 1.00 
mmol scale, delivering the product 109a with a longer reaction time and no loss of 
enantiomeric excess (Table 16, entry 2). A larger, 2-naphthyl substrate was amenable to 
the reaction conditions, delivering 109b in 78% yield and 90% ee (Table 16, entry 3). The 
extremely hindered 1-naphthyl substrate revealed a limitation of this methodology, forming  
Table 16: Performance of aryl substrates in the iodolactonization of symmetric carboxylic 
acids. 
  a Isolated yields reported on 0.10 mmol reaction scale. b 1.00 mmol reaction scale. 
iodolactone 109c in much poorer enantiomeric excess (67%, Table 16, entry 4). Meta-chloro 
and para-bromo phenyl substitutents performed well under the reaction conditions (89% ee 
and 89% ee, Table 16, entries 5 and 6). The electron rich p-methoxyphenyl iodolactone, 
107f, was also produced in decent yield and 91% ee (Table 16, entry 7). The electron poor 
107g, bearing a p-nitrophenyl group, required a five-day reaction time to furnish 78% of 
product in good enantioselectivity (86%, Table 16, entry 8). Biphenyl substrate 107h 
reacted slower, but yielded 109h in 94% ee (Table 16, entry 9). Finally, the heterocyclic 
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substrate 107i reacted well despite the oxidative reaction conditions (69% yield, 92% ee; 
Table 16, entry 10). 
 Alkyl substrates also performed well in the reaction, albeit in slightly lower 
enantioselectivities. Isopropyl-cyclopentenecarboxylic acid was efficiently converted to 
iodolactone 109j in 74% yield and 87% ee (Table 17, entry 1). The benzyl and methyl 
substrates both yielded 66% of product in good enantiomeric excesses (87% and 86% 
respectivel, Table 17, entries 2 and 3). tert-Butyl ester lactone, 109m, was formed with 
poor selectivity (64% ee, Table 17,  entry 4). Interestingly, the slightly larger tert-butyl 
thioester lactone 109n was delivered in 10% higher enantioselectivity (74% ee, Table 17,  
entry 5). The cyclizations of 3-cyclopentenecarboxylic acid (where R = H) and cyano-
cyclopentenecarboxylic acid (where R = CN) could not be accomplished (Table 17, entries 
6 and 7). It appears that successful substrates require some degree of ground state 
destabilization. The substituent of the substrate forces the carboxylic acid closer to the 
alkene, predisposing it to cyclization. If the substituent, R, is too small, then poor reactivity 
and possibly poor selectivity can be expected.  
 
Table 17: Performance of alkyl and ester substrates in the iodolactonization of symmetric 
carboxylic acids. 
 
a Isolated yields reported on 0.10 mmol reaction scale. 
 
 Several other interesting substrates were screened. Alkenyl substrate 131 was 
synthesized to test the relative reactivity of the cis-alkene and the monosubstituted alkene 
(Figure 40A). Needless to say, all conversion of starting material was 5-exo cyclization upon 
the monosubstituted alkene. This byproduct, 132, was produced in relatively high 
enantioselectivity (79% ee) compared to typical yields on monosubstituted alkenes by BAM 
catalysis. The reason for this selectivity is unclear, as both alkenes are 5 atoms away from 
the nucleophile, and the cis-alkene ought to be more electron rich. Cyclohexadiene 
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carboxylic acid 133 could undergo exclusively 4-exo cyclization to deliver 134 in 57% yield 
and 72% ee (Figure 40B). If the reaction was run using a different catalyst or at higher 
temperatures, an inseparable mixture of 4-exo and 5-endo products is formed. This product 
was assigned as the 4-exo product by HMBC analysis. Additionally, 134 is slightly unstable 
at room temperature and isomerizes to the 5-endo product, losing enantiomeric excess in 
the process. The ability of the catalyst to discriminate between two alkenes was gratifying 
to discover, and opens future avenues in which this catalysis can be further investigated. 
The cycloheptene carboxylic acid 135 was submitted, and it yielded the [3.2.2] bicyclic 
lactone 136 in 79% yield but only 39% ee (Figure 40C). The high reactivity was surprising, 
and the greater alkene flexibility in this ring size likely lead to less conformational control 
than in the cyclopentene case. Additionally, the previously used 1,1-disubstituted alkene  
 
Figure 40: Compatibility of methodology with A) alkene, B) diene, C) heptene, and D) 
1,1-disubstituted alkene substrates.  
substrate (48) was found to react completely in 24 hours, with a slight preference for the 
minor enantiomer (99% yield. -14% ee, Figure 40D).37 Since the free base BAM catalyst did 
not perform well in this system before, the triflimidic acid salt of 126d was used, and it 
also provided nearly quantitative yield but with high enantioselectivity for the other 
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enantiomer (80% ee, Figure 40D). This is an interesting result, and it appears to support 
the hypothesis that the protonated catalysts are beneficial for 1,1-disubstituted alkenes. 
The Z-alkene substrates are not aided by the acid addition, however. 
 
1.2.7 Mechanistic investigations of the enantioselective desymmetrization of carboxylic acids 
 
The effect of weak acid additives and strong acid additives was examined. This was 
conducted to determine if the free base of catalyst 126d was really the most efficient 
catalyst (Table 18). A range of equivalents from one half to eight of the weakly acidic 
benzoic acid was added relative to the catalyst. Increasing benzoic acid amounts steadily 
decreases the selectivity of the catalyst (Table 18, entries 2-5). At eight equivalents of 
benzoic acid, the reactivity if finally impacted, dropping to 52% yield and 75% ee (Table 
18, entry 6). These results contrast with the impact of a strong acid additive. One equivalent 
of triflimidic acid relative to the catalyst does not impact the reactivity of the catalyst and 
only diminishes the selectivity by 6% (Table 18, entry 7). The doubly protonated catalyst 
126d•(HNTf2)2 was unable to promote the reaction (Table 18, entry 8). This appears to 
indicate that protonation of the free quinoline does not significantly alter the catalyst mode 
of action. A weakly acidic additive, like benzoic acid, may be exchanged for the weakly 
acidic substrate carboxylic acid, whereas the strongly acidic additive cannot exchange with 
the substrate. These findings are consistent with the hypothesis that the free base of the 
catalyst is operative. 
  
Table 18: Effect of acidic additives on the reaction outcome. 
 
entry (acid)x yield (%)a ee (%) 
1 None 83 94 
2 (PhCO2H)1/2 85 88 
3 (PhCO2H)1 89 88 
4 (PhCO2H)2 85 81 
5 (PhCO2H)4 87 80 
6 (PhCO2H)8 52 75 
7 (HNTf2)1 85 88 
8 (HNTf2)2 <5 – 
a Yield determined by 1HNMR analysis relative to an internal 
standard (CH2Br2). 
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The catalyst could also hypothetically play two distinct roles in catalysis by involving 
two catalyst molecules in the enantiodetermining step. To investigate this, a non-linear 
effect study was conducted (Figure 41).104 Batches of varying enantiopurities of catalyst 
126d were prepared by combination of (R,R)- and (S,S)- 126d. Since a linear correlation 
of catalyst % ee and product % ee was observed, there is no evidence of two catalyst 
molecules participating in the enantioselective step. If two catalyst molecules are involved 
in the enantioselective step, a positive enhancement (an upward curve the line) or negative 
impedance (a downward curve of the line) of the product ee can be observed relative to the 
ee of the catalyst batch (i.e. 50% ee catalyst delivering 90% ee product). This arises from a 
difference in rates between a “homodimeric” catalyst species (i.e. two (R,R) catalysts) and 
to a “heterodimeric” catalyst species (i.e. an (R,R) catalyst and a (S,S) catalyst), indicating 
the presence of two catalysts in the selective step. However, no evidence for multiple catalyst 
molecules was found in this case. 
 
 
Figure 41: Non-linear effect study of the iodolactonization reaction with catalysts of 
varying enantiopurities. 
Caution is required when information about reactive conformations is derived from 
crystal structures. Due to crystal packing in the solid state, positions and orientations can 
deviate from the actual, reactive conformations in solution. A useful technique to 
compliment the visual information from an X-ray structure is isothermal titration 
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calorimetry (ITC).105 ITC is most commonly used to measure protein-ligand interactions, 
however it is also occasionally applied to investigate small molecule catalyst-substrate 
binding.106 In ITC, a known amount of a compound is loaded into a calorimetry cell, and a 
known amount of another compound is sequentially titrated into the calorimeter. After each 
injection, the amount of heat generated or absorbed from the interactions of the two 
compounds is measured, and that change of heat is plotted to generate a titration curve. 
From this physical measurement, the Gibbs free energy (∆G), enthalpy of binding (∆H), 
and entropy (∆S) can all be determined. This information gives insight into the interactions 
of compounds in solution, i.e. the binding constant (KD), binding stoichiometry, whether a 
binding event is exothermic or endothermic, and whether complexes of higher order are 
being formed (which is entropically unfavorable).  
Three thermodynamic profiles that are commonly observed in ITC experiments are 
shown in Figure 42.107 All three are favorable processes due to their negative overall Gibbs 
free energy, however, three different combinations of enthalpic and entropic values can lead 
to a favorable binding process. Each of these scenarios provides information about the 
nature of binding occurring in solution. For scenario A, a highly exothermic binding event  
 
Figure 42: Three thermodynamic scenarios resulting in spontaneous binding events.  
                                      
105 Velázquez-Campoy, A.; Ohtaka, H.; Nezami, A.; Muzammil, S.; Freire, E. In Current Protocols in Cell Biology; John 
Wiley & Sons, Inc.: 2001. 
106 Lah, J.; Maier, N. M.; Lindner, W.; Vesnaver, G. J. Phys. Chem. B 2001, 105, 1670. 
107 Figure adapted from “Introduction to Microcalorimetry” by Malvern. 
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 (-∆H) is able to overcome an unfavorable entropic change (+T∆S), which is characteristic 
of strong hydrogen bonding accompanied by an increase in conformational order. The next 
scenario shows an endothermic binding with a favorable entropic change (-T∆S), which 
indicates strong hydrophobic interactions (scenario B). Finally, strong hydrogen bonding 
and hydrophobic interactions can both be operative, leading to an enthalpically and 
entropically favorable binding (scenario C). Thus, ITC was applied to the titration of 
substrates 107 into BAM catalysts to compare binding constants and the nature of binding. 
Titration of the substrate and the two catalysts for which co-crystal structures could 
be obtained was performed (Table 19). Titration of substrate 107a into catalyst 14a, 
resulted in a favorable and strong binding constant of 2.52e5 M-1 was observed. This is 
consistent with previously observed carboxylic acids binding to cinchonidine catalysts,106 
and stronger than the binding constant observed between phosphoric acids and carboxylic 
acids.91 The binding between 14a and 107a is driven by deprotonation and hydrogen 
bonding (∆H = -13.0 kcal/mol), which overcomes an entropically unfavorable increase in 
order (-T∆S = +5.6 kcal/mol, Table 19, entry 1). This strong hydrogen bonding observed 
by ITC supports a structure in solution similar to the solid-state structure (Figure 30). It 
should also be noted that only one substrate binding event could be detected. An interesting 
comparison arises when the same titration is carried out between substrate 107a and 
optimized catalyst 126d (Table 19, entry 2). A weaker binding constant is observed (KA = 
8.40e4 M-1), which correlates with the decreased basicity of the aniline based catalyst 
relative to pyrrolidyl-catalyst 14a. Strong hydrogen bonding drives the formation of the 
substrate-catalyst complex to a similar degree (∆H = -12.9 kcal/mol, Table 19, entry 2 
versus entry 1). Interestingly, a greater increase in order leads to a 0.6 kcal/mol increase in 
entropy (-T∆S = +6.2 kcal/mol, Table 19, entry 2). This greater entropy value represents 
formation of a more highly ordered substrate-catalyst complex than in entry 1. This tracks 
well with the much higher enantioselectivity delivered by catalyst 126d over 14a, as well 
as the greater steric influence of catalyst 126d on the substrate. Vesnaver and coworkers 
describe ITC measurements for a similar system of DNB-Leucine binding by cinchona 
alkaloids as: “the observed highly exothermic values result most likely from the attractive 
noncovalent intermolecular interactions, such as van der Waals interactions, hydrogen 
bonding and π-π interaction, whereas the negative entropy contributions apparently reflect 
the generation of highly ordered bimolecular ionic associates.”106 Therefore, physical 
measurements of binding in solution support the hypothesized mode of activation provided 
by X-ray crystal structures.  
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Table 19: Thermodynamic comparison of the substrate binding between catalyst 14a 
and 126d 
 
 
entry catalyst ∆H 
(kcal/mol) 
-T∆S 
(kcal/mol) 
∆G 
(kcal/mol) 
KA (M-1) 
1 14a -13.0 +5.6 -7.4 2.52e5 
2 126d -12.9 +6.2 -6.7 8.40e4 
 
 Binding of several substrates to catalyst 126d was examined to see if the subtle 
differences in enantioselectivities could also be represented by differences in entropies of 
binding. The iodolactonization reaction results are also listed with each titration entry for 
correlation with the entropies of binding (Table 20). For the phenyl substrate under 
optimized conditions, 93% ee was achieved and this correlated to a highly unfavorable 
entropy change (+6.2 kcal/mol, Table 20, entry 1). Another substrate that reacted with 
high enantiomeric excess (90% ee), 2-naphthyl, had a similar exothermic binding but was 
less unfavorable (+5.6 kcal/mol, Table 20, entry 2). The results of an alkyl substrate were 
desired for comparison, and the benzyl substrate was found to be less exothermic than the 
aryl substrates. It was also less entropically unfavorable (+4.0 kcal/mol, Table 20, entry 3). 
All three of these substrates reacted well in the lactonization, so poorer substrates were 
tested next. The tert-butyl ester substrate was significantly less exothermic (-7.7 kcal/mol) 
and also generated a less ordered bimolecular complex (+1.1 kcal/mol, Table 20, entry 4). 
Thus far, these substrates had appeared to demonstrate a positive correlation between 
entropy and enantiomeric excess in the lactonization reaction. However, the 1-naphthyl 
substrate did not fit into this pattern. Although it had similar reactivity (72% yield versus 
64% yield) and enantioselectivity (67% versus 64%) to the tert-butyl ester substrate (Table 
20, entry 5 versus entry 4), the entropy measured was higher than that of the benzyl 
substrate (4.7 versus 4.0 kcal/mol, Table 20,  entry 5 versus entry 3). Perhaps the dramatic 
steric hindrance of the 1-naphthyl substrate still generates an entropically unfavorable 
complex, but this obviously does not necessitate high enantioselectivity. Overall, these 
substrates all display favorable enthalpy and unfavorable entropy values in binding to 
catalyst 126d. The magnitude of these values ranges throughout the substrates in a manner 
that at times correlates with the reaction outcome. Interestingly, despite a range of -12.9 to 
-7.7 kcal/mol for the measured enthalpies, the Gibb’s free energy remains relatively stable, 
ranging only from -6.7 to -6.5 kcal/mol.  
 
Ph
HO
O
catalyst + Ph
O
O
catalyst-H+  •
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Table 20: Thermodynamics of substrates binding to catalyst 126d 
 
 
entry R = ∆H (kcal/mol) -T∆S (kcal/mol) ∆G (kcal/mol) KA (M-1) reaction yield (%) ee (%) 
1 -Ph -12.9 +6.2 -6.7 8.40e4 87 93 
2 -2-naphthyl -13.0 +5.6 -6.5 5.41e4 78 90 
3 -Bn -10.6 +4.0 -6.5 6.13e4 66 87 
4 -CO2tBu -7.7 +1.1 -6.6 6.49e4 64 64 
5 -1-naphthyl -11.3 +4.7 -6.6 4.46e4 72 67 
   
 
In addition to physical measurements, theoretical calculations have been initiated. 
The calculations were conducted at the B3LYP level of theory with the 6-311g basis set 
(adding parameters to account for the large iodine atom). Since no experimental method to 
determine which oxygen atom was attacking the alkene, DFT calculations were considered 
to be an insightful alternative. Additionally, the N-iodophthalimide could be included in 
these calculations, which was a limitation of the X-ray crystal structures. Energy and 
frequency calculations were converged for several conformations of the substrates and 
products bound to the catalyst. Attempts are ongoing to find transition state structures of 
the pathways leading to each product enantiomer.  
The nature of the substrate binding to catalyst 126d was investigated first, primarily 
to understand the difference in energy between binding with the alkene forward (as is shown 
in the crystal structures) and the alkene reversed (Figure 43A and B, respectively). In these 
minimized structures, the N-iodopthalimide takes up a position above the alkene opposite 
the nucleophile, and the same hydrogen bonding network from the catalyst to the substrate 
is observed. As anticipated, an almost indistinguishable energy difference was calculated 
between the two considered conformations, with the “alkene reversed” conformation being 
only 0.34 kcal/mol lower in energy.  
R
HO
O
126d + R
O
O
126d-H+  •
toluene, 25 ºC
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Figure 43: Calculated structures and relative energies for two plausible alkene 
conformations of the starting material: A) alkene forward and B) alkene behind. 
The products of the reaction were also submitted to structure optimization. The two 
substrate conformations calculated above were extended to the catalyst bound to the 
iodolactone major enantiomer and a phthalimide anion (Figure 44). The “product forward” 
conformation was calculated to be 9.5 kcal/mol less stable than the “product reversed” 
conformation. Three hydrogen bonds exist in each complex, however, the major difference 
appears to be the ability of succinimide to hydrogen bond to the positively charged N-H in 
the “product reversed” structure. The product minor enantiomer was examined in an 
analogous “product behind” type of structure, and it was found to be 1.4 kcal/more less 
stable than for the major enantiomer (Figure 45). Altogether, the structures of the 
substrates and products bound to the catalyst appear to indicate that the “reversed” 
structures may actually be operative in solution, due to their greater stability. This is mere 
speculation, however, without the calculations converging to transition state structures, yet. 
“alkene forward”: 0 kcal/mol “alkene reversed”: -0.34 kcal/mol 
A) B) 
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Figure 44: Two optimized structures of iodolactone product and phthalimide bound to 
catalyst 126d.  
“product forward”: 0 kcal/mol 
“product reversed”: -9.5 kcal/mol 
A) 
B) 
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Figure 45: Minor enantiomer of the product bound in a “reversed” fashion. 
 
1.2.8 Derivatization of bicyclic lactones 
 
The bicyclic lactone products generated from this methodology can be derivatized 
toward a range of functionalized bicycles and cyclopentanes. Several of these methods are 
demonstrated on enantioenriched iodolactone 109a in Figure 46. If the lactone is reduced 
a -78 ºC, diol product 137 can be produced in 42% isolated yield with complete conservation 
of enantiopurity (Figure 46A). This was surprising, as the lithium alkoxide generated from 
the reduction was expected to cyclize on the iodine to form a meso-epoxide. The relatively 
low yield was due to the formation of ether 138, which results from the intramolecular 
etherification of the primary alcohol on the iodide. When the reduction was run at higher 
temperatures, this etherification product could be isolated in 59% yield with conversion of 
enantiomeric excess (Figure 46B). Radical reductions were also feasible, with deiodination 
(139) and allylation (140) both reacting well (81% and 53% yield, respectively, Figure 46C 
and D). The allyation was achieved with moderate levels of diastereoselectivity. All 
attempts to substitute the iodine with nucleophiles such as azide, cyanide, or alkoxides were 
unsuccessful. This was typically due to poor conversion, and any conversion was from 
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nucleophilic acyl substitution at the ester carbon. Deiodinated lactone, 139, could undergo 
aminolysis by monosubstituted amines, with the benzyl amine addition proceeding in 70% 
yield (Figure 46E). Synthesis of this amide product, 141, opened this methodology to the 
possibility of being a viable route to carbocyclic nucleoside analogues.108   
  
 
Figure 46: Derivatizations of iodolactone products. 
 
1.2.9 Application towards a biologically active carbocyclic ribonucleoside 
 
Carbocyclic nucleosides are structurally similar to natural nucleosides, with the 
replacement of the furanose oxygen with a methylene. This alteration gives the molecule 
greater stability towards enzymatic degradation,109 while taking advantage of their 
involvement in numerous biological processes.110 Nucleoside analogues can target viral 
telomerases, reverse transcriptases, and DNA polymerases (of HIV, hepatitis B, herpes, etc) 
by competitive binding to the active site, as well as their termination of DNA chain 
elongation.  
                                      
108 a) Marquez, V. E.; Lim, M.-I. Med. Res. Rev. 1986, 6, 1. b) Stewart, W. S. Current Topics in Medicinal Chemistry 
2002, 2, 1087. 
109 Stoeckler, J. D.; Cambor, C.; Parks, R. E. Biochemistry 1980, 19, 102. 
110 Matyugina, E. S.; Khandazhinskaya, A. P.; Sergei, N. K. Russ. Chem. Rev. 2012, 81, 729. 
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Figure 47: Strategies for the synthesis of enantioenriched carbocyclic nucleoside 
analogues.  
Syntheses of these molecules are typically racemic, however several strategies to 
access enantioenriched nucleoside analogues exist, such as the elegant enzymatic kinetic 
resolution to produce Vince lactam (142, Figure 47A),111 kinetic resolution of cyclopentene 
caroboxylic acids,112 functionalization of sugars from the chiral pool, or diastereoselective 
aldol, ring closing metathesis, then palladium coupling with purine bases (as in the syntheses 
of carbovir and abacavir).113 Asymmetric hydroboration of cyclopentadiene derivatives has 
also been employed to generate 143 in good enantioselectivity (Figure 47B).114 The lithium 
salt of (1R,2S)-norephedrine can also be used as a chiral base for the enantioselective 
opening of meso-epoxides 144 (Figure 47C).115Asymmetric synthetic methods are generally 
more limited.116 The rhodium catalyzed, intramolecular hydroacylation of alkenes provided 
                                      
111 Singh, R.; Vince, R. Chem. Rev. 2012, 112, 4642. 
112 Hildbrand, S.; Troxler, T.; Scheffold, R. Helv. Chim. Acta 1994, 77, 1236. 
113 Crimmins, M. T.; King, B. W. J. Org. Chem. 1996, 61, 4192. 
114 Jessel, S.; Meier, C. Eur. J. Org. Chem. 2011, 2011, 1702. 
115 Hodgson, D. M.; Witherington, J.; Moloney, B. A. J. Chem. Soc., Perkin Trans. 1 1994, 3373. 
116 Boutureira, O.; Matheu, M. I.; Diaz, Y.; Castillon, S. Chem. Soc. Rev. 2013, 42, 5056. 
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ketone 145 in 85% yield and 95% ee (Figure 47D).117 The carbonyl could be converted to 
the base linkage by reduction and Mitsunobu with adenine. The Trost group reported the 
enantioselective desymmetrization of diphenylacetate 146 by a palladium catalyzed 
coupling to provide an advanced intermediate 147 in good yield and excellent 
enantioselectivity (Figure 47E). Interestingly, authors of a review on enantioselective routes 
to these analogues assert that “processes based on transition metals are still scarce, and the 
use of organocatalysts to obtain carbocyclic nucleosides remains unexplored.”116  
 (–)-Carbovir, one of the most well-known nucleoside analogue examples, did not 
succeed in clinical trials, due to poor pharmacokinetic and toxicological properties. However, 
abacavir (Ziagen) was approved in 1998, and has increased bioavailability and penetration 
of the central nervous system (Figure 48).110 Entecavir was approved in 2005 for the 
treatment of hepatitis B by inhibiting DNA polymerase activity. As of 2012, resistance had 
still not been developed, and it was effective at treating a lamivudine-resistant strain of 
HBV. Nucleoside analogues have also been developed as candidates for the treatment of 
autoimmune diseases by targeting chemokine receptors. For example, MK-0812 was 
developed as a chemokine receptor antagonist for the treatment of inflammatory diseases, 
such as rheumatoid arthritis and multiple sclerosis (Figure 48).118 Chemokines play a major 
role in inflammation response by recruiting monocytes, T-cells, basophils, and other 
inflammatory response cells. Chemokine receptor 2 (CCR2) is a G-protein-coupled receptor 
found on the surface of these cells, and chemokine ligand 2 (CCL2) activates them by 
binding to CCR2. This ligand and receptor pair are overexpressed in some inflammatory 
diseases, and knock down experiments indicate that their inhibition may be a useful 
therapeutic target. MK-0812 failed in clinical trials due to a lack of efficacy, and some 
believed that it could possibly be due to poor residency time, or the lifetime of the ligand-
receptor complex.119 Vertex optimized a different compound, 148, for improved residency 
time while attempting to preserve the potency of MK-0812. These two compounds appeared 
to be prime targets for desymmetrizing iodolactonization methodology due to the 
substitution of an isopropyl group at the 4’ position, which is required for lactonization to 
occur (see Table 17, entry 6).  
 
                                      
117 Marcé, P.; Díaz, Y.; Matheu, M. I.; Castillón, S. Org. Lett. 2008, 10, 4735. 
118 Wisniewski, T.; Bayne, E.; Flanagan, J.; Shao, Q.; Wnek, R.; Matheravidathu, S.; Fischer, P.; Forrest, M. J.; 
Peterson, L.; Song, X.; Yang, L.; DeMartino, J. A.; Struthers, M. J. Immunol. Methods 2010, 352, 101. 
119 a) Vilums, M.; Zweemer, A. J. M.; Yu, Z.; de Vries, H.; Hillger, J. M.; Wapenaar, H.; Bollen, I. A. E.; Barmare, F.; 
Gross, R.; Clemens, J.; Krenitsky, P.; Brussee, J.; Stamos, D.; Saunders, J.; Heitman, L. H.; Ijzerman, A. P. J. Med. 
Chem. 2013, 56, 7706. b) Vilums, M.; Zweemer, A. J. M.; Barmare, F.; van der Gracht, A. M. F.; Bleeker, D. C. T.; 
Yu, Z.; de Vries, H.; Gross, R.; Clemens, J.; Krenitsky, P.; Brussee, J.; Stamos, D.; Saunders, J.; Heitman, L. H.; 
Ijzerman, A. P. Eur. J. Med. Chem. 2015, 93, 121. 
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Figure 48: Carbocyclic ribonucleoside based drugs and drug candidates. 
Retrosynthetic analysis of MK-0812 provided a highly convergent proposed route to 
the target molecule (Figure 49A). The amino-pyran could be installed via a substitution of 
cyclopentane alcohol 149. This alcohol would be arrived at by a key aminolysis step, 
wherein lactone 150 is opened by quinuclidine 151. This lactone results from the 
deiodination of iodolactone ent-109j, which was synthesized via iodolactonization of 
isopropyl cyclopentenecarboxylic acid 107j by (S,S)-126d. Iodolactonization and 
deiodination could be readily achieved, as was demonstrated previously (Figure 46C), 
however aminolysis of this lactone proved quite difficult. Aminolysis had only been 
previously performed using the monosubstituted benzyl amine, whereas amine 151 was 
disubstituted. Basic, Brønsted acidic, Lewis acidic, and harsh (microwave in neat 151) 
conditions were screened, all to no avail. Quinuclidine 151 would decompose under high 
enough temperatures, and it was never observed to open the lactone ring. Saponification of 
the lactone could be performed, however attempts to functionalize the resultant seco-acid 
always resulted in reformation of lactone 150. These results made the limitation of 
iodolactone products 109 toward functionalization by nucleophiles, namely disubstituted 
amines, more evident. 
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Figure 49: A) Retrosynthetic analysis of MK-0812 incorporating the iodolactonization 
of cyclopentene carboxylic acids. B) Attempts to open lactone 150 with disubstituted 
amine 151. 
Efforts were then made toward the synthesis of Vertex compound, 148 (Figure 48). 
Whereas MK-0812 had been dropped from clinical trials, 148 still had hope of being a more 
efficacious compound than MK-0812. The same 4’ isopropyl substitution was still present, 
a similar route could be employed, and a monosubstituted benzyl amine could be used for 
the aminolysis step. Iodolactonization of 107j proceeded smoothly on gram scale, providing 
the product in 73% yield and -79% ee, which could be recrystallized to -95%ee with a 56% 
overall yield (Figure 50). 107j could be deiodinated with full and clean conversion. This 
material was carried forward to the aminolysis crude. Aminolysis in neat 3,5-
bis(trifluoromethyl)benzyl amine provided the desired syn-alcohol 152 in 51% yield over 
two steps.  
  
 
Figure 50: Iodolactonization and aminolysis to alcohol 152.  
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The western portion of Vertex compound 148 was synthesized from known 
compound bromo-indanone 153 (Figure 51).120 Oxime formation followed by zinc reduction 
yielded rac-154. This amine was resolved by salt formation with N-acyl-D-leucine, and two 
rounds of recrystallization provided amine 154 in 95% ee. 
 
 
Figure 51: Synthesis and resolution of amine (R)-154.  
 
Figure 52: A) Convergence of amine (R)-154 and alcohol 152 to produce CCR2 
antagonist, 148. B) Assignment based on NMR analysis of the major diastereomer. 
                                      
120 Taveras, A., et. al. Preparation of pyrimidinecarboxamides and analogs thereof as metalloprotease inhibitors. 
WO 2008002671. 2008. 
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Alcohol 152 was initially inverted to the corresponding bromide by phosphorous 
tribromide, however subsequent alkylation attempts by amine (R)-154 yielded only an 
intramolecular cyclization of the amide functionality onto the bromide. Reductive amination 
was then employed. Alcohol 152 was oxidized by PCC cleanly, and the ketone was carried 
into the next step crude. Reduction of the iminium by sodium triacetoxyborohydride yielded 
the final Vertex compound 148 in 60% and 3:1 diastereomeric ratio (Figure 52A). The 
identity of the major diastereomer was confirmed as the using COSY and ROESY (Figure 
52B). This target molecule could be synthesized in 5 steps (LLS) in 17% overall yield using 
an organocatalyst as opposed to the previously reported 9 step synthesis from Vince 
lactam.119a 
 
1.3 Conclusions and future directions  
 
Altogether, a methodology for the enantioselective desymmetrization of carboxylic 
acid substrates by iodolactonization was achieved. Key to the optimization of the reaction 
rate and selectivity was the acquisition of a catalyst-substrate cocrystal structure. From 
this structure, a hypothesis for oxygen atom desymmetrization by hydrogen bonding was 
derived. Additionally, new testable theories for improving the enantioselectivity could also 
be made. Guided by this crystal structure, a new catalyst 126d was developed to facilitate 
the reaction in high enantioselectivity and yield. A second co-crystal structure of the 
optimized catalyst and substrate corroborated initial hypotheses for the origin of 
enantioselectivity. Mechanistic investigations using isothermal titration calorimetry allowed 
for comparisons of the relative binding constants and entropies between different catalysts 
and substrates. In general, it appeared that the cases with higher enantioselectivity also 
formed a more ordered complex with the catalyst. The methodology was further applied 
successfully to a range of aryl and alkyl cyclopentene carboxylic acids. These iodolactones 
possess three stereocenters, with one being an all carbon quaternary center. Derivatizations 
provided access to a variety of functionalized cyclopentanes, and a Vertex CCR2 antagonist 
molecule could be synthesized in 5 steps and 21% overall yield using a novel organocatalytic 
methodology. Future directions include optimization of an 4-exo lactonization on 
cyclohexadiene carboxylic acid substrates (Figure 40B), as well as continued computational 
studies to calculate plausible transition state structures of the desymmetrization by catalyst 
126d. 
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2 Multigram preparation of an arylglycine dipeptide by 
Umpolung amide synthesis (UmAS) 
 
2.1 Introduction 
 
2.1.1 Arylglycine a-amino amides and their synthesis 
 
 Arylglycine a-amino amides are important residues due to their presence in 
medicinally significant natural products like glycopeptide antibiotics (vancomycin, 
teicoplanins, and ristomycin) and a-lactam antibiotics (nocardicins A-G, amoxicillin) 
(Figure 53).121  
 
Figure 53: Arylglycine a-amino amides in glycopeptide antibiotics and a-lactam 
antiobiotics with arylglycine residues highlighted. 
                                      
121 a) Williams, R. M.; Hendrix, J. A. Chem. Rev. 1992, 92, 889. b) Al Toma, R. S.; Brieke, C.; Cryle, M. J.; Sussmuth, 
R. D. Nat. Prod. Rep. 2015, 32, 1207. c) Nicolaou, K. C.; Boddy, C. N. C.; Bräse, S.; Winssinger, N. Angew. Chem. 
Int. Ed. 1999, 38, 2096. d) Schwieter, K. E.; Johnston, J. N. J. Am. Chem. Soc. 2016, 138, 14160. 
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Significant effort has been applied toward the stereoselective synthesis of the 
corresponding arylglycine amino acids. Evans and coworkers reported one of the earliest 
routes towards these, using a chiral auxiliary to facilitate a diastereoselective a-azidation of 
amides (155, Figure 54A).122 An enantioselective route employs the osmium catalyzed 
aminohydroxylation of styrenes to deliver aminoalcohols 156 in good yield and 
enantioselectivity (76% and 97%, respectively; Figure 54B).123 Iminoesters (157) have also 
been used as precursors for the enantioselective, rhodium catalyzed hydrogenation to deliver 
arylglycine esters 158 in excellent yield (99%) and selectivity (95% ee) (Figure 54C).124 The 
Fu group has also reported an N-H insertion for accessing arylglycine amino acids, where 
copper catalyzes the insertion of boc-carbamate into aryl diazoesters 159 to generate 
aminoesters 160 in good yield and excellent enantiomeric excess (Figure 54D).125  
 
 
Figure 54: Methods for the synthesis of enantioenriched arylglycine amino acid 
precursors. 
                                      
122 Evans, D. A.; Evrad, D. A.; Rychnovsky, S. D.; Früh, T.; Whittingham, W. G.; deVries, K. M. Tetrahedron Lett. 
1992, 33, 1189. 
123 Reddy, K. L.; Sharpless, K. B. J. Am. Chem. Soc. 1998, 120, 1207. 
124 Shang, G.; Yang, Q.; Zhang, X. Angew. Chem. Int. Ed. 2006, 45, 6360. 
125 Lee, E. C.; Fu, G. C. J. Am. Chem. Soc. 2007, 129, 12066. 
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2.1.2 Incorporation of arylglycine residues by UmAS 
 
Integration of these arylglycine amino acids into peptides has proved challenging due 
to their increased propensity towards epimerization.126 The aryl group increases the acidity 
of the a-proton, and upon activating the carboxylate for coupling, racemization can occur 
more easily than for canonical amino acids. This issue was circumvented using aza-
Henry/UmAS in tandem. a-Bromo nitroalkanes (161) are prepared in high enantiopurity 
by the addition of bromonitromethane into imines by BAM catalysis (Figure 55A).127 
Bromonitroalkanes 161 are then reacted with an amine, base, and oxidant to produce the 
corresponding amides (162, Figure 55B).128 This unique set of conditions is hypothesized to 
proceed in an Umpolung fashion relative to standard condensative amide coupling 
conditions.129 The bromonitroalkane can be deprotonated and add into the N-haloamine 
generated from amine reaction with NIS. This reversal of nucleophile and electrophile avoids 
the formation of an acidic, activated ester intermediate, making Umpolung Amide Synthesis 
(UmAS) a useful tool for incorporating aryglycine amino acids. To improve the utility of 
this methodology, a highly reproducible procedure for the multigram preparation of an 
arylglycine peptide was developed.130 
 
Figure 55: Synthesis of arylglycine containing peptides using BAM catalysis and UmAS. 
2.2 Application of UmAS on larger scale preparations  
 
                                      
126 a) Konig, W.; Geiger, R. Chemische Berichte-Recueil 1970, 103, 2024. b) Han, S.-Y.; Kim, Y.-A. Tetrahedron 2004, 
60, 2447. c) Goodman, M.; McGahren, W. J. J. Am. Chem. Soc. 1966, 88, 3887. d) Dettner, F.; Hänchen, A.; Schols, 
D.; Toti, L.; Nußer, A.; Süssmuth, R. D. Angew. Chem. Int. Ed. 2009, 48, 1856. 
127 Davis, T. A.; Wilt, J. C.; Johnston, J. N. J. Am. Chem. Soc. 2010, 132, 2880. 
128 Shen, B.; Makley, D. M.; Johnston, J. N. Nature 2010, 465, 1027. 
129 Shackleford, J. P.; Shen, B.; Johnston, J. N. Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 44. 
130 Knowe, M.; Tsukanov, S. V.; Johnston, J. N. Org. Synth. 2017, 94, 388. 
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The multigram-scale synthesis of a-aryl bromonitroalkane (163) was accomplished 
starting from the para-benzyloxy benzaldehyde 164 (Figure 56A).131 Synthesis of the amido 
sulfone 165 and subsequent elimination provided grams of the crude Boc-protected imine 
cleanly (166, Figure 56B). This imine could then be used in a large-scale aza-Henry reaction 
catalyzed by 5 mol % of the PBAM free base (13) (Figure 56C). a-Aryl bromonitroalkane 
(163) was produced in good yield and high enantioselectivity. After a silica plug and 
recrystallization, grams of the product were produced in 36% overall yield and 97%/95% ee 
of each diastereomer. This procedure describes the chromatography-free production of large 
amounts of a starting material for further use in the synthesis of a-arylglycine containing 
peptides. 
 
 
Figure 56: Enantioselective synthesis of an a-aryl bromonitroalkane. 
2.2.1 First generation synthesis and purification 
Initial investigations for the optimization of the UmAS coupling of aryl bromonitro 
alkane 163 began on a 1g test scale (Figure 57). The goal was to develop a practical method 
for the synthesis of useful quantities of arylglycine containing peptides, which was defined 
as synthesizing and fully purifying 5 g of a peptide in at least 50% yield without any column 
chromatography.  
Phenylalanine methyl ester was chosen as the amine coupling partner for its 
increased crystallinity within the peptide product (167). Cesium carbonate (2 equivalents) 
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was used as the base, and recrystallized NIS was used as the oxidant. An oxygen balloon 
was included as well to aid in reaction conversion.132 A biphasic solvent system of 2-methyl 
THF and water was used to ensure solubility of all reaction components. Vigorous stirring 
was required to mix the two phases. UmAS reactions have been typically run at 0 ºC, so a 
cryocool was used to control the reaction temperature. The reaction was run for two days 
before reductive quenching with saturated aqueous sodium thiosulfate. An acid wash could 
also be used to remove any remaining phenylalanine. Concentration of the extracts afforded 
a viscous red oil from which crystalline product could not be easily obtained. Polar 
impurities were removed by filtration through a silica plug, and off white, solid material 
was obtained. At this stage, the crude material was primarily unreacted starting material, 
product, and succinimide. This material could be recrystallized by dissolving in hot 
benzene/cyclohexane (3:2) to provide product in 56% isolated yield and 93% purity. It 
should be noted that conversion on this small scale was essentially complete, simplifying 
purification of the crude reaction mixture.  
 
 
Figure 57: Synthesis of peptide 167 by UmAS on 1g scale. 
To achieve the goal of 5 g of peptide 167 with an estimated 50% yield, the reaction 
was scaled up to 8.9 g of starting material. In a larger reaction flask, conversion was much 
worse, achieving only 40% yield by NMR after two days. A mechanical stirrer was used 
with a dimpled flask for maximized phase mixture (Figure 58). A typical case for this large-
scale reaction is shown in Figure 59. After two days, conversion was not complete and 
appeared to stall out. The ratio of starting material to product was monitored by 1H NMR 
analysis of reaction aliquots over the course of eleven days (Table 21). Additions of extra 
equivalents of NIS, refilling the oxygen balloon, increasing reaction temperature, or 
extending reaction times did not improve the conversion. A balance between yield and 
purity in the isolation procedure was therefore difficult to achieve. The recrystallization 
could provide over 5 grams of material in lower purity (5.4 g, 83% pure, Figure 59), but to 
obtain pure material the recrystallization would need to be filtered early, providing less 
than the 5 g goal. Second rounds of recrystallization were never able to compensate the 
pure material. 
                                      
132 Schwieter, K. E.; Shen, B.; Shackleford, J. P.; Leighty, M. W.; Johnston, J. N. Org. Lett. 2014, 16, 4714. 
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Figure 58: Reaction set up for the large scale UmAS of am arylglycine containing 
peptide. 
 
 
Figure 59: A common result from large scale reaction. 
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Table 21: Conversion compared to reaction time estimated from ratio of product to 
starting material. 
 
Entry Reaction time (d) 
Starting material : 
producta 
1 2 1:2.8 
2 3 1:3.6 
3 4 1:3.7 
4 5 1:4.5 
5 6 1:6.5 
6 11 1:7.7 
a Measured by 1H NMR analysis of reaction aliquots. 
 
2.2.2 Second generation synthesis and purification 
 
 In a hopeful bid to synthesize the peptide in large quantities with high purity, the 
benzyl ester of phenylalanine (168) was used instead of the methyl ester (Figure 60A). 
Unlike the methyl ester, this ester provided favorable results at room temperature after only 
one day, simplifying the procedure drastically. Additionally, commercially available NIS 
could be used without further purification. It performed well on small scale and was  
 
Figure 60: A) Performance of phenylalanine benzyl ester in the UmAS reaction, and B) 
results of a scaled up reaction. 
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recrystallized easily to provide pure peptide 169 in 51% yield. Gratifyingly, the large-scale 
reaction using a mechanical stirrer reached full conversion after one day at room 
temperature. An aqueous thiosulfate quench followed by silica plug quickly provided the 
solid crude material. Recrystallization from toluene/cyclohexane (3:2) provided 6.7 g of the 
product in greater than 20:1 dr and 99% purity (Figure 60B). This procedure was 
additionally repeated and validated by a third party, completing the first large-scale 
preparation of a peptide using UmAS methodology.130  
In summary, a method was developed for the incorporation of aryl glycine residues 
into dipeptides, enabling the straightforward production of relevant quantities. Alterations 
to previously developed UmAS conditions to improve the practicality of this methodology 
include: raising the reaction temperature to 25 ºC, using commercially available NIS as-is 
rather than recrystallized, and shortening reaction times to one day. Unfortunately, the use 
of the more expensive cesium carbonate could not be avoided. The use of large quantities 
of distilled 2-methyl THF could not be circumvented either. Due to the heterogeneous 
conditions of the reaction, vigorous stirring by a mechanical stirrer was required. Ultimately, 
however, a benzyl ester of phenylalanine (rather than a methyl ester) was required for 
fastest conversion and ease of purification. The reason for the faster conversion has not been 
investigated yet, however it is logical that the benzyl ester could make the product more 
crystalline, allowing for a more reproducible purification. It also remains to be investigated 
if this robust procedure is amenable to other amino acid benzyl esters. 
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3 Progress toward the total synthesis of (+)-zwittermicin A 
 
 
3.1 Background  
 
3.1.1 Isolation and biological activity of (+)-zwittermicin A 
 
Scientific and technological advance is intimately connected to the improvement of 
society, and total synthesis of biologically relevant molecules not only advances 
understanding in the chemical community but also in global society, providing solutions to 
practical problems. With the population of the earth increasing, consumption rising, and 
natural resources diminishing, more efficient global food production needs to be developed, 
and a part of addressing this complex problem relies on chemical innovation to control 
diseases and pests that threaten food production.133a An estimated 10-16%, or $220 billion, 
of the global food harvest is lost to plant diseases, and 6-10% is also lost after harvest for 
various reasons.133b Food insecurity, defined as a reduced quality, variety, desirability, or 
availability of diet, is a problem currently faced by 24% of the world (802 million people in 
2012) and 14.5% of Americans, according to the US Department of Agriculture.134 The 
identification of antibiotics that can protect food supplies from a variety of threats is 
instrumental in addressing food insecurity worldwide, and it can combat the development 
of resistance to current antibiotics. 
 
 
Figure 61: Structure of (+)-zwittermicin A, highlighting the pseudo-C2 symmetric core 
from carbons 9 to 15. 
(+)-Zwittermicin A (170, zwA; Figure 61) represents the first of its kind as an 
aminopolyol antibiotic. It is a synthetically challenging, linear, and highly oxidized natural 
product with a pseudo C2-symmetric C9-C15 core and seven stereocenters in close proximity. 
It was first isolated in 1994 from Bacillus cereus UW85, a very common and widespread 
                                      
133 a) Godfray, H. C. J.; Beddington, J. R.; Crute, I. R.; Haddad, L.; Lawrence, D.; Muir, J. F.; Pretty, J.; Robinson, S.; 
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bacterium.135 This bacterium was found to suppress a variety of diseases in a range of 
agricultural crops, and it became an attractive organism for identification of new drugs and 
antibiotics.136 From culturing this bacterium, zwittermicin A was able to be isolated in an 
average yield of 2-4 mg/L culture.135 It was found to be responsible for growth inhibition of 
the alfalfa pathogen Phytophtora medicaginis, a protist, and inhibits a plethora of fungi 
responsible for the destruction of beets, corn, grasses, berries, apples, and general stored 
fruits and vegetables, as well as several gram-negative and gram-positive bacteria, and 
enhances the insecticidal activity of Bacillus thuringiensis.136 ZwA producing organisms are 
pervasive in soil, and ZwA is unique in its broad range of biological activity, suggesting that 
it acts upon a evolutionarily conserved pathway across many organisms.137,138 It has potential 
for development of antibiotics that are agriculturally relevant across large geographic 
regions as well as environmentally friendly. An attempt to investigate the mechanism of 
action through studying resistant strains of bacteria identified a correlation between 
resistance and an inability to maintain electrical membrane potential properly. It also 
identified DNA transcription, replication, and DNA gyrase or topoisomerase as possible 
targets but the authors were unable to observe any alteration in the amount of DNA or 
RNA processing, which together could suggest a novel mechanism of action.138  
 
3.1.2 Structural elucidation and previous formal total synthesis 
 
The structure of (+)-Zwittermicin A was originally determined by mass spectrometry 
and NMR studies, and the relative stereochemistry at carbons 8, 9, and 10 was determined 
by nOe of a cyclized derivative,133 however the remaining stereochemistry was unknown 
until 2007 when a series of 8 diastereomeric compounds resembling the C9-C15 core were 
synthesized by Molinski and coworkers.139 The 13C NMR shifts were compared pairwise with 
the natural product, thereby determining the relative stereochemistry of the C8-C15 core 
of ZwA. The proposed absolute stereochemistry was based on the sequence of the non-
ribosomal peptide synthetase—polyketide synthase megasynthese responsible for synthesis 
of ZwA, which identified the starting unit as serine.140,141,142 Since L-serine is naturally 
occurring and epimerase domains were absent from the cluster, the absolute stereochemistry 
was assigned (171, Figure 62) assuming the configuration of C14 was derived from L-serine. 
                                      
135 He, H.; Silo-Suh, L. A.; Handelsman, J.; Clardy, J. Tetrahedron Lett. 1994, 35, 2499. 
136 Silo-Suh, L. A.; Stabb, E. V.; Raffel, S. J.; Handelsman, J. Curr. Microbiol. 1998, 37, 6. 
137 Stabb, E. V.; Jacobson, L. M.; Handelsman, J. Appl. Environ. Microbiol. 1994, 60, 4404. 
138 Stabb, E. V.; Handelsman, J. Mol. Microbiol. 1998, 27, 311. 
139 Rogers, E. W.; Molinski, T. F. Org. Lett. 2007, 9, 437. 
140 Emmert, E. A.; Klimowicz, A. K.; Thomas, M. G.; Handelsman, J. Appl. Environ. Microbiol. 2004, 70, 104. 
141 Stohl, E. A.; Milner, J. L.; Handelsman, J. Gene 1999, 237, 403. 
142 Kevany, B. M.; Rasko, D. A.; Thomas, M. G. Appl. Environ. Microbiol. 2009, 75, 1144. 
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The C4 stereocenter was determined by hydrolysis of the natural product, derivatizing the 
liberated amino acid, and comparing to known S-albizziin.  
  
 
Figure 62: Original stereochemical assignment of zwA. 
In 2008, Molinski and coworkers published their first attempt at total synthesis of 
(+)-zwA, based on their proposed absolute stereochemical assignment (171, Figure 63).143 
Suprisingly, their assignment based on L-serine proved wrong, and they revised the natural 
product configuration based on synthesis of the enantiomer, (-)-zwA. Their synthesis begins 
with azidodiol 172 which they prepared previously (Scheme 1.2).139 This is selectively 
protected at the terminal alcohol, before the secondary alcohol is MOM protected and the 
silyl group removed. Azide 173 is reduced, benzyl protected, and the terminal alcohol 
oxidized to prepare for the Evans aldol with 174. The reaction proceeds with good yield 
and diastereoselection, and the chiral auxiliary is removed in good yield over the two steps.  
 
Figure 63: Total synthesis of 171. 
The requisite carboxylic acid 175 is coupled in high yield to amide (-)-176, and global 
deprotection affords 171 in good yield. When compared with the natural product, the NMR 
                                      
143 Rogers, E. W.; Dalisay, D. S.; Molinski, T. F. Angew. Chem. Int. Ed. 2008, 47, 8086. 
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spectra of 171 were slightly different, and the specific rotation was opposite and greater in 
magnitude than for (+)-zwittermicin A, suggesting they had synthesized a diastereomer. 
They hypothesized that their assumption based on L-serine as the starting material 
was incorrect, and adjusted their synthesis to make (-)-zwittermicin A.143 By coupling acid 
175 with (+)-176 then deprotecting, they synthesized (-)-zwittermicin in 24 steps from an 
L-serine derivative, and it had an identical NMR spectrum with and exactly opposite specific 
rotation to the natural product. This proved the absolute configuration of (+)-zwittermicin 
A to be that depicted as (+)-170, and indicated the biosynthetic incorporation of D-serine. 
In 2009, Molinski and Rogers published a shorter route to the opposite enantiomer of 173, 
which completed the first formal total synthesis of (+)-zwittermicin A in 19 steps.144 
(-)-Zwittermicin A was tested for biological activity against several fungal strains in 
comparison to (+)-zwittermicin A and was found to be inactive.143 Molinski and coworkers 
synthesized a series of thirteen analogues and diastereomers of (+)-zwittermicin A to test 
for biological activity and structure-activity relationships.145 None of the aminopolyol 
derivatives and analogues showed any activity, however, indicating (+)-zwittermicin A has 
a highly stereospecific mechanism of action, with every stereocenter playing a vital role.  
 
3.2 Approach to (+)-zwittermicin A 
 
3.2.1 Retrosynthetic analysis 
 
A bidirectional, convergent, and stereoselective synthetic strategy was planned for 
the total synthesis of (+)-zwittermicin A 170, using key Brønsted acid-promoted azide-
olefin [3+2] cycloaddition, desymmetrization, and diastereoselective Passerini steps.146 A key 
disconnection between C7 and C8 that could be achieved by this diastereoselective Passerini 
reaction with isonitrile 177 and alcohol 178 (Figure 64). This would form the C7 a-oxy 
amide and convergently unite the western urea fragment with the eastern aminoalcohol 
fragment. Primed for all final functional group manipulations, isonitrile 177 could be 
synthesized from L-Aspartic Acid. Alcohol 178 would be obtained from fragmentation and 
desymetritization of C2 symmetric bis(oxazolidine) dione 179. This protected aminoalcohol 
intermediate is the goal of the stereoselective, bidirectional approach to the pseudo-
symmetric core of (+)-zwittermicin A from C9-C15.  
                                      
144 Rogers, E. W.; Molinski, T. F. J. Org. Chem. 2009, 74, 7660. 
145 Rogers, E. W.; Dalisay, D. S.; Molinski, T. F. Bioorg. Med. Chem. Lett. 2010, 20, 2183. 
146 Muchalski, H. Stereospecific Reactions of α-Amino-β-Diazonium Intermediates; Mechanistic Studies, New Reaction 
Discovery and their Application to a Two-Directional Total Synthesis of (+)-Zwittermicin A, PhD Dissertation, 
Vanderbilt University, 2012. 
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This bidirectional strategy to bis(oxazolidine dione) 179 (Figure 64) would be 
achieved using methodology for the Brønsted acid-promoted, formal aminohydroxylation of 
olefins.147,148,149 179 could be formed by the acid promoted fragmentation of bis(triazoline) 
180, which would be acquired from the diastereoselective [3+2] addition of benzyl azide to 
bisimide 181. This could result from the HWE olefination of diene 182 with 
phosphonoimide 183. Diene 182 could be synthesized according to known procedures from 
readily available acetylacetone.  
 
 
Figure 64: Retrosynthetic analysis. 
 
3.2.2 Acid-promoted formal aminohydroxylation 
 
The methodology that led to the pursuit of a total synthesis of (+)-zwittermicin A 
was Brønsted acid-promoted olefin aziridination (Figure 65).147 This was achieved by the 
addition of nucleophilic alkyl azide to an electron deficient olefin to produce the 
corresponding triazoline 184 (Figure 65A). Triazolines were known to decompose under 
various conditions, with the exception of acid promoted decomposition. This work’s 
contribution included the first example of their useful acid promoted decomposition to 
                                      
147 Mahoney, J. M.; Smith, C. R.; Johnston, J. N. J. Am. Chem. Soc. 2005, 127, 1354. 
148 Hong, K. B.; Donahue, M. G.; Johnston, J. N. J. Am. Chem. Soc. 2008, 130, 2323. 
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aziridines 185. When ester 186, bearing an activating group possessing a Lewis basic 
oxygen, was submitted to the same reaction conditions, triazoline 187 would decompose to 
deliver 188 with a,b-substituted anti-amino hydroxylation (Figure 65B). This participation 
in the decomposition by the carbonyl oxygen occurs in a stereospecific fashion capable of 
producing diastereomeric ratios greater than 20:1. Further investigations into the 
mechanism were carried out, confirming the presence of a triazoline intermediate and 
gathering mechanistic evidence by in situ IR for its formation and decomposition to 
oxazolidine dione.148,150 
 
 
Figure 65: Brønsted acid-promoted reactions of azide with olefins. 
 
2.2.2 Model system for synthesis of (+)-zwittermicin A core 
 
With a robust methodology to provide aminohydroxylated products in high 
diastereoselection and under relatively mild conditions, a synthesis of a complex natural 
product was pursued to display its viability and utility. Zwittermicin A became an attractive 
candidate, as it contains a complex, C2 symmetric aminopolyol core that could be 
synthesized in a bidirectional fashion utilizing a novel substrate controlled anti-
diastereoselective azide olefin reaction.151 The assembly of this core diastereoselectively was 
tested on imide 189 bearing a chiral center similar to that in the natural product.152 The 
alcohol bore a bulky TBDPS group to aid in selectivity (Figure 66). Under thermal 
conditions (Figure 66A) the yield of 190 is modest, and the diastereoselectivity is minimal. 
But under the acid promoted conditions, the yield is slightly higher, and the selectivity is 
much better, but produces the SN2’ product 191 in almost equal amount (Figure 66B).  
                                      
150 Donahue, M. G.; Hong, K. B.; Johnston, J. N. Bioorg. Med. Chem. Lett. 2009, 19, 4971. 
151 At the time of this study, the absolute stereochemistry of (+)- zwittermicin A had not been confirmed. Therefore, 
the opposite enantiomer is shown in the schemes of this section. 
152 Hong, K. B. Brønsted Acid Promoted Olefin Functionalization (Anti-Aminohydroxylation) and Progress Toward 
(+)-Zwittermicin A. PhD Dissertation, Vanderbilt University, 2010. 
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Figure 66: Model system for diastereoselective [3+2] cycloaddition. 
Both the anti,anti-190 and syn,anti-190 products were subjected to fragmentation 
conditions, and provided the corresponding diastereomeric oxazolidine diones 192 and 193 
in 68% and 60% yields, respectively (Figure 67). This model study showed promise for the 
assembly of the core of (+)-zwittermicin A and synthesis was begun. 
 
 
Figure 67: Fragmentation of model system triazoline. 
 
3.2.3 Synthesis of bis(Imide) 181 
 
The bidirectional synthesis of (+)-zwittermicin A begins with the known preparation 
of the C2 symmetric diol 194 (Figure 68).153 Pentanedione is activated by a Lewis acid and 
undergoes nucleophilic acyl substitution with two equivalents of chloroacetyl chloride. The 
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conversion of this intermediate is then driven to completion by removal of acetyl chloride 
by distillation from the mixture. The resulting dichloropentanedione is unstable, and must 
be stabilized by coordination with copper(II). This copper complex is formed in 58% yield 
(88 g) on up to 750 mmol scale. 
Complex 195 (Figure 68) can be deprotected under aqueous acid conditions, then 
immediately subjected to Noyori reduction by ruthenium(II), (R) BINAP, and a hydrogen 
atmosphere to yield chiral diol 194 as a single enantiomer.153 This reduction originally 
appeared problematic, with yields of 194 averaging around 18% on 80 mmol scale, while 
the reported yield is 40%. This difference in yield was originally attributed solely to an 
increased presence of oxygen and water, as it was not performed in a glove box. Yet, in 
previous preparations, neither the toluene used for catalyst preparation nor the methanol 
used during the reduction were dried or degassed. After formation, the Noyori catalyst also 
must be heated and dissolved in the reaction solvent, or else poor solubility likely leads to 
poor conversion. In addition, the reaction bomb was previously used without a glass insert 
and was therefore incapable of holding a stir bar. Without stirring, the surface area between 
the reaction mixture and hydrogen was limited during the reaction, leading to poor 
conversion. Making these adaptions increased the yield of 194 to 29% on the same scale. 
This reduction is the lone enantioselective reaction of the synthesis, and the chirality of this 
substrate is the basis of all future stereoselection. 
 
 
Figure 68: Enantioselective preparation of chiral diol precursor 194. 
 
To prepare the substrate for the Horner-Wadsworth-Emmons olefination, diol 194 
is then treated with trimethyl sulfonium iodide and strong base to effect bis(olefination) 
yielding compound 196 (Figure 69).154 Again, this known reaction was originally yielding 
half of the expected 80%, with poor conversion of starting material and decomposition of 
product. This was initially addressed by using THF dried over sieves so maximal ylide could 
be generated. Additionally, this reaction requires 10 equivalents of trimethyl sulfonium 
iodide, and with that amount of salt in the reaction slurry, magnetic stirring becomes 
ineffective. To remedy this, a dimpled flask equipped with a mechanical stirrer was used to 
maximize turbulence and temperature consistency throughout the mixture. Elimination of 
sulfonium to olefin 196 is hypothesized to be the slow step, and these sulfonium 
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intermediates may be sensitive at temperatures above -40 °C, so the reaction was kept at -
50 °C to ensure minimal decomposition before slowly warming to room temperature. The 
concentration was also lowered to discourage any intermolecular decomposition pathways. 
These changes increased the yield of diene 196 from 45% to 73% on 300 mmol scale, 
relieving a major bottleneck in the synthesis. The diol moiety of diene 196 was next silyl 
protected prior to oxidative cleavage of the olefins. Tetraisopropyldisiloxane (-TIPDS-) was 
employed because of its high diastereoselectivity in the azide-olefin [3+2] cycloaddition.139 
After extraction, crude 182 appeared very clean, however the mass balance was too high, 
possibly due to excess TIPDSCl2. Column chromatography of 182 revealed a significant 
amount of a byproduct, possibly from methanol opening of the siloxane ring. 
 
 
Figure 69: Preparation of TIPDS protected diene 196. 
Diene 182 was converted to bis(aldehyde) 197 by a two-step procedure, as direct 
ozonolysis led to complex reaction mixtures with little aldehyde observed by 1H NMR.146 
Muchalski found that a two-step procedure utilizing an Upjohn dihydroxylation155 followed 
by Johnson-Lemieux oxidation,156 was able to provide bis(aldehyde) 197 cleanly. When  
 
Figure 70: Optimized synthesis of bis(imide) 181.  
crude diene 182 was dihydroxylated with catalytic OsO4 and NMO, a mixture of 
diastereomers 198 was isolated in 65% yield (Figure 70). When 196 was purified prior to 
dihydroxylation, yields were as high as 82%, but the unwanted byproduct generated by its 
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purification led to use of 182 crude. Reacting 199 with silica-gel supported NaIO4 yielded 
bis(aldehyde) 197, which was unstable and used immediately in unpurified form. Treatment 
with the stabilized phosphonate ester anion effected the Horner-Wadsworth-Emmons 
olefination yielding 80% of the E,E–bis(imide) 181 after purification. This approach 
convergently and bidirectionally provided 181 in 7 steps and 10% overall yield from 2,4 
pentanedione.  
 
3.2.4 Synthesis of bis(acid) 208 
 
With an efficient route to bis(imide) 181 in hand, Muchalski screened a range of 
imide substituents, as well as cyclic and acyclic silyl protecting groups for their effect on 
the diastereoselection and yield of the [3+2] azide-olefin cycloaddition (Table 22).146,149 
Acyclic silyl protecting groups (TIPS, TBS, TBDPS) could not be used in ozonolysis or 
Johnson-Lemiuex oxidative cleavage due to decomposition. Cyclic silyl groups, TIPDS and 
DTBS, were then examined because of their increased conformational restraint and steric 
hindrance, which could improve stability of bis(aldehyde) 197 while also improving 
diastereoselection in the subsequent cycloaddition. DTPS protected methyl carbamate 199a 
was formed in good yield (79%). However, TIPDS protected methyl carbamate 199b formed 
in low yield. Byproduct 200 was isolated and hypothesized to form from fast acyl transfer 
over the slower oxaphosphetane formation. By changing R2 to tert-butyl, 199c could be 
synthesized in good yield. However, the tert-butyl carbamate was labile in the strongly-
acidic conditions of the [3+2], yielding only the bis(amide) byproduct 201. Therefore, the 
iso-propyl carbamate 199d was chosen for its steric deterrence of acyl transfer in the HWE 
and its stability under acidic conditions.  
 
Table 22: Imide substituent and silyl group screen 
 
 
Entry 199 R1 R2 R3 
1 199a Bn Me -DTBS- 
2 199b Bn Me -TIPDS- 
3 199c Bn tBu -TIPDS- 
4 199d Bn iPr -TIPDS- 
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Muchalski found when the various (bis)imides were screened under both thermal and 
acidic conditions for triazoline formation, 199d was found to be the optimal substrate under 
acidic conditions (Figure 71).146,149 It yielded the desired anti,anti diastereomer 180a in an 
18:1:1 ratio over the anti,syn-180a and syn,syn-180a diastereomers (as determined by 
NOESY). Use of the DTBS protecting group (199a) gave lower yield and a 1:9:9 ratio of 
diastereomers under the same conditions, suggesting that the flexibility provided by the 8 
membered disiloxane ring was important for adopting a conformation conducive to high 
diastereoselection.  
 
 
Figure 71: Triflic acid promoted, diastereoselective [3+2] cycloaddition. 
Triazoline 180a was treated with triflic acid at room temperature to induce 
fragmentation of the triazoline ring, releasing dinitrogen, and forming the bis(oxazolidine 
dione) 202a in 71% yield (Figure 72). For the next conversion, a variety of hydroxide 
sources, Brønsted acid, hydrides, and Lewis acids were tested for opening the bis(oxazolidine 
dione) rings to yield bis(amide), however, none were successful.146 
 
 
Figure 72: Triazoline fragmentation and functionalization. 
Believing this poor reactivity was due to the electron donating effect of the benzyl 
substituent, the route was adjusted by Muchalski to interchange it with a phenyl substituent 
(Figure 73). Diethylphosphonoacetic acid 203 was converted to the acid chloride prior to 
coupling with aniline to form amide 204. This amide was deprotonated with LHMDS and 
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then added into isopropyl chloroformate to yield imide 205 in 70% yield over the four steps. 
This imide is highly susceptible to hydrolytic decomposition at the amide carbon, thus the 
complete purification must be carried out immediately after quenching the reaction. 
Muchalski also developed a more cost-effective protocol for the HWE olefination to give 
bis(imide) 199e in similar yields. The [3+2] cycloaddition converted faster and in similar 
yields and diastereoselction. The equivalents of benzyl azide could be reduced without 
diminishing yield or selectivity. Bis(triazoline) 180b was problematic in the subsequent 
fragmentation. Use of triflic acid could no longer accelerate the reaction of 180b as it did 
with 180a, and decomposition was observed at higher temperatures. Weaker acids such as 
methanesulfonic and para-toluene sulfonic acid provided much faster conversion, and using 
para-toluene sulfonic acid allowed for simple chromatographic purification of bis(oxazolidine 
dione) 202b in 70-90% yield.  
 
 
Figure 73: Adjusted route to N-Ph bis(oxazolidine dione) 202b. 
With phenyl substituted bis(oxazolidine dione) 202b prepared, opening of the 
oxazolidine dione rings was attempted again.146 Hydroxides and alkoxides only caused 
decomposition or epimerization. A Lewis acid, Ti(OiPr)4, was mildly successful, causing ring 
opening in 55% yield but with low conversion, irreproducibility, and an inseparable mixture 
of starting material and product. When treated with methanol and ammonia (Figure 74), 
both starting material and product were converted to bis(amide) 206, which not only opens 
the oxazolidine dione rings with methoxide, but also cyclizes the requisite carbonate with 
the benzyl amine to form the bis(amide). This mechanism is evidenced by isolation of 
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partially cyclized intermediate 207. The 1H NMR of the crude reaction mixture generally 
indicated that 202b cleanly converted to 206. After concentration, however, the 1H NMR 
showed significant degradation to unknown byproducts, and chromatography was very 
difficult, never yielding more than 42%. It was hypothesized that this decomposition was 
due to the remaining ammonia before concentration. The protocol was altered to include an 
argon purge of the reaction mixture after full conversion was reached, and consequently, 
yields increased to 66% of 206. This mechanism in one step effectively reveals the terminal 
carbons for later functionalization as well as protects the secondary amines as oxazolidinone 
rings. 
 
 
Figure 74: Isomerization to bis(amide) 206. 
 
Figure 75: Preparation of bis(acid) 208. 
Bis(amide) 206 could not be directly converted to bis(acid) 208 using ammonium 
hydroxide, but could by a two-step procedure (Figure 75). Boc protection proceeded well, 
then 209 is saponified to bis(acid) 208, which had to be used crude, due to its high polarity. 
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3.2.5 Synthesis of isonitrile 177 and initial route to an advanced intermediate 
 
With a route established to synthesize bis(acid) 208 efficiently, the pseudo C2-
symmetric core of (+)-zwittermicin A was complete, and five of seven stereocenters are 
established. Desymmetrization, removal of one of the terminal carbons, and a 
diastereoselective Passerini reaction still remained.  
First, preparation of isonitrile 210 (Figure 76) was attempted by Muchalski for 
coupling in the Passerini reaction. This isonitrile would allow for the most convergent route 
possible, as no further functional group manipulations would be necessary after the 
Passerini. However, preparation of this proved difficult, due to incompatible preparations 
for the urea, amide, and isonitrile functional groups. When the urea was formed first, the 
amide could not subsequently be formed. By protecting the secondary amine, the urea and 
amide could be constructed, however this amine could not then be formylated in route to 
the isonitrile. When isonitrile preparation was attempted after installation of the urea, the 
compound could not be isolated. The urea amine was even brought in as an azide, which 
was also incompatible with isonitrile formation. At the expense of convergence, the urea 
would need to be formed after the Passerini from the Boc-protected amine. Thus, synthesis 
of isonitrile 177 was begun with the conversion of L-aspartic acid to L-DAP 211 by a 
Schmidt reaction (Figure 76). The acid was then converted to methyl ester 212, which was 
selectively Boc-protected in 73% yield. The free amine could then be formylated to yield 
compound 213. Triphosgene and NMM effect the dehydration of the formamide, and  
 
Figure 76: Synthesis of isonitrile 177. 
isonitrile 177 was formed in 70% yield. Attempts to convert the methyl ester to an amide 
failed, indicating that this would need to take place after the Passerini as well. Methodology 
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for the main convergent connection could be developed to employ a diastereoselective Henry 
reaction with nitromethane. Oxidation of the resultant nitroalkane to a carboxylic acid 
would allow for a simple amide coupling with a more highly functionalized western piece. 
This could possibly shorten the longest linear sequence dramatically. 
At this point, Muchalski explored a route that was not ultimately successful, but 
was vastly significant in developing the current one. From bis(acid) 208, reduction to the 
alcohols, followed by trityl protection, yielded desymmetrized mono alcohol 214 in 30% 
(86% brsm) (Figure 77). Swern oxidation was found to be the best method for aldehyde 
formation, which had to be used immediately in the Passerini reaction with isonitrile 177 
due to aldehyde instability. The Passerini provided adduct 215 in 65% yield and modest 
2:1 dr. The identities of the diasteromers could not be determined, and will need to be 
assigned by comparison to the natural product.  
 
 
Figure 77: Initial route to Passerini adduct 215.  
 
Figure 78: Amide 216 formation. 
With all stereocenters now set, decarbonylation, several functional group 
manipulations, and global deprotection remained. Conversion of methyl ester 215 to the 
free amide could be achieved by saponification with trimethyltin hydroxide, which was 
effective at avoiding epimerization (Figure 78). Diastereomers were separated, then 
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converted to the mixed anhydride before amide formation by ammonium hydroxide to yield 
216.  
Boc deprotection of the terminal amine was attempted with TFA but caused 
epimerization of the product. Thus, Muchalski attempted to globally deprotect the methyl 
ester, the benzoate ester and the oxazolidinone rings of 216 at once using a variety of 
strongly basic conditions (Figure 79), however the oxazolidinone rings were never reactive.  
 
 
Figure 79: Attempted deprotection of 216. 
Again, this poor reactivity was attributed to the N-benzyl substituent’s electron rich 
character, decreasing the electrophilicity of the carbamate. Using a model system (Figure 
80), Muchalski determined that a protecting group exchange to the more electron 
withdrawing N-tosyl would allow for oxazolidinone deprotection. However, seeing the 
difficulty of the amide formation and deprotections, it was decided to remove a terminal 
carbon prior to the Passerini. The conclusions drawn from this initial pass through the final 
stages of the synthesis were tremendously useful in shaping the current route towards (+)-
zwittermicin A. 
 
 
Figure 80: Model system for N-tosyl carbamate deprotection. 
 
3.2.6 Desymmetrization, decarbonylation, and preparation of Passerini substrate 178 
 
The knowledge gained from the initial route indicated the molecule must not only 
be desymmetrized before the Passerini, but must lose one carbon as well. Therefore bis(acid) 
208 needed to be monoprotected prior to radical decarbonylation at the free carboxylic 
acid. Muchalski attempted several monoesterification methods, and the most effective one 
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found was developed by Nishiguchi for dicarboxylic acids of 4-14 carbon units.157,158 The 
bis(acid) was subjected to a toluene-HCO2nBu mixture with DOWEX 50WX8 resin at high 
temperatures to yield the purified monoprotected ester in up to 57% yield. Since the resin 
is about 50% water by weight, the bis(acid) is more soluble and reactive at the resin surface. 
This allows the bis(acid) to react faster than the monoprotected product 217 (Figure 81). 
An added benefit to this method was that bis(ester) 218 could be easily isolated in 40-60% 
yield and treated with LiOH to recover additional bis(acid) 208 for recycling. 
 
 
Figure 81: Desymmetrization and monoprotection of bis(acid) 208. 
 
Figure 82: Synthesis of decarbonylated ester 220. 
With desymmetrization accomplished, removal of the terminal carboxylic acid 
carbon could be undertaken. Several trials were required to determine that activation of the 
acid before treatment with benzeneselenol gave the best conversion of starting material to 
selenoester 219 (Figure 82). Without isolation, the selenoester was dried over P2O5 then 
treated with 2 equivalents of nBu3SnH and 1 equivalent of AIBN at high temperature to 
cause decarbonylation in yields averaging 65%. Product 220 cannot be produced if the 
selenoester is not sufficiently dried and if the AIBN has not been recently recrystallized.  
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As previously determined by Muchalski’s first route, the carbamate benzyl group 
needed to be converted to tosyl to provide for facile deprotection after the Passerini. Thus, 
ester 220 had to be reduced and protected (Figure 83). Several stronger reducing agents 
were examined in the initial route, however only the milder NaBH4 could convert the ester 
to the alcohol. This was carried out and then protected by MOMCl to yield the MOM ether. 
Now the benzyl groups could be removed by Birch reduction to yield unprotected carbamate 
221 in 78% yield over three steps. This was deprotonated with nBuLi and quenched with 
tosyl chloride. The MOM ether could then be removed with TFA to provide the Passerini 
substrate 178 in 82% yield.  
 
 
Figure 83: Preparation of Passerini precursor 178.  
 
3.2.7 Passerini and final steps twowards (+)-zwittermicin A 
 
With the stage set for the Passerini, the oxidation of the primary alcohol again 
needed optimization. Many conditions using DMP, DMSO, PCC, TPAP, and TEMPO were 
examined before an NMR study with DMP was conducted. This showed that the alcohol 
was completely consumed in fifteen minutes to produce the aldehyde product. The reagents 
for the Passerini could be added directly to the reaction mixture, and complete conversion 
was achieved quickly. The aldehyde is extremely reactive and therefore very sensitive to 
water and air. Passerini adduct 222 could be isolated from the reaction in 50% yield in a 
4:1 diastereomeric ratio (Figure 84), however the configuration of the major diastereomer 
will remain unknown until comparison with the natural product. 
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Figure 84: Optimized oxidation and Passerini to yield compound 222.  
The proposed model for the Passerini reaction is shown in Figure 85. This model 
positions the more electronegative oxygen substituent perpendicular to the carbonyl and 
opposite the approach of the nucleophile regardless of the steric influences of the largest 
substituent, as dictated by the Felkin-Anh model.159 This relieves the dipole-dipole repulsion 
that would occur in the transition state as the nucleophile-carbon bond is forming, and 
would provide conformation A (Figure 85). It is hypothesized, however, that the steric 
interaction of the large, amino methine substituent with the carbonyl will cause 
conformation B to predominate, with the oxygen substituent still perpendicular, but the 
largest group furthest from the carbonyl, as dictated by the Cram model.160 If predicted 
correctly, conformation B would lead to the correct configuration found in (+)-zwittermicin 
A. If incorrect, the counterion could be modified, perhaps to a chiral acid, to modulate the 
diastereoselectivity. If still unsuccessful, either epimerization by Mitsunobu reaction can be 
employed, or the Passerini can be run at higher temperature to afford a diastereomeric ratio 
closer to 1:1.  
 
 
Figure 85: Proposed model for the diastereoselective Passerini. 
With the final key reaction accomplished, all that remained were several functional 
group manipulations and deprotections (Figure 86). First, as found in Muchalski’s initial 
route, methyl ester 222 had to be converted to the amide by a two-step procedure. 
Saponification with trimethyltin hydroxide successfully avoided epimerization at the 
position a to the amide, but proceeded only in moderate yield due to poor conversion. 
Formation of the mixed anhydride allowed for amide 223 formation in 49% yield. Next, the 
urea was installed, since it could not be formed in the presence of the isonitrile prior to the 
                                      
159 Chérest, M.; Felkin, H.; Prudent, N. Tetrahedron Lett. 1968, 9, 2199. 
160 Cram, D. J.; Wilson, D. R. J. Am. Chem. Soc. 1963, 85, 1245. 
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Passerini. This was accomplished by first deprotecting the Boc amine with trifluoroacetic 
acid, then the crude amine was treated with trimethylsilyl isocyanate to yield urea 224 in 
50%. The tosylated oxazolidine rings will be opened with Cs2CO3, as was successfully done 
by Muchalski in 51% yield with a model system. Removal of the cyclic silyl protecting 
group, TIPDS, from 225 will be effected by HF•pyridine to afford 226. Finally, the tosyl 
groups will be removed by Birch reduction to complete the total synthesis of (+)-
zwittermicin A.  
 
 
Figure 86: Final manipulations for the synthesis of (+)-zwittermicin A. 
In summary of this author’s throughput, copper complex 195 was prepared on a half 
mol scale (Figure 87). This was converted to 150 mmol of chiral diol after the Noyori 
reduction was optimized up to 25% yield. Careful alteration of the olefination reaction 
procedure increased the yield to 70% and yielded 22g of the bis(olefin) product, 196. 74 
mmol (58 g) of the HWE product 199e was produced, as opposed to 22g previously. 
Increased yield over the next several steps allowed for an increase from the previous 18% 
yield over those same steps. Conversion of all material to the desymmetrized mono acid 
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217 provided 10 g of the product, which was passed along to coworkers specializing in the 
backend of the synthesis. If the final two steps can be optimized, this material could be 
enough to provide several milligrams of (+)-zwittermicin A. 
 
Figure 87: Summary of synthetic sequence with optimized yields and material 
throughput. 
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4 Experimental appendix 
 
A Characterization of organic molecules  
 
General Experimental Details  
All reagents and solvents were commercial grade and purified prior to use when 
necessary. Toluene and tetrahydrofuran was dried by passage through a column of activated 
alumina as described by Grubbs.i N-Iodosuccinimide was recrystallized from dioxane and 
carbon tetrachloride. Thin layer chromatography (TLC) was performed using glass-backed 
silica gel (250 μm) plates and flash chromatography utilized 230–400 mesh silica gel from 
Sorbent Technologies.  
UV light, and/or the use of iodine/SiO2 were used to visualize products. Nuclear 
magnetic resonance spectra (NMR) were acquired on a Bruker DRX-500 (500 MHz), Bruker 
AV- 400 (400 MHz) or Bruker AV II-600 (600 MHz) instrument. Chemical shifts are 
measured relative to residual solvent peaks as an internal standard set to δ 7.26 (1H) and δ 
77.0 (13C) (CDCl3) and δ 2.50 (1H) and δ 39.52 (13C) (DMSO-d6). IR spectra were recorded 
on a Thermo Nicolet IR100 spectrophotometer and are reported in wavenumbers (cm-1). 
Compounds were analyzed as neat films on a NaCl plate (transmission). Mass spectra were 
recorded on a Waters LCT spectrometer by use of the ionization method noted.  
 
Catalyst Synthesis 
 
 
 
6-(tert-Butyl)-2,4-dichloroquinoline (S1).  
To a 50 mL round-bottom flask in an ice bath was added malonic acid (3.85 g, 37.0 
mmol) and POCl3 (15.0 mL, 160 mmol). After stirring for five minutes, 4-tert-butyl aniline 
(5.90 mL, 37.0 mmol) was added slowly. The flask was then moved to an oil bath, equipped 
with a condenser and argon balloon, and stirred for 6 hours at reflux. The reaction was then 
removed from the oil bath and poured into a 500 mL beaker containing 250 mL of ice-water. 
Water was used to rinse the reaction flask into the beaker. The mixture was stirred 
vigorously and solid NaOH was added slowly until the pH was neutral. The mixture was 
filtered, and the collected solid was transferred to a 500 mL round-bottom flask. Hexanes 
was added to the flask, and the mixture was triturated by stirring in a warm water bath 
NH2
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Cl
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HO OH
OO
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tBu
(25%)
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for 15 minutes. The mixture was filtered, and the filtrate was concentrated to a yellow oil. 
The oil was purified by flash column chromatography (SiO2, 0-10% ethyl acetate in hexanes) 
to yield 2.38 g (25%) as a yellow solid. Mp 45-47 °C; Rf = 0.58 (10% EtOAc/hexanes); IR 
(film) 2960, 2870, 1563, 1494, 1390, 1263, 1195 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.09 (d, 
J = 2.1 Hz, 1H), 7.96 (d, J = 8.9 Hz, 1H), 7.87 (dd, J = 8.9, 2.1 Hz, 1H), 7.46 (s, 1H), 1.43 
(s, 9H); 13C NMR (100 MHz, CDCl3) ppm 151.3, 149.2, 146.8, 144.3, 130.6, 128.7, 124.8, 
121.8, 119.3, 35.4, 31.2; HRMS (EI): Exact mass calcd for C13H14Cl2N [M+H]+ 254.0503, 
found 254.0498. MTK-4-176. 
 
 
 
(1R,2R)-N1,N2-bis(6-(tert-Butyl)-4-chloroquinolin-2-yl)-1,2-diphenylethane-
1,2-diamine (S2). 
To a 100 mL, flame-dried round-bottom flask was added Pd(dba)2 (34 mg, 59 µmol), 
rac-BINAP (73 mg, 120 µmol) and NaOtBu (944 mg, 9.83 mmol) in a glovebox. The flask 
was removed from the glovebox and charged with diamine (835 mg, 3.93 mmol), quinoline 
(2.00 g, 7.87 mmol) and toluene (40 mL). The flask was heated at 80 ºC under argon 
atmosphere for 22 hours, and then removed from heat and quenched with 10 mL of satd aq 
NH4Cl. The mixture was transferred to a separatory funnel and the layers were separated. 
The aqueous layer was extracted with ethyl acetate, and the organic layers were combined, 
dried with Mg2SO4, filtered, and concentrated to an orange oil. The oil was purified by flash 
column chromatography (SiO2, 5-10% ethyl acetate in hexanes) to yield 1.20 g (47%) as a 
yellow solid. Mp 135-138 °C; [a]  +7.60 (c 1.12, CHCl3); Rf = 0.35 (10% EtOAc/hexanes); 
IR (film) 3236, 3063, 2961, 1599, 1479, 1396, 1252 cm-1; 1H NMR (400 MHz, DMSO-
d6/CDCl3, 10:1) δ 7.88 (br d, J = 6.8 Hz, 2H), 7.75 (d, J = 2.0 Hz, 2H), 7.62 (dd, J = 8.8, 
2.0 Hz, 2H), 7.47 (d, J = 8.8 Hz, 2H), 7.33 (d, J = 7.6 Hz, 4H), 7.14 (t, J = 7.6 Hz, 4H), 
7.05 (t, J = 7.6 Hz, 2H), 7.02 (s, 2H), 5.63 (br d, J = 5.2 Hz, 2H), 1.32 (s, 18H); 13C NMR 
(100 MHz, DMSO-d6/CDCl3, 10:1) ppm 155.8, 146.5, 144.5, 141.5, 140.5, 128.6, 127.7, 127.5, 
126.5, 126.0, 119.8, 118.1, 112.1, 59.2, 34.2, 31.0; HRMS (EI): Exact mass calcd for 
C40H41Cl2N4 [M+H]+ 647.2708, found 647.2728. MTK-4-181. 
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N2,N2'-((1R,2R)-1,2-Diphenylethane-1,2-diyl)bis(N4-phenylquinoline-2,4-
diamine) (123c). 
To a 2-5 mL microwave vial with a stir bar was added 4-Cl quinoline (95 mg, 180 
µmol), isopropanol (1.8 mL), trifluoroacetic acid (35 µL, 440 µmol) and aniline (65 µL, 710 
µmol). The vial was sealed (which was less than half-filled), placed behind a blast shield 
and heated in an oil bath at 110 °C for 18 hours, and then removed from heat. The mixture 
was concentrated under reduced pressure, and then dissolved in dichloromethane (20 mL) 
and transferred to a separatory funnel. The organic layer was washed with 2 M HCl (20 
mL), and the aqueous layer was extracted with dichloromethane. The combined organic 
layers were washed with 6 M NaOH (20 mL), and the aqueous layer was extracted with 
dichloromethane. The organic layers were combined, dried (Mg2SO4), filtered, and 
concentrated to an off-white solid (20 mg, 17%). Mp 109-111 °C; [a]  +5.36 (c 1.00, CHCl3); 
Rf = 0.37 (20% MeOH/CH2Cl2); IR (film) 3235, 3056, 2923, 2856, 1589, 1526, 1500, 1437, 
1254, 1083, 1033 cm-1; 1H NMR (400 MHz, DMSO-d6/CDCl3, 10:1) δ 8.38 (br s, 2H), 7.99 
(br d, J = 8.3 Hz, 2H), 7.40-7.29 (m, 14H), 7.17-7.13 (m, 8H), 7.09-7.02 (m, 6H), 6.30 (br 
s, 2H), 5.52 (br s, 2H); 13C NMR (125 MHz, DMSO-d6/CDCl3, 10:1) ppm 157.6, 148.7, 147.3, 
142.4, 141.2, 129.1 (2C), 128.9, 127.6, 127.5, 126.3, 126.0, 122.6, 121.7, 121.6, 119.9, 116.6, 
90.7; HRMS (EI): Exact mass calcd for C44H37N6 [M+H]+ 649.3074, found 649.3076. MTK-
6-128. 
 
 
 
 
N2,N2'-((1R,2R)-1,2-Diphenylethane-1,2-diyl)bis(6-(tert-butyl)-N4-
phenylquinoline-2,4-diamine) (126a). 
To a 10-20 mL microwave vial with a stir bar was added 4-Cl quinoline (500 mg, 
770 µmol), isopropanol (7 mL), trifluoroacetic acid (150 µL, 1.93 mmol) and aniline (280 
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µL, 3.09 mmol). The vial was sealed (which was less than half filled), placed behind a blast 
shield and heated in an oil bath at 110 ºC for 18 hours, and then removed from heat. The 
mixture was concentrated under reduced pressure, and then dissolved in dichloromethane 
(20 mL) and transferred to a separatory funnel. The organic layer was washed with 2 M 
HCl (20 mL), and the aqueous layer was extracted with dichloromethane. The combined 
organic layers were washed with 6 M NaOH (20 mL), and the aqueous layer was extracted 
with dichloromethane. The organic layers were combined, dried with Mg2SO4, filtered, and 
concentrated to an off white solid (573 mg, 98%). Mp 165-168 °C; [a]  +4.80 (c 1.58, 
CHCl3); Rf = 0.63 (20% MeOH/CH2Cl2); IR (film) 3249, 3055, 2958, 1589, 1498, 1260 cm-1; 
1H NMR (400 MHz, DMSO-d6/CDCl3, 10:1) δ 8.42 (br s, 2H), 7.92 (br s, 2H), 7.48 (d, J = 
8.8 Hz, 2H), 7.36-7.31 (m, 12H), 7.17 (m, 8H), 7.06 (m, 4H), 6.26 (br s, 2H), 5.51 (br s, 2H), 
1.34 (s, 18H); 13C NMR (100 MHz, DMSO-d6/CDCl3, 10:1) ppm 157.3, 147.5, 146.9, 142.4, 
141.3, 129.2 (2C), 127.6, 127.5, 127.1, 126.3, 125.6, 122.7, 122.0, 117.1, 115.9, 90.8, 59.7, 
34.5, 31.4; HRMS (EI): Exact mass calcd for C52H53N6 [M+H]+ 761.4332, found 761.4331. 
MTK-4-186. 
 
 
 
N2,N2'-((1R,2R)-1,2-Diphenylethane-1,2-diyl)bis(6-(tert-butyl)-N4-(p-
tolyl)quinoline-2,4-diamine) (126d). 
To a 10 mL microwave vial with a stir bar was added 4-Cl quinoline (1.00 g, 1.54 
mmol), isopropanol (6 mL), trifluoroacetic acid (295 µL, 3.85 mmol) and p-toluidine (662 
mg, 6.18 mmol). The vial was sealed and heated at 110 ºC for 18 hours, and then removed 
from the oil bath. The mixture was concentrated by rotary evaporator, and then dissolved 
in dichloromethane (20 mL) and transferred to a separatory funnel. The organic layer was 
washed with 2 M HCl (20 mL), and the aqueous layer was extracted with dichloromethane. 
The combined organic layers were washed with 6 M NaOH (20 mL) by vigorous stirring for 
2 h, and the aqueous layer was extracted with dichloromethane. The organic layers were 
combined, dried with Mg2SO4, filtered, and concentrated to an off-white solid. The solid 
was recrystallized from CH2Cl2/heptanes to yield colorless crystals (610 mg, 50%). Note 
that prior to use of this highly crystalline material, it must be dissolved in hot toluene or 
ethyl acetate and then be reconcentrated to enhance solubility. Mp 175-178 °C; [a]  +58.7 
(c 1.02, CHCl3); Rf = 0.39 (20% MeOH/CH2Cl2); IR (film) 3249, 3055, 2958, 1589, 1498, 
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1260 cm-1; 1H NMR (400 MHz, DMSO-d6/CDCl3, 10:1) δ 8.31 (br s, 2H), 7.92 (br s, 2H), 
7.46 (d, J = 8.8 Hz, 2H), 7.32-7.27 (m, 6H), 7.18-7.05 (m, 16H), 6.12 (br s, 2H), 5.52 (br s, 
2H), 2.32 (s, 6H), 1.34 (s, 18H); 13C NMR (100 MHz, DMSO-d6/CDCl3, 10:1) ppm 157.3, 
147.5, 146.9, 142.4, 141.3, 129.2, 127.6, 127.5, 127.1, 126.3, 125.6, 122.7, 122.0, 117.1, 115.9, 
90.8, 59.7, 34.5, 31.4; HRMS (EI): Exact mass calcd for C54H57N6 [M+H]+ 789.4645, found 
789.4684.  MTK-4-232. 
 
 
 
(1R,2R)-N1,N2-bis(6-(tert-Butyl)-4-(pyrrolidin-1-yl)quinolin-2-yl)-1,2-
diphenylethane-1,2-diamine (14i). 
A 2-5 mL microwave vial equipped with a stir bar was charged with 4-Cl, 6-tBuStilb-
BAM (100 mg, 150 µmol), pyrrolidine (60 µL, 770 μmol), and trifluoromethylbenzene (1.5 
mL). The vial was sealed, and this solution was heated with stirring at 180 °C in the 
microwave for 2 h. The reaction mixture was diluted with dichloromethane and transferred 
to a separatory funnel, and washed with 4 M NaOH (50 mL). The resulting organic layer 
was dispensed into a 125 mL Erlenmeyer flask and dried (Mg2SO4). The solution was 
removed in vacuo to provide a light brown powder (101 mg, 92%). Mp 261-263 °C; [a]  
+26.8 (c 1.00, CHCl3); Rf = 0.34 (10% MeOH/CH2Cl2); IR (film) 3239, 2959, 2866, 1582, 
1438, 1361, 1277 cm-1; 1H NMR (400 MHz, DMSO-d6) δ 7.82 (br d, J = 1.3 Hz, 2H), 7.46-
7.35 (m, 10H), 7.18 (d, J = 7.4 Hz, 2H), 7.16 (d, J = 7.4 Hz, 2H), 7.07 (dd, J = 7.2, 7.2 
Hz, 2H), 5.84 (br s, 2H), 5.59 (br s, 2H), 3.46-3.41 (br m, 4H), 3.36-3.31 (br m, 4H), 1.88 
(br s, 8H), 1.30 (s, 18H); 13C NMR (100 MHz, DMSO-d6) ppm 157.1, 153.0, 142.4, 141.2, 
127.7 (3C), 126.5, 126.4, 125.6, 120.0, 117.3, 92.3, 60.1, 51.5, 34.1, 31.3, 25.3; HRMS (EI): 
Exact mass calcd for C48H57N6 [M+H]+ 717.4639, found 717.4638.  MTK-6-130. 
 
Preparation of Cyclopentene Carboxylic Acids  
Known compounds were synthesized according to published procedures.  
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1-(Naphthalen-2-yl)cyclopent-3-ene-1-carboxylic acid (107b). 
To a flame-dried round-bottom flask under nitrogen atmosphere was added NaH (60 
mg, 2.5 mmol, 2.0 eq), THF (2.5 mL) and DMPU (600 µL). The mixture was cooled to 0 
ºC while stirring, upon which the methyl ester (250 mg, 1.25 mmol, 1 eq) was added.  The 
mixture was warmed to room temperature for 10 minutes before recooling to 0 ºC. 
Dichlorobutene (160 µL, 1.50 mmol, 1.2 eq) was then added dropwise, and the reaction was 
stirred at room temperature overnight. The reaction was quenched by careful addition of of 
water (5 mL). The layers were separated, and the aqueous layer was extracted with ethyl 
acetate. The organic layers were combined, dried, filtered and concentrated to an oil. The 
oil was purified by flash column chromatography (SiO2, 10% ethyl acetate in hexanes) to 
yield an inseparable mixture of the methyl ester cyclopentene and cyclopropane (~10:1 ratio) 
as a colorless oil (270mg, 85%). This mixture was then dissolved in EtOH (11 mL), combined 
with KOH (300 mg, 5.29 mmol, 5 eq) and stirred under reflux overnight. The reaction was 
cooled to room temperature and acidified to pH 2 with 2 M H2SO4. The aqueous layer was 
extracted with ethyl acetate, and the combined organic layers were dried, filtered, and 
concentrated to a colorless solid. The solid was recrystallized from CH2Cl2/hexanes to yield 
the pure cyclopentene carboxylic acid as colorless crystals (180 mg, 60%, two steps). Mp 
162-164 °C; Rf = 0.31 (25% EtOAc/hexanes); IR (film) 3500-2500, 3418, 3061, 2902, 1690, 
1272 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.81-7.28 (m, 4H), 7.50-7.43 (m, 3H), 5.80 (s, 2H), 
3.52 (d, J = 15.2 Hz, 2H), 2.88 (d, J = 14.6 Hz, 2H), no CO2H observed; 13C NMR (100 
MHz, CDCl3) ppm 181.9, 140.2, 133.3, 132.5, 129.3, 128.3, 128.2, 127.6, 126.3, 126.1, 125.51, 
125.47, 58.5, 42.6; HRMS (CI): Exact mass calcd for C16H14O2 [M]+ 238.0988, found 238.0977.  
MTK-4-018. 
 
 
 
1-(Naphthalen-1-yl)cyclopent-3-ene-1-carbonitrile (S3). 
To a flame-dried round-bottom flask under nitrogen atmosphere was added LHMDS 
(4.51 g, 27.0 mmol, 3.5 eq) and THF (40 mL). The mixture was cooled to 0 ºC while stirring, 
at which time the nitrile (1.29 g, 7.70 mmol, 1 eq) was added.  The mixture was warmed 
to room temperature for 10 minutes before recooling to 0 ºC. Dichlorobutene (810 µL, 7.70 
mmol, 1 eq) was then added dropwise, and the reaction was stirred at room temperature 
overnight. The reaction was quenched by addition of water (5 mL) and ethyl acetate (5 
mL). The layers were separated, and the aqueous layers were extracted with ethyl acetate. 
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The organic layers were combined, dried, filtered and concentrated to an oil. The oil was 
purified by flash column chromatography (SiO2, 5% ethyl acetate in hexanes) to yield the 
pure cyclopentene nitrile as a yellow oil (325 mg, 19%). Rf = 0.58 (25% EtOAc/hexanes); 
IR (film) 3059, 2934, 2868, 2234, 1601, 1512, 1448, 1252 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 7.96-7.91 (m, 2H), 7.84 (d, J = 7.7 Hz, 2H), 7.55-7.51 (m, 2H), 7.45 (dd, J = 7.8, 7.8 Hz, 
1H), 5.96 (s, 2H), 3.40 (m, 4H), no CO2H observed; 13C NMR (100 MHz, CDCl3) ppm 134.9, 
134.3, 129.9, 129.5, 128.8 (2C), 126.4, 125.9, 125.6, 125.2, 125.0, 123.8, 47.4, 45.9; HRMS 
(CI): Exact mass calcd for C16H13N [M]+ 219.1043, found 219.1042.  MTK-4-084. 
 
 
 
1-(Naphthalen-1-yl)cyclopent-3-ene-1-carboxylic acid (107c). 
To a round-bottom flask was added cyclopentene nitrile (325 mg, 1.50 mmol, 1 eq), 
EtOH (15 mL) and KOH (270 mg, 4.70 mmol, 3.2 eq). The reaction was stirred at reflux 
for three days, and then cooled to room temperature. Water (5 mL) and ethyl acetate (5 
mL) were added. The layers were separated, and the aqueous layer was extracted with ethyl 
acetate. The organic layers were combined, dried, filtered and concentrated to provide the 
cyclopentene amide (204 mg, 58%). The amide material was refluxed with EtOH (1 mL) 
and 6 M HCl (1 mL) overnight, after which the reaction was cooled to room temperature, 
basified with aq. KOH, and diluted with dichloromethane (10 mL). The layers were 
separated, and the aqueous layer was acidified with 2 M H2SO4 and extracted with DCM. 
The combined organic layers were dried, filtered and concentrated to yield the carboxylic 
acid product as a colorless solid (57 mg, 16%). Mp 141-143°C; Rf = 0.32 (25% 
EtOAc/hexanes); IR (film) 3426, 3040, 2926, 2859, 1699, 1262 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.96-7.91 (m, 2H), 7.84 (d, J = 7.7 Hz, 2H), 7.55-7.51 (m, 2H), 7.45 (t, J = 7.8 
Hz, 2H), 5.96 (s, 2H), 3.40 (m, 4H); 13C NMR (100 MHz, CDCl3) ppm 182.0, 138.5, 134.7, 
131.5, 129.5, 128.51, 128.47, 126.3, 125.5, 125.2, 124.5, 124.1, 57.2, 44.1; HRMS (CI): Exact 
mass calcd for C16H14O2 [M]+ 238.0988, found 238.0983.  MTK-4-183. 
 
 
 
1-(3-Chlorophenyl)cyclopent-3-ene-1-carboxylic acid (107d).  
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To a flame-dried round-bottom flask under nitrogen atmosphere was added NaH 
(485 mg, 20.2 mmol, 2.1 eq), THF (20 mL) and DMPU (5 mL). The mixture was cooled to 
0 ºC while stirring, upon which the methyl ester (1.50 mL, 10.0 mmol, 1 eq) was added. 
The mixture was warmed to room temperature for 10 minutes then cooled to 0 ºC again. 
Dichlorobutene (1.26 mL, 12.0 mmol, 1.2 eq) was then added dropwise, and the reaction 
was stirred at room temperature for three days. The reaction was quenched by addition of 
water (5 mL). The layers were separated, and the aqueous layer was extracted with ethyl 
acetate. The organic layers were combined, dried, filtered and concentrated to an oil. The 
oil was purified by flash column chromatography (SiO2, 10% ethyl acetate in hexanes) to 
yield an inseparable mixture of the methyl ester cyclopentene and cyclopropane (~10:1 ratio) 
as a colorless oil (1.54 g). This mixture was then dissolved in EtOH (15 mL), combined 
with KOH (1.70 g, 29.6 mmol, 5 eq) and stirred under reflux overnight. The reaction was 
cooled to room temperature and acidified to pH 2 with 2 M HCl. The aqueous layer was 
extracted with ethyl acetate, and the combined organic layers were dried, filtered, and 
concentrated to a colorless solid. The solid was recrystallized from DCM/hexanes to yield 
the pure cyclopentene carboxylic acid as pale yellow crystals (565 mg, 13% two steps). Mp 
124-128 °C; Rf = 0.41 (20% EtOAc/hexanes); IR (film) 3300-2500, 3066, 2975, 2891, 2651, 
1691, 1586, 1473, 1407, 1288, 1199 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.34 (s, 1H), 7.24 (br 
s, 3H), 5.76 (s, 2H), 3.40 (d, 15.2 Hz, 2H), 2.73 (d, 15.2 Hz, 2H), no CO2H observed; 13C 
NMR (100 MHz, CDCl3) ppm 181.7, 144.8, 134.5, 129.8 (2C), 129.2, 127.4, 125.4, 58.3, 42.5; 
HRMS (CI): Exact mass calcd for C12H11ClO2 [M]+ 222.0442, found 222.0447.  SS224. 
 
 
 
1-(4-Bromophenyl)cyclopent-3-ene-1-carboxylic acid (107e).  
To a flame-dried round-bottom flask under nitrogen atmosphere was added NaH 
(330 mg, 13.8 mmol, 2.1 eq), THF (13 mL) and DMPU (3 mL). The mixture was cooled to 
0 ºC while stirring, upon which the methyl ester (1.50 g, 6.55 mmol, 1 eq) was added.  The 
mixture was warmed to room temperature for 10 minutes then cooled to 0 ºC again. 
Dichlorobutene (830 µL, 7.86 mmol, 1.2 eq) was then added dropwise, and the reaction was 
stirred at room temperature overnight. The reaction was quenched by addition of water (5 
mL). The layers were separated, and the aqueous layer was extracted with ethyl acetate. 
The organic layers were combined, dried, filtered and concentrated to an oil. The oil was 
purified by flash column chromatography (SiO2, 10% ethyl acetate in hexanes) to yield an 
CO2H
Br
CO2Me
Br
1) NaH, DMPU
THF
Cl
Cl
2) KOH, EtOH
reflux
 111 
inseparable mixture of the methyl ester cyclopentene and cyclopropane (~10:1 ratio) as a 
colorless oil (1.0 g). This mixture was then dissolved in EtOH (15 mL), combined with KOH 
(1.00 g, 17.8 mmol, 5 eq) and stirred at reflux temperature (18 hours). The reaction was 
cooled to room temperature and acidified to pH 2 with 2 M H2SO4. The aqueous layer was 
extracted with ethyl acetate, and the combined organic layers were dried, filtered, and 
concentrated to a colorless solid. The solid was recrystallized from DCM/hexanes to yield 
the pure cyclopentene carboxylic acid as colorless crystals (475 mg, 28%, two steps). Mp 
169-172 °C; Rf = 0.41 (25% EtOAc/hexanes); IR (film) 3068, 2973, 2884, 1681, 1485, 1399, 
1284 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.44 (d, J = 8.6 Hz, 2H), 7.23 (d, J = 8.6 Hz, 2H), 
5.76 (s, 2H), 3.40 (d, J = 15.0 Hz, 2H), 2.71 (d, J = 14.7 Hz, 2H), no CO2H observed; 13C 
NMR (100 MHz, CDCl3) ppm 181.8, 141.9, 131.7, 129.3, 128.9, 121.3, 58.1, 42.5; HRMS 
(EI): Exact mass calcd for C12H11BrO2 [M]+ 391.8909, found 391.8906.  MTK-5-072. 
 
 
 
1-(4-Methoxyphenyl)cyclopent-3-ene-1-carboxylic acid (107f).   
A 100 mL round-bottom flask with stir bar was flame-dried and backfilled with 
argon. To the flask was added NaH (484 mg, 20.2 mmol). The flask was equipped with an 
argon balloon, then DMPU (5.0 mL) and THF (20 mL) were added. The flask was cooled 
to 0 °C in an ice bath and the ester (1.27 mL, 8.00 mmol) was added dropwise. The flask 
was warmed to room temperature for 10 minutes, then cooled again to 0 °C. Dichlorobutene 
(850 µL, 8.00 mmol) was added dropwise, and the flask was removed from the ice bath and 
stirred for one day. The mixture was quenched with water, the layers were separated, and 
the aqueous layer was extracted with ethyl acetate. The organic layers were combined, 
dried, filtered and concentrated to an oil. The oil was purified by flash column 
chromatography (SiO2, 10% ethyl acetate in hexanes) to yield an inseparable mixture of the 
methyl ester cyclopentene and cyclopropane (SiO2, 5-10% ethyl acetate in hexanes) as a 
yellow oil (1.26 g). In a 50 mL round-bottomed flask, the ester (630 mg, 2.70 mmol) was 
dissolved in EtOH (20 mL) before KOH (760 mg, 13.6 mmol) was added. The mixture was 
stirred for 24 hours at reflux temperature, cooled to room temperature, and acidified to pH 
2 with 2 M HCl. The aqueous layer was extracted with CH2Cl2, and the combined organic 
layers were dried, filtered, and concentrated to a colorless solid. The solid was recrystallized 
in hexanes and DCM to yield a white solid (638 mg, 22%). Mp 117-118 ºC, Rf = 0.17 (20% 
EtOAc/hexanes); IR (film) 3500-2800, 3060, 2951, 1699, 1512, 1250, 1181 cm-1; 1H NMR 
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(400 MHz, CDCl3) δ 7.28 (d, J = 8.8 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 5.77 (s, 2H), 3.79 
(s, 3H), 3.40 (d, J = 14.8 Hz, 2H), 2.74 (d, J = 14.8 Hz, 2H), CO2H not observed; 13C NMR 
(100 MHz, CDCl3) ppm 180.7, 158.6, 134.8, 129.4, 128.2, 114.0, 57.7, 55.4, 42.6; HRMS (CI): 
Exact mass calcd for C13H14O3 [M]+ 218.0943, found 218.0941. SS238. 
 
 
 
1-(4-Nitrophenyl)cyclopent-3-ene-1-carboxylic acid (107g).  
A 100 mL round-bottom flask with stir bar was flame-dried and backfilled with 
argon. To the flask was added NaH (484 mg, 20.2 mmol, 2.1 eq). The flask was equipped 
with an argon balloon, then DMPU (5.0 mL) and THF (20 mL) were added. The flask was 
cooled to 0°C in an ice bath and the ester (1.95 g, 10.0 mmol) was added dropwise. The 
flask was warmed to room temperature for 10 minutes, then cooled again to 0 °C. 
Dichlorobutene (1.26 mL, 12.0 mmol, 1.2 eq) was next added dropwise, then the flask was 
removed from the ice bath and stirred for one day. The mixture was quenched with water, 
the layers were separated, and the aqueous layer was extracted with ethyl acetate. The 
organic layers were combined, dried, filtered and concentrated to an oil. The oil was purified 
by flash column chromatography (SiO2, 10% ethyl acetate in hexanes) to yield an 
inseparable mixture of the methyl ester cyclopentene and cyclopropane (SiO2, 5-10% ethyl 
acetate in hexanes) to yield a yellow oil (2.09 g. In a 50 mL round-bottomed flask, the ester 
(1.00 g, 4.10 mmol) was dissolved in EtOH (10 mL) and H2O (10 mL) before KOH (1.16 g, 
20.6 mmol) was added and stirred for 30 minutes at reflux. The reaction was cooled to room 
temperature and acidified to pH 2 with 2 M HCl. The aqueous layer was extracted with 
CH2Cl2, and the combined organic layers were dried, filtered, and concentrated to a colorless 
solid. The solid was recrystallized in hexanes and DCM to yield a yellow solid (216 mg, 
23%). Mp 145-150 ºC,  Rf = 0.03 (20% EtOAc/hexanes); IR (film) 3600-2600, 3412, 3071, 
2960, 1693, 1596, 1515, 1443, 1405, 1351, 1289, 1231, 1110 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 8.18 (d, J = 9.2 Hz, 2H), 7.52 (d, J = 8.8 Hz, 2H), 5.79 (s, 2H), 3.46 (d, J = 14.8 Hz, 2H), 
2.78 (d, J = 14.8 Hz, 2H), no CO2H observed; 13C NMR (100 MHz, CDCl3) ppm 179.6, 
150.2, 147.1, 129.1, 128.0, 123.8, 58.4, 42.8; HRMS (CI): Exact mass calcd for C12H12O4N 
[M+H]+ 234.0766, found 234.0758. SS255. 
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1-([1,1'-Biphenyl]-4-yl)cyclopent-3-ene-1-carboxylic acid (107h).  
To a flame-dried round-bottom flask under nitrogen atmosphere was added NaH 
(170 mg, 7.05 mmol), THF (7 mL) and DMPU (1.5 mL). The mixture was cooled to 0 ºC 
while stirring, to which the methyl ester (760 mg, 3.36 mmol) was added.  The mixture was 
warmed to room temperature for 10 minutes then cooled to 0 ºC again. Dichlorobutene (430 
µL, 4.0 mmol) was then added dropwise, and the reaction was stirred at room temperature 
overnight. The reaction was quenched by the addition of water (5 mL). The layers were 
separated, and the aqueous layer was extracted with EtOAc. The organic layers were 
combined, dried, filtered and concentrated to an oil. The oil was purified by flash column 
chromatography (SiO2, 10% ethyl acetate in hexanes) to yield an inseparable mixture of the 
methyl ester cyclopentene and cyclopropane (~10:1 ratio) as a colorless oil (590 mg). This 
mixture was then dissolved in EtOH (15 mL), combined with KOH (595 mg, 10.6 mmol, 5 
eq) and stirred at reflux temperature overnight. The reaction was cooled to room 
temperature and acidified to pH 2 with 2 M aq H2SO4. The aqueous layer was extracted 
with ethyl acetate, and the combined organic layers were dried, filtered, and concentrated 
to a colorless solid. The solid was recrystallized from DCM/hexanes to yield the pure 
cyclopentene carboxylic acid as gray crystals (242 mg, 43% two steps). Mp 188-190 °C; Rf 
= 0.37 (25% EtOAc/hexanes); IR (film) 3400-2800, 3271, 3068, 2924, 2858, 1690, 1277 cm-
1; 1H NMR (400 MHz, DMSO-d6) δ 7.66-7.61 (m, 4H), 7.48-7.34 (m, 5H), 5.79 (s, 2H), 3.33 
(d, J = 14.8 Hz, 2H), 2.67 (d, J = 14.8 Hz, 2H), no CO2H observed; 13C NMR (100 MHz, 
DMSO-d6) ppm 176.7, 143.0, 139.8, 138.4, 129.2, 128.9, 127.4, 127.1, 126.60, 126.58, 57.6, 
42.3; HRMS (CI): Exact mass calcd for C18H17O2 [M+H]+ 265.1229, found 265.1229.  MTK-
5-097. 
 
 
 
2-Allyl-2-(thiophen-2-yl)pent-4-enoic acid (S5).  
To a flame-dried round-bottom flask under nitrogen atmosphere was added distilled 
diisopropyl amine (2.20 mL, 15.5 mmol) and THF (30 mL). The solution was cooled to -78 
°C and treated with nBuLi (7.4 mL, 15.0 mmol) added dropwise, before stirring for 15 
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minutes. The carboxylic acid (1.00 g, 7.03 mmol) was added, and the reaction was removed 
from the ice bath and stirred at room temperature for 10 minutes. The reaction was placed 
in an ice bath and allyl bromide (670 µL, 7.70 mmol) was added. The reaction was removed 
from the ice bath and stirred at room temperature for 4 hours. To the reaction was added 
water (5 mL) and Et2O (20 mL). The organic and aqueous layers were separated, and the 
aqueous layer was acidified to pH 1 by 2 M H2SO4. This aqueous solution was extracted by 
Et2O. The combined organic layers were dried, filtered and concentrated to an oil. This oil 
was then alkylated a second time using the same procedure as above, and was purified by 
flash column chromatography (SiO2, 50% ethyl acetate in hexanes) to yield the product as 
a white solid (380 mg, 24%). Mp 89-91 ºC; Rf = 0.47 (50% EtOAc/hexanes); IR 3300-2500, 
3077, 2971, 2914, 2668, 1701, 1283, 1235 (film) cm-1; 1H NMR (400 MHz, CDCl3) δ 7.25 (dd, 
J = 5.0, 1.3 Hz, 1H), 7.01-6.97 (m, 2H), 5.64 (dddd, J = 17.2, 10.2, 7.1, 7.1 Hz, 2H), 5.16-
5.09 (m, 4H), 2.88 (dd, J = 14.0, 7.4 Hz, 2H), 2.80 (dd, J = 14.0, 7.4 Hz, 2H), no CO2H 
observed; 13C NMR (100 MHz, CDCl3) ppm 178.6, 145.2, 132.8, 126.8, 125.2, 124.8, 119.4, 
51.7, 40.4; HRMS (EI): Exact mass calcd for C12H14O2S [M]+ 222.0715, found 222.0705. 
MTK-5-021. 
 
 
 
1-(Thiophen-2-yl)cyclopent-3-ene-1-carboxylic acid (107i).  
To a flame-dried round-bottom flask under nitrogen atmosphere was added diene 
(200 mg, 900 µmol), CH2Cl2 (9 mL) and Grubbs IIii (8 mg, 10 µmol), and the solution was 
stirred for 24 h at room temperature. The solution was loaded onto a silica plug, flushed 
with ethyl acetate, and concentrated to a solid. This solid was purified by flash column 
chromatography (SiO2, 15% ethyl acetate in hexanes) to yield the product as a white solid 
(150 mg, 87%). Mp 118-121 ºC; Rf = 0.19 (25% EtOAc/hexanes); IR 3200-2500, 3068, 2962, 
2861, 1649, 1545, 1693, 1281, 1214 (film) cm-1; 1H NMR (400 MHz, CDCl3) δ 7.18 (dd, J = 
5.1, 1.2 Hz, 1H), 7.01 (dd, J = 3.6, 1.2 Hz, 1H), 6.94 (dd, J = 5.1, 3.6 Hz, 1H), 5.74 (s, 2H), 
3.40 (d, J = 14.7 Hz, 2H), 2.88 (d, J = 14.6 Hz, 2H), no CO2H observed; 13C NMR (100 
MHz, CDCl3) ppm 180.5, 147.0, 129.0, 126.9, 125.0, 124.3, 55.3, 44.7; HRMS (EI): Exact 
mass calcd for C10H10O2S [M]+ 194.0402, found 194.0393. MTK-5-022. 
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1-Phenylcyclohept-4-ene-1-carboxylic acid (128).  
To a flame-dried round-bottom flask under nitrogen atmosphere was added diene 
(100 mg, 410 µmol), CH2Cl2 (5 mL) and Grubbs IIii (3 mg, 4 µmol), and the solution was 
stirred for 24 h at room temperature. The solution was loaded onto a silica plug, flushed 
with ethyl acetate, and concentrated to a solid. This solid was purified by flash column 
chromatography (SiO2, 25% ethyl acetate in hexanes) to yield the product as an off-white 
solid (89 mg, 99%). Mp 109-111 ºC; Rf = 0.52 (75% EtOAc/hexanes); IR (film) 3200-2500, 
3017, 2920, 2848, 1689, 1444, 1299, 1267 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.18 (dd, J = 
5.1, 1.2 Hz, 1H), 7.01 (dd, J = 3.6, 1.2 Hz, 1H), 6.94 (dd, J = 5.1, 3.6 Hz, 1H), 5.74 (s, 2H), 
3.40 (d, J = 14.7 Hz, 2H), 2.88 (d, J = 14.6 Hz, 2H), no CO2H observed; 13C NMR (100 
MHz, CDCl3) ppm 180.5, 147.0, 129.0, 126.9, 125.0, 124.3, 55.3, 44.7; HRMS (EI): Exact 
mass calcd for C10H10O2S [M]+ 217.1223, found 217.1233. MTK-4-284. 
 
 
 
 
1-Isopropylcyclopent-3-ene-1-carboxylic acid (107j).  
To a flame-dried round-bottom flask under nitrogen atmosphere was added 
diisopropyl amine (1.60 mL, 11.5 mmol) and THF (8 mL), and then cooled to -78 ºC. nBuLi 
(5.30 mL, 11.0 mmol, 2.07 M in hexanes) was added dropwise. The solution was warmed to 
0 ºC for 10 min and then recooled to -78 ºC. The cyclopentene carboxylic acid (560 mg, 
5.00 mmol) was then added dropwise and allowed to stir for 10 minutes.  2-Bromopropane 
(700 µL, 7.50 mmol) was added dropwise and the reaction was allowed to warm to room 
temperature and then stirred at 45 ºC for 12 hours. The reaction was quenched by addition 
of 5 mL of water and 5 mL Et2O. The layers were separated and the aqueous layer was 
acidified by addition of 2M H2SO4, and then extracted with Et2O. The organic extracts were 
combined, dried, filtered and concentrated to an oil. The oil was purified by flash column 
chromatography (SiO2, 10% ethyl acetate in hexanes) to yield a colorless oil (235 mg, 30%). 
Rf = 0.52 (25% EtOAc/hexanes); IR (film) 3400-2600, 2968, 2924, 1690 cm-1; 1H NMR (400 
MHz, CDCl3) δ 5.59 (s, 2H), 2.88 (d, J = 14.8 Hz, 2H), 2.36 (d, J = 14.7 Hz, 2H), 2.12 
(sept, J = 6.8 Hz, 1H), 0.88 (d, J = 6.8 Hz, 6H), no CO2H observed; 13C NMR (100 MHz, 
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CDCl3) ppm 184.7, 128.9, 56.7, 39.4, 35.0, 18.0; HRMS (CI): Exact mass calcd for C9H14O2 
[M]+ 154.0988, found 154.0987.  MTK-5-042. 
 
 
 
1-Benzylcyclopent-3-ene-1-carboxylic acid (107k).  
To a flame-dried round-bottom flask under nitrogen atmosphere was added 
diisopropyl amine (1.40 mL, 6.96 mmol) and THF (23 mL), and then cooled to -78 ºC. 
nBuLi (2.80 mL, 6.15 mmol, 2.20 M in hexanes) was added dropwise. The solution was 
warmed to 0 ºC for 10 minutes and then recooled to -78 ºC. The cyclopentene carboxylic 
acid (300 mg, 2.68 mmol, 1 eq) was then added dropwise as a solution in THF (2 mL) and 
allowed to stir for 10 minutes. Benzyl bromide (480 µL, 4.01 mmol, 1.5 eq) was added 
dropwise and the reaction was allowed to stir at room temperature overnight. The reaction 
was quenched by addition of water (5 mL) and Et2O (5 mL). The layers were separated 
and the aqueous layer was acidified by the addition of 2 M H2SO4, and then extracted with 
Et2O. The organic extracts were combined, dried, filtered and concentrated to an oil. The 
oil was purified by flash column chromatography (SiO2, 10% ethyl acetate in hexanes) to 
yield a yellow oil (50 mg, 17%). Rf = 0.35 (25% EtOAc/hexanes); IR (film) 3600-2400, 3032, 
2925, 2608, 1699, 1444, 1412, 1282, 1224 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.33-7.23 (m, 
5H), 5.69 (s, 2H), 3.10 (s, 2H), 2.91 (d, J = 15.2 Hz, 2H), 2.52 (d, J = 15.0 Hz, 2H), no 
CO2H observed; 13C NMR (100 MHz, CDCl3) ppm 183.8, 138.0, 129.9, 128.6, 128.3, 126.8, 
54.0, 44.0, 41.8; HRMS (CI): Exact mass calcd for C13H14O2 [M]+ 202.0988, found 202.0992.  
MTK-3-245. 
 
 
 
S-(tert-Butyl) cyclopent-3-ene-1-carbothioate (S6).  
To a round-bottom flask under nitrogen atmosphere was added carboxylic acid (500 
µL, 4.8 mmol), DCM (20 mL), EDC (1.11 g, 5.81 mmol), DMAP (710 mg, 5.81 mmol) and 
stirred at room temperature for 5 minutes. Then tert-butyl thiol (650 µL, 5.8 mmol) was 
added, and the reaction was stirred for 18 hours. The reaction was quenched by the addition 
of 1 M aq HCl (10 mL). The organic and aqueous layers were separated, and the aqueous 
layer was further extracted by DCM. The combined organic layers were dried, filtered, and 
concentrated to an oil. The oil was purified by flash column chromatography (SiO2, 100% 
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hexanes) to yield the product as an oil (670 mg, 75%). Rf = 0.56 (100% hexanes); IR (film) 
3061, 2955, 2862, 1681, 1453, 1168, 1017 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.64 (s, 2H), 
3.26 (tt, J = 6.8, 6.7 Hz, 1H), 2.69-2.55 (m, 4H), 1.47 (s, 9H); 13C NMR (100 MHz, CDCl3) 
203.3, 128.9, 51.1, 47.9, 36.9, 30.0 ppm; HRMS (TIC): Exact mass calcd for C10H17OS 
[M+H]+ 185.0995, found 185.0995.  MTK-5-075 
 
 
 
1-((tert-Butylthio)carbonyl)cyclopent-3-ene-1-carboxylic acid (107n).  
To a flame-dried round-bottom flask under nitrogen atmosphere was added distilled 
diisopropyl amine (310 µL, 2.2 mmol) and THF (10 mL) and stirred in a dry ice bath for 
15 minutes. Then nBuLi (1.0 mL, 2.1 mmol) was added dropwise and the solution was 
stirred for 15 minutes. The thioester (370 mg, 2.00 mmol) was added dropwise, and the 
nitrogen line was exchanged for a balloon of CO2. The reaction was allowed to warm to 
room temperature and stirred for 18 hours. To the reaction was added water (5 mL) and 
Et2O (10 mL). The organic and aqueous layers were separated, and the aqueous layer was 
acidified to pH 1 by 2 M H2SO4. This aqueous solution was extracted with Et2O. The 
combined organic layers were dried, filtered, and concentrated to an oil. The oil was purified 
by flash column chromatography (SiO2, 50% ethyl acetate in hexanes) to g the product as 
a white solid (70 mg, 16%). Mp 126-128 ºC; Rf = 0.26 (75% EtOAc/hexanes); IR (film) 
3200-2800, 3071, 2963, 2919, 1675, 1404, 1281, 1090 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.61 
(s, 2H), 3.07 (s, 4H), 1.47 (s, 9H), no CO2H observed; 13C NMR (100 MHz, CDCl3) ppm 
198.8, 78.1, 128.0, 67.5, 49.0, 41.0, 29.9; HRMS (CI): Exact mass calcd for C11H17O2S [M+H]+ 
229.0898, found 229.0898.  MTK-5-077 
 
Enantioselective Iodobicyclization 
 
 
 
General Procedure for Enantioselective Iodobicyclization 
To a 0.5-2 mL microwave vial with stir bar is added carboxylic acid (100 µmol), 
6tBuStilb(pMeAn)BAM 3a (7.9 mg, 10 µmol) and toluene (2 mL, 0.05 M). The solution was 
stirred at -50 ºC for 30 minutes before N-iodophthalimide (28.4 mg, 104 µmol) was added 
and the mixture was stirred for 1 day. The reaction mixture was then quenched by adding 
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50 mg of 15% Na2S2O3/SiO2, and allowing the slurry to stir for 15 minutes as it warmed to 
room temperature. The slurry was loaded onto a 15% Na2S2O3/SiO2 plug and flushed with 
5 mL of 50% ethyl acetate in hexanes. The eluent was concentrated, and the residue was 
purified by flash column chromatography (SiO2, ethyl acetate in hexanes) to yield the 
product. 
 
General Procedure for Iodobicyclization to Racemic Product 
Racemic products were produced using the general procedure with racemic 
6tBuStilb(pMeAn)BAM 3a, which was produced by mixing equal amounts of (R,R)-3a and 
(S,S)-3a.  
 
 
 
(1R,4R,6R)-6-Iodo-4-phenyl-2-oxabicyclo[2.2.1]heptan-3-one (109a).  
This substrate was treated at 1.0 mmol scale. The carboxylic acid (188 mg, 1.0 mmol) 
was treated according to the general procedure to give the lactone as a yellow solid (207 
mg, 66%). The product was determined to be 94% ee by chiral HPLC analysis (Chiralpak 
IA, 10% iPrOH/hexanes, 1 mL/min, tr(e1 minor) = 7.9 min, tr(e2 major) = 11.3 min. Mp 
54-56 ºC. [a]  83.6 (c 1.37, CHCl3); Rf = 0.36 (10% EtOAc/hexanes); IR (film) 3030, 2927, 
2860, 1786 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.43-7.34 (m, 5H), 5.05 (d, J = 1.2 Hz, 1H), 
4.28 (dddd, J = 6.6, 4.2, 2.4, 0.6 Hz, 1H), 2.97 (ddd, J = 13.8, 7.8, 1.8 Hz, 1H), 2.90 (d, J 
= 10.8, 1H), 2.72 (br dddd, J = 10.8, 2.4, 2.4, 2.4 Hz, 1H), 2.62 (dd, J = 13.8, 4.2 Hz, 1H); 
13C NMR (150.9 MHz, CDCl3) ppm 176.0, 134.0, 128.7, 128.2, 127.2, 83.3, 56.2, 42.9, 41.1, 
16.8; Exact mass calcd for C12H12IO2 [M+H]+ 314.9876, found 314.9872. MTK-5-010. 
 
  
 
(1R,4R,6R)-6-Iodo-4-(naphthalen-2-yl)-2-oxabicyclo[2.2.1]heptan-3-one (109b).  
The carboxylic acid (24 mg, 100 µmol) was treated according to the general 
procedure to give the lactone as a white solid (28.3 mg, 73%) which was determined to be 
90% ee by chiral HPLC analysis (Chiralpak IA, 10% iPrOH/hexanes, 1 mL/min, tr(e1 minor) 
=  11.2 min, tr(e2 major) =  12.4 min). Mp 107-110 ºC. [a]  -82.0 (c 1.42, CHCl3); Rf = 
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0.55 (25% EtOAc/hexanes); IR (film) 3053, 2926, 1784, 1098 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.89-7.83 (m, 4H), 7.52-7.47 (m, 3H), 5.09 (d, J = 0.9 Hz, 1H), 4.32 (dddd, J = 
7.5, 4.2, 2.0, 0.8 Hz, 1H), 3.07 (ddd, J = 14.2, 7.9, 2.1 Hz, 1H), 2.99 (d, J = 10.9 Hz, 1H), 
2.83 (br dddd, J = 10.9, 2.1, 2.1, 2.1 Hz, 1H), 2.71 (dd, J = 14.2, 4.2 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) ppm 176.16, 133.2, 133.1, 131.6, 128.6, 128.1, 127.8, 126.6, 126.6, 126.3, 
125.1, 83.6, 56.5, 43.0, 41.5, 17.0; HRMS (CI): Exact mass calcd for C16H14IO2 [M+H]+ 
365.0033, found 365.0032. MTK-5-120. 
 
 
 
(1R,4R,6R)-6-Iodo-4-(naphthalen-1-yl)-2-oxabicyclo[2.2.1]heptan-3-one (109c).  
The carboxylic acid (24 mg, 100 µmol) was treated according to the general 
procedure to give the lactone as a foam (26.1 mg, 72%) which was determined to be 67% 
ee by chiral HPLC analysis (Chiralpak IA, 20% EtOH/hexanes, 1 mL/min, tr(e1 minor) = 
9.1 min, tr(e2 major) = 10.7 min). [a]  -76.1 (c 1.31, CHCl3); Rf = 0.38 (25% 
EtOAc/hexanes); IR (film) 2924, 1784, 1082, 779 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.92-
7.86 (m, 3H), 7.54-7.49 (m, 2H), 7.47-7.38 (m, 2H), 5.15 (d, J = 1.7 Hz, 1H), 4.38 (dddd, J 
= 7.6, 4.4, 2.0, 0.7 Hz, 1H), 3.38 (ddd, J = 14.1, 7.8, 2.4 Hz, 1H), 3.19 (br dddd, J = 11.1, 
2.2, 2.2, 2.2 Hz, 1H), 2.89 (d, J = 11.1 Hz, 1H), 2.85 (dd, J = 14.2, 4.4 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) ppm 175.7, 134.6, 131.5, 130.5, 129.9, 129.4, 126.1, 125.9, 125.7, 125.6, 
125.1, 83.8, 57.3, 42.7, 42.3, 16.7; HRMS (CI): Exact mass calcd for C16H13IO2 [M]+ 363.9955, 
found 363.9942. MTK-5-111. 
 
 
 
(1R,4R,6R)-4-(3-Chlorophenyl)-6-iodo-2-oxabicyclo[2.2.1]heptan-3-one (109d).  
The carboxylic acid (22 mg, 100 µmol) was treated according to the general 
procedure to give the lactone as a white foam (24.1 mg, 69%) which was determined to be 
89% ee by chiral HPLC analysis (Chiralpak IA, 10% iPrOH/hexanes, 1 mL/min, tr(e1 minor) 
= 8.1 min, tr(e2 major) = 11.3 min). [a]  -81.9 (c 1.21, CHCl3); Rf = 0.58 (20% 
EtOAc/hexanes); IR (film) 2923, 1785, 1597, 1477, 1102 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 7.31 (m, 4H), 5.05 (dd, J = 1.6, 0.8 Hz, 1H), 4.27 (dddd, J = 7.6, 4.3, 2.2, 0.9 Hz, 1H), 
2.94 (ddd, J = 14.2, 7.9, 2.2 Hz, 1H), 2.90 (d, J = 10.9 Hz, 1H), 2.70 (br dddd, J = 10.8, 
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2.1, 2.1, 2.1 Hz, 1H), 2.58 (dd, J = 14.2, 4.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) ppm 
175.5, 136.2, 134.8, 130.1, 128.6, 127.6, 125.6, 83.5, 56.0, 43.1, 41.2, 16.5; HRMS (CI): Exact 
mass calcd for C12H10ClIO2 [M]+ 347.9409, found 347.9394. MTK-5-107, SS225. 
 
 
 
(1R,4R,6R)-1-(4-Bromophenyl)cyclopent-3-ene-1-carboxylic acid (109e).  
The carboxylic acid (27 mg, 100 µmol) was treated according to the general 
procedure to give the lactone as a white solid (29.1 mg, 74%) which was determined to be 
89% ee by chiral HPLC analysis (Chiralpak IA, 10% iPrOH/hexanes, 1 mL/min, tr(e1 minor) 
= 9.6 min, tr(e2 major) = 13.0 min). Mp 169-172 ºC; [a]  -67.3 (c 1.46, CHCl3); Rf = 0.53 
(25% EtOAc/hexanes); IR (film) 3010, 2928, 1772, 1489, 1103 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.53 (d, J = 8.5 Hz, 2H), 7.25 (d, J = 8.5 Hz, 2H), 5.04 (d, J = 1.3 Hz, 1H), 4.27 
(dddd, J = 7.5, 4.1, 2.1, 0.9 Hz, 1H), 2.94 (ddd, J = 14.2, 7.9, 2.2 Hz, 1H), 2.89 (d, J = 
10.9 Hz, 1H), 2.68 (br dddd, J = 10.9, 2.2, 2.2, 2.2 Hz, 1H), 2.57 (dd, J = 14.2, 4.3 Hz, 1H); 
13C NMR (100 MHz, CDCl3) ppm 175.6, 133.2, 132.0, 129.0, 122.5, 83.5, 55.9, 43.0, 41.1, 
16.6; HRMS (EI): Exact mass calcd for C12H10BrIO2 [M]+ 391.8909, found 391.8906. MTK-
5-100.  
 
 
 
(1R,4R,6R)-6-Iodo-4-(4-methoxyphenyl)-2-oxabicyclo[2.2.1]heptan-3-one 
(109f).  
The carboxylic acid (22 mg, 100 µmol) was treated according to the general 
procedure to give the lactone as a white solid (22.3 mg, 65%) which was determined to be 
91% ee by chiral HPLC analysis (Chiralpak IA, 10% iPrOH/hexanes, 1 mL/min, tr(e1 minor) 
= 11.8 min, tr(e2 major) = 13.4 min). Mp 166-168 ºC; [a]  -80.9 (c 1.12, CHCl3); Rf = 0.32 
(20% EtOAc/hexanes); IR (film) 2930, 2845, 1785, 113, 1518, 1251, 1100 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.29 (d, J = 8.8 Hz, 2H), 6.92 (d, J = 8.8 Hz, 2H), 5.02 (d, J = 1.2 
Hz, 1H), 4.26 (dddd, J = 7.4, 4.2, 2.1, 0.8 Hz, 1H), 3.81 (s, 3H), 2.93 (ddd, J = 15.2, 7.9, 
2.2 Hz, 1H), 2.86 (d, J = 10.9 Hz, 1H), 2.68 (br dddd, J = 10.8, 2.2, 2.2, 2.2 Hz, 1H), 2.59 
(dd, J = 14.2, 4.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) ppm 176.5, 159.6, 128.4, 126.2, 
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114.3, 83.5, 55.8, 55.5, 43.1, 41.4, 17.1; HRMS (EI): Exact mass calcd for C12H10BrIO2 [M]+ 
391.8909, found 391.8906. MTK-5-099. 
 
 
 
(1R,4R,6R)-6-Iodo-4-(4-nitrophenyl)-2-oxabicyclo[2.2.1]heptan-3-one (109g).  
The carboxylic acid (23 mg, 100 µmol) was treated according to the general 
procedure to give the lactone as a white solid (27.9 mg, 78%) which was determined to be 
86% ee by chiral HPLC analysis (Chiralpak IA, 30% iPrOH/hexanes, 1 mL/min, tr(e1 minor) 
= 12.3 min, tr(e2 major) = 18.5 min). Mp 109-111 ºC; [a]  -58.4 (c 1.40, CHCl3); Rf = 0.27 
(20% EtOAc/hexanes); IR (film) 3118, 2923, 2855, 1779, 1512, 1350 cm-1; 1H NMR (400 
MHz, CDCl3) δ 8.26 (d, J = 8.7 Hz, 2H), 7.58 (d, J = 8.7 Hz, 2H), 5.10 (s, 1H), 4.27 (br 
ddd, J = 5.9, 3.6, 1.6 Hz, 1H), 3.04-2.97 (m, 2H), 2.75 (br dddd, J = 10.8, 2.2, 2.2, 2.2 Hz, 
1H), 2.60 (dd, J = 14.1, 4.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) ppm 174.8, 147.9, 141.3, 
128.5, 124.0, 83.6, 56.2, 43.3, 41.1, 29.8; HRMS (EI): Exact mass calcd for C12H10INO4 [M]+ 
359.9733, found 359.9724. MTK-5-101. 
 
 
 
(1R,4R,6R)-4-([1,1'-Biphenyl]-4-yl)-6-iodo-2-oxabicyclo[2.2.1]heptan-3-one 
(109h).  
The carboxylic acid (26 mg, 100 µmol) was treated according to the general 
procedure to give the lactone as a white solid (21.4 mg, 55%) which was determined to be 
94% ee by chiral HPLC analysis (Chiralpak IA, 10% iPrOH/hexanes, 1 mL/min, tr(e1 minor) 
= 12.5 min, tr(e2 major) = 14.9 min). Mp 158-160 ºC; [a]  -58.3 (c 1.07, CHCl3); Rf = 0.44 
(25% EtOAc/hexanes); IR (film) 3030, 2931, 1779, 1318, 1186, 1099, 907 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.65-7.58 (m, 4H), 7.47-7.44 (m, 4H), 7.37 (dddd, J = 7.4, 7.4, 1.2, 1.2 
Hz, 1H), 5.07 (d, J = 1.6 Hz, 1H), 4.30 (dddd, J = 7.4, 4.1, 2.0, 0.7 Hz, 1H), 3.01 (ddd, J 
= 14.2, 7.9, 2.2 Hz, 1H), 2.93 (d, J = 10.8 Hz, 1H), 2.76 (br dddd, J = 10.9, 2.1, 2.1, 2.1 
Hz, 1H), 2.66 (dd, J = 14.2, 4.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) ppm 176.2, 141.3, 
140.6, 133.1, 129.0, 127.74, 127.67, 127.6, 127.3, 83.5, 56.2, 43.0, 41.3, 16.9; HRMS (CI): 
Exact mass calcd for C18H15IO2 [M]+ 390.0117, found 390.0109. MTK-5-103. 
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(1R,4S,6R)-6-Iodo-4-(Thiophen-2-yl)-2-oxabicyclo[2.2.1]heptan-3-one (109i).  
The carboxylic acid (19 mg, 100 µmol) was treated according to the general 
procedure to give the lactone as a colorless oil (22.0 mg, 69%). The product was determined 
to be 92% ee by chiral HPLC analysis (Chiralpak IA, 10% iPrOH/hexanes, 1 mL/min, tr(e1 
minor) =  7.2 min, tr(e2 major) = 12.4 min). [a]  -63.7 (c 1.10, CHCl3); Rf = 0.39 (25% 
EtOAc/hexanes); IR (film) 3103, 2924, 2857, 1758, 1446, 1313, 1187, 1096 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.32 (dd, J = 5.1, 1.1 Hz, 1H), 7.11 (dd, J = 3.6, 1.1 Hz, 1H), 7.04 (dd, 
J = 5.1, 3.6 Hz, 1H), 5.03 (d, J = 1.5 Hz, 1H), 4.25 (dddd, J = 7.6, 5.4, 2.2, 0.8 Hz, 1H), 
2.99-2.93 (m, 2H), 2.70-2.66 (m, 2H); 13C NMR (100 MHz, CDCl3) ppm 175.1, 136.4, 127.2, 
126.1, 125.7, 83.9, 54.5, 44.3, 43.5, 16.4; HRMS (EI): Exact mass calcd for C10H9IO2S [M]+ 
319.9368, found 319.9363. MTK-5-096. 
 
 
 
(1R,4R,6R)-6-Iodo-4-isopropyl-2-oxabicyclo[2.2.1]heptan-3-one (109j).  
The carboxylic acid (15 mg, 100 µmol) was treated according to the general 
procedure to give the lactone as a white solid (20.7 mg, 74%) which was determined to be 
87% ee by chiral HPLC analysis (Chiralpak IA, 10% iPrOH/hexanes, 1 mL/min, tr(e1 minor) 
= 4.8 min, tr(e2 major) =  6.5 min). Mp 51-53 ºC; [a]  -75.1 (c 1.04, CHCl3); Rf = 0.65 
(25% EtOAc/hexanes); IR (film) 2956, 2925, 2865, 1787 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 4.87 (d, J = 1.4 Hz, 1H), 4.13 (dddd, J = 7.2, 4.0, 2.1, 0.9 Hz, 1H), 2.43 (ddd, J = 14.3, 
7.9, 2.0 Hz, 1H), 2.49 (d, J = 10.9 Hz, 1H), 2.31 (dd, J = 14.3, 4.2 Hz, 1H), 2.18 (br dddd, 
J = 10.8, 2.1, 2.1, 2.1 Hz, 1H), 2.12 (sept, J  = 6.8 Hz, 1H), 1.04 (d, J = 6.9 Hz, 6H); 13C 
NMR (100 MHz, CDCl3) ppm 177.3, 83.2, 57.2, 38.8, 38.1, 26.5, 18.9, 18.3, 17.7; HRMS 
(EI): Exact mass calcd for C9H13IO2 [M]+ 279.9960, found 279.9966. MTK-5-116. 
 
 
 
(1R,4R,6R)-4-Benzyl-6-iodo-2-oxabicyclo[2.2.1]heptan-3-one (109k).  
O
O
I
S
€ 
D
20
O
O
I
Me
Me
€ 
D
20
O
O
I
Ph
 123 
The carboxylic acid (20 mg, 100 µmol) was treated according to the general 
procedure to give the lactone as an oil (21.8 mg, 66%) which was determined to be 87% ee 
by chiral HPLC analysis (Chiralpak IA, 5% EtOH/hexanes, 1 mL/min, tr(e1 minor) = 9.4 
min, tr(e2 major) = 14.0 min). [a]  -93.0 (c 1.09, CHCl3); Rf = 0.47 (25% EtOAc/hexanes); 
IR (film) 2925, 1785, 1089, 913 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.33-7.20 (m, 5H), 4.85 
(d, J = 1.4 Hz, 1H), 4.10 (dddd, J = 7.2, 5.2, 3.1, 0.9 Hz, 1H), 3.16 (d, J = 14.2 Hz, 1H), 
2.92 (d, J = 14.1 Hz, 1H), 2.47 (ddd, J = 14.2, 7.9, 2.2 Hz, 1H), 2.32 (d, J = 11.0 Hz, 1H), 
2.19 (dd, J = 14.2, 4.2 Hz, 1H), 2.07 (br dddd, J = 11.0, 2.1, 2.1, 2.1 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) ppm 177.5, 136.8, 129.9, 128.7, 127.1, 83.6, 54.1, 41.0, 40.1, 34.5, 17.1; 
HRMS (CI): Exact mass calcd for C13H15IO2 [M+H]+ 329.0033, found 329.0042. MTK-5-105. 
 
 
 
(1R,4R,6R)-6-Iodo-4-methyl-2-oxabicyclo[2.2.1]heptan-3-one (109l).  
The carboxylic acid (13 mg, 100 µmol) was treated according to the general 
procedure to give the lactone as a white solid (16.6 mg, 66%) which was determined to be 
86% ee by chiral HPLC analysis (Chiralpak IA, 10% iPrOH/hexanes, 1 mL/min, tr(e1 minor) 
= 5.6 min, tr(e2 major) =  8.5 min). Mp 56-58 ºC; [a]  -71.6 (c 0.83, CHCl3); Rf = 0.28 
(25% EtOAc/hexanes); IR (film) 2927, 2862, 1787 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.89 
(d, J = 1.2 Hz, 1H), 4.12 (dddd, J = 7.5, 4.2, 2.2, 0.8 Hz, 1H), 2.50 (ddd, J = 14.3, 7.9, 2.2 
Hz, 1H), 2.49 (d, J = 10.7 Hz, 1H), 2.23 (dd, J = 14.2, 4.2 Hz, 1H), 2.18 (br dddd, J = 
10.9, 2.1, 2.1, 2.1 Hz, 1H), 1.37 (s, 3H); 13C NMR (100 MHz, CDCl3) ppm 178.4, 83.9, 49.0, 
43.0, 42.6, 17.4, 13.8; HRMS (EI): Exact mass calcd for C7H9IO2 [M]+ 251.9647, found 
251.9652. MTK-5-108. 
 
 
 
tert-Butyl (1R,4S,6R)-6-iodo-3-oxo-2-oxabicyclo[2.2.1]heptane-4-carboxylate 
(109m).  
The carboxylic acid (21 mg, 100 µmol) was treated according to the general 
procedure to give the lactone as a white solid (21.7 mg, 64%). The product was determined 
to be 64% ee by chiral HPLC analysis (Chiralpak IA, 3% iPrOH/hexanes, 1 mL/min, tr(e1 
minor) = 7.8 min, tr(e2 major) = 8.1 min. Mp 124-127 ºC. [a]  -35.3 (c 1.09, CHCl3); Rf = 
0.31 (25% EtOAc/hexanes); IR (film) 2975, 2923, 1783, 1725, 1337, 1166, 1058, 910 cm-1; 
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1H NMR (400 MHz, CDCl3) δ 4.94 (d, J = 1.3 Hz, 1H), 4.13 (dddd, J = 7.6, 4.3, 2.1, 0.9 
Hz, 1H), 2.78 (ddd, J = 14.7, 7.9, 2.0 Hz, 1H), 2.74 (d, J = 10.8 Hz, 1H), 2.66-2.59 (m, 2H), 
1.50 (s, 9H); 13C NMR (100 MHz, CDCl3) ppm 172.5, 165.8, 84.1, 83.3, 58.4, 40.2, 38.4, 28.1, 
15.8; HRMS (EI): Exact mass calcd for C11H15IO4Na [M+Na]+ 360.9913, found 360.9925. 
MTK-5-112. 
 
 
 
S-(tert-Butyl)-(1R,4S,6R)-6-iodo-3-oxo-2-oxabicyclo[2.2.1]heptane-4-
carbothioate (109n).  
The carboxylic acid (23 mg, 100 µmol) was treated according to the general 
procedure to give the lactone as a white solid (23.4 mg, 66%) which was determined to be 
74% ee by chiral HPLC analysis (Chiralpak IA, 5% iPrOH/hexanes, 1 mL/min, tr(e1 minor) 
= 7.2 min, tr(e2 major) =  8.3 min). Mp 127-132 ºC (decomp); [a]  -37.3 (c 1.17, CHCl3); 
Rf = 0.31 (25% EtOAc/hexanes); IR (film) 2956, 2918, 2863, 1779, 1661, 1447, 1163, 1081, 
846 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.94 (d, J = 1.3 Hz, 1H), 4.14 (dddd, J = 7.5, 4.1, 
2.1, 0.8 Hz, 1H), 2.84 (ddd, J = 14.4, 7.9, 2.0 Hz, 1H), 2.77 (d, J = 11.0 Hz, 1H), 2.69 (br 
dddd, J = 11.1, 2.0, 2.0, 2.0 Hz, 1H), 2.64 (dd, J = 14.4, 4.2 Hz, 1H), 1.52 (s, 9H); 13C NMR 
(100 MHz, CDCl3) ppm 193.0, 171.8, 83.6, 64.3, 49.8, 40.4, 39.1, 29.8, 15.4; HRMS (EI): 
Exact mass calcd for C11H15IO4SNa [M+Na]+ 376.9684, found 376.9701. MTK-5-113. 
 
 
(1S,4R,5R)-4-Iodo-1-phenyl-6-oxabicyclo[3.2.2]nonan-7-one (136).  
The carboxylic acid (22 mg, 100 µmol) was treated according to the general 
procedure to give the lactone as an oil (25.0 mg, 73%) which was determined to be 41% ee 
by chiral HPLC analysis (Chiralpak IA, 10% iPrOH/hexanes, 1 mL/min, tr(e1 minor) = 11.7 
min, tr(e2 major) =  13.8 min. [a]  -18.2 (c 1.25, CHCl3); Rf = 0.52 (25% EtOAc/hexanes); 
IR (film) 3060, 2944, 1742, 1594, 1447, 1377, 1139 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.38-
7.33 (m, 4H), 7.30-7.25 (m, 1H), 5.04 (d, J = 5.8 Hz, 1H), 4.53 (dddd, J = 9.0, 8.4, 1.3, 1.2 
Hz, 1H), 2.65-2.53 (m, 4H), 2.42-2.27 (m, 3H), 2.31 (ddd, J = 14.5, 4.4, 4.0 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) 174.9, 142.9, 128.2, 127.2, 126.8, 81.9, 47.0, 37.9, 35.0, 27.9, 27.2, 
19.1 ppm; HRMS (EI): Exact mass calcd for C14H15IO2 [M]+ 342.0117, found 342.0118.  
MTK-5-128. 
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Derivatization of Bicyclic Iodolactones 
 
 
 
(1R,2R,4S)-4-(Hydroxymethyl)-2-iodo-4-phenylcyclopentan-1-ol (137).  
To a flame died vial with stir bar was added LiAlH4 (6 mg, 150 µmol) and THF (1 
mL). The mixture was cooled to -78 ºC, the iodolactone (31 mg, 100 µmol, 95% ee) was 
added slowly, and the mixture was stirred at -78 ºC for 30 minutes. The reaction was 
quenched by addition of satd aq NaHCO3 (1 mL) and Et2O (1 mL). The layers were 
separated and the aqueous layer was extracted with Et2O. The combined organic layers 
were dried, filtered, and concentrated. The product was purified by flash column 
chromatography (SiO2, 20% ethyl acetate in hexanes) to yield a colorless oil (13.1 mg, 42 
%). The product was determined to be 95% ee by chiral HPLC analysis (Chiralpak IA, 10% 
iPrOH/hexanes, 1 mL/min, tr(e1 minor) = 9.21 min, tr(e2 major) =  12.0 min). [a]  -24.9 
(c 0.63, CHCl3); Rf = 0.37 (50% EtOAc/hexanes); IR (film) 3332, 3062, 2927, 2870, 1493, 
1445, 1042 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.31-7.27 (m, 2H), 7.21-7.17 (m, 3H), 4.41 
(ddd, J = 7.2, 5.0, 5.0 Hz, 1H), 4.19 (br ddd, J = 7.2, 7.2, 5.5 Hz, 1H), 3.51 (d, J = 10.4 
Hz, 1H), 3.45 (d, J = 10.4 Hz, 1H), 2.91 (dd, J = 14.3, 6.8 Hz, 1H), 2.67 (dd, J = 14.1, 7.2 
Hz, 1H), 2.53 (dd, J = 14.3, 8.0 Hz, 1H), 2.01 (dd, J = 14.1, 4.5 Hz, 1H); 13C NMR (100 
MHz, CDCl3) ppm 145.9, 128.7, 126.9, 126.7, 71.8, 72.1, 51.8, 44.4, 41.5, 31.5; HRMS (CI): 
Exact mass calcd for C12H15O2 [M-I]+ 191.1072, found 191.1070. MTK-5-297. 
 
 
 
(1S,4R,6R)-4-Phenyl-2-oxabicyclo[2.2.1]heptan-6-ol (138).  
To a flame-dried vial with stir bar was added LiAlH4 (6 mg, 150 µmol) and THF (1 
mL). The mixture was cooled to 0 ºC, iodolactone (31 mg, 100 µmol, 95% ee) was added 
slowly, and the mixture was stirred at 0 ºC for 30 minutes. The reaction was quenched by 
addition of satd aq NaHCO3 (1 mL) and Et2O (1 mL). The layers were separated and the 
aqueous layer was extracted with Et2O. The combined organic layers were dried, filtered, 
and concentrated. The product was purified by flash column chromatography (SiO2, 10% 
ethyl acetate in hexanes) to yield a colorless solid (11.2 mg, 59%). The product was 
determined to be 95% ee by chiral HPLC analysis (Chiralpak IA, 15% iPrOH/hexanes, 1 
mL/min, tr(e1 major) = 7.4 min, tr(e2 minor) =  8.1 min). Mp 129-131 ºC. [a]  +21.9 (c 
O
OPh
I
LAH
THF
-78 ºC
Ph
OH
OH
I
€ 
D
20
O
OPh
I
LAH
THF
0 ºC
O
Ph
OH
€ 
D
20
 126 
1.12, CHCl3); Rf = 0.38 (75% EtOAc/hexanes); IR (film) 3425, 2926, 2871, 1446, 1406, 1114 
cm-1; 1H NMR (400 MHz, CDCl3) δ 7.35-7.32 (m, 2H), 7.27-7.21 (m, 3H), 4.32 (dd, J = 2.5, 
2.5 Hz, 1H), 4.23 (br d, J = 9.5 Hz, 1H), 3.91 (d, J = 6.9 Hz, 1H), 3.83 (dd, J = 6.8, 3.5 
Hz, 1H), 2.81 (br s, 1H), 2.26-2.20 (m, 2H), 1.89 (d, J = 10.5 Hz, 1H), 1.65 (ddd, J = 13.3, 
3.6, 2.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) ppm 140.2, 128.7, 127.2, 126.4, 80.2, 78.3, 
72.9, 52.9, 44.9, 40.7; HRMS (EI): Exact mass calcd for C14H15IO2 [M]+ 190.0994, found 
190.1037. MTK-5-132. 
 
 
 
(1S,4S)-4-Phenyl-2-oxabicyclo[2.2.1]heptan-3-one (139).  
To a flame-dried microwave vial with stir bar was added iodolactone (60 mg, 0.20 
mmol, 93% ee), Bu3SnH (110 µL, 0.40 mmol), and benzene (2.0 mL). The mixture was 
degassed (freeze-pump-thaw, 3 cycles) and then heated to 80 ºC. One portion of AIBN (2 
mg, 0.05 eq) was added, and the mixture was stirred for 30 minutes. A second portion of 
AIBN (2 mg, 0.05 eq) was added, and the mixture was stirred for another 30 minutes until 
full conversion was achieved. The reaction was cooled to room temperature, and the mixture 
was loaded onto a 15% K2CO3/SiO2 pipette column and flushed with Et2O. The eluent was 
concentrated to an oil that was purified by column chromatography (SiO2, 20% ethyl acetate 
in hexanes) to yield a colorless solid (30.3 mg, 81%). The product was determined to be 
91% ee by chiral HPLC analysis (Chiralpak IA, 3% iPrOH/hexanes, 1 mL/min, tr(e1 minor) 
= 14.1 min, tr(e2 major) =  14.8 min). Mp 67-70 ºC; [a]  -103 (c 1.52, CHCl3); Rf = 0.24 
(25% EtOAc/hexanes); IR (film) 3027, 2952, 2873, 1772, 1501, 1449, 1324, 1102 cm-1; 1H 
NMR (400 MHz, CDCl3) 7.44-7.31 (m, 5H), 4.98 (d, J = 1.3 Hz, 1H), 2.56 (dd, J = 10.2, 
1.5 Hz, 1H), 2.16-2.09 (m, 4H), 2.03 (d, J = 10.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) ppm 
177.8, 135.9, 128.6, 127.8, 127.4, 79.1, 55.3, 44.3, 30.2, 30.0; HRMS (EI): Exact mass calcd 
for C12H12O2Na [M+Na]+ 211.0735, found 211.0745. MTK-5-153. 
 
 
 
(1R,4S)-6-Allyl-4-phenyl-2-oxabicyclo[2.2.1]heptan-3-one (140).  
To a flame-dried microwave vial with stir bar was added iodolactone (16 mg, 0.05 
mmol, 93% ee), allylSnBu3 (60 µL, 0.20 mmol), and benzene (1.0 mL). The mixture was 
degassed (freeze-pump-thaw, 3 cycles) and then heated to 80 ºC. One portion of AIBN (1 
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mg, 0.05 eq) was added, and the mixture was stirred for 30 minutes. A second portion of 
AIBN (1 mg, 0.05 eq) was added, and the mixture was stirred for 4 hours until full 
conversion was achieved. The reaction was cooled to room temperature, and the mixture 
was loaded onto a 15% K2CO3/SiO2 pipette column and flushed with Et2O. The eluent was 
concentrated to an oil that was purified by column chromatography (SiO2, 20% ethyl acetate 
in hexanes) to yield a colorless oil (5.3 mg, 46%, 5:1 dr). [a]  -55.9 (c 0.58, CHCl3); Rf = 
0.47 (25% EtOAc/hexanes); IR (film) 3066, 2925, 2857, 1777, 1451, 1317, 1232, 1103 cm-1; 
1H NMR (400 MHz, CDCl3) 7.39-7.31 (m, 5H), 5.85-5.75 (m, 1H), 5.09 (dd, J = 13.8, 1.9 
Hz, 2H), 4.73 (d, J = 1.6 Hz, 1H), 2.54 (br dddd, J = 10.5, 2.2, 2.2, 2.2 Hz, 1H), 2.48-2.41 
(m, 1H), 2.37 (dd, J = 12.4, 2.1 Hz, 1H), 2.28-2.21 (m, 1H), 2.17 (d, J = 10.4 Hz, 1H), 2.16-
2.11 (m, 1H), 1.69 (dd, J = 12.5, 4.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) ppm 177.7, 
135.8, 135.1, 128.6, 127.9, 127.4, 117.1, 81.6, 55.1, 42.1, 41.5, 38.0, 37.1; HRMS (EI): Exact 
mass calcd for C15H16O2 [M]+ 228.1155, found 228.1150. MTK-5-063. 
 
 
 
(1R,3S)-N-Benzyl-3-hydroxy-1-phenylcyclopentane-1-carboxamide (141).  
To a flame-dried 100-500 µL microwave vial with stir bar was added lactone (19 mg, 
0.10 mmol) and benzyl amine (100 µL). The mixture microwaved at 170 ºC for 20 minutes. 
The reaction mixture was purified directly by column chromatography (SiO2, 40% ethyl 
acetate in hexanes) to yield a colorless solid (20.5 mg, 70%). Mp 77-79ºC; [a]  -191 (c 1.03, 
CHCl3); Rf = 0.38 (100% EtOAc); IR (film) 3340, 3059, 3033, 2928, 1644, 1526, 1448, 1276 
cm-1; 1H NMR (400 MHz, CDCl3) 7.57-7.51 (m, 4H), 7.48-7.40 (m, 4H), 7.24 (d, J = 6.6 Hz, 
2H), 5.77 (br s, 1H), 4.85 (br s, 1H), 4.60-4.54 (m, 2H), 4.52 (dd, J = 15.2, 5.8 Hz, 1H), 
2.90 (dd, J = 14.1, 0.9 Hz, 1H), 2.79-2.72 (m, 1H), 2.48-2.29 (m, 3H), 2.13-2.05 (m, 1H); 
13C NMR (100 MHz, CDCl3) ppm 179.0, 144.1, 138.1, 129.2, 128.8, 127.6, 127.5, 127.3, 127.1, 
73.1, 58.6, 47.2, 43.9, 36.4, 36.2; HRMS (EI): Exact mass calcd for C19H21NO2 [M+H]+ 
296.1651, found 296.1161. MTK-5-279. 
 
 
(1S,3R)-N-(3,5-bis(trifluoromethyl)benzyl)-3-hydroxy-1-isopropylcyclopentane-
1-carboxamide (152). 
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To a flame-dried microwave vial with stir bar was added iodolactone (150 mg, 540 
µmol, 95% ee), Bu3SnH (290 µL, 1.08 mmol), and benzene (3.0 mL). The mixture was 
degassed (freeze-pump-thaw, 3 cycles) and then heated to 80 ºC. One portion of AIBN (2 
mg, 0.05 eq) was added, and the mixture was stirred for 30 minutes. A second portion of 
AIBN (5 mg, 0.05 eq) was added, and the mixture was stirred for another 30 minutes until 
full conversion was achieved. The reaction was cooled to room temperature, and the mixture 
was loaded onto a 15% K2CO3/SiO2 pipette column and flushed with Et2O. The eluent was 
concentrated to an oil. This oil was transferred to a 2-5 mL microwave vial and 3,5-
bis(trifluoromethyl)benzylamine (1.3 g, 5.4 mmol) was added. The reaction was microwaved 
neat at 220 ºC for 2 h. After completion, the contents were washed into a separatory funnel 
with dichloromethane (5 mL) and 3M HCl (5 mL). The layers were separated and the 
aqueous layer was extracted with dichloromethane. The combined organic layers were dried, 
filtered, and concentrated. The product was purified by flash column chromatography (SiO2, 
10% ethyl acetate in hexanes) to yield a colorless solid (109 mg, 56%). Mp 99-102 ºC; [a]  
+ 1.75 (c 0.93, CHCl3); Rf = 0.30 (50% EtOAc/hexanes); IR (film) 3328, 2931, 1637, 1533 
cm-1; 1H NMR (400 MHz, CDCl3) 7.75-7.73 (m, 3H), 7.14 (br dd, J = 5.6, 5.0 Hz, 1H), 4.58 
(dd, J = 15.6, 6.2 Hz, 1H), 4.51 (dd, J = 15.7, 5.7 Hz, 1H), 4.43 (br m, 1H), 2.69 (br s, 1H), 
2.18 (sept, J = 6.8 Hz, 1H), 2.22-2.02 (m, 2H), 1.82-1.68 (m, 4H), 0.87 (d, J = 6.9 Hz, 3H), 
0.85 (d, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) ppm 179.5, 141.9, 131.9 (q, 2JCF = 
33.1 Hz), 127.6 (br q, 3JCF = 3.0 Hz), 123.3 (q, 1JCF = 271 Hz), 121.3 (dq, 3JCF = 3.6, 3.6 
Hz), 74.1, 57.1, 43.0, 38.5, 36.3, 34.5, 34.2, 19.2, 17.2; HRMS (EI): Exact mass calcd for 
C18H22F6NO2 [M+H]+ 398.1549, found 398.1555. MTK-6-192 and 193. 
 
 
(1S,3R)-N-(3,5-Bis(trifluoromethyl)benzyl)-3-(((R)-5-bromo-2,3-dihydro-1H-
inden-1-yl)amino)-1-isopropylcyclopentane-1-carboxamide (148) 
To a 10 mL round bottomed flask with stir bar was added alcohol (73 mg, 180 µmol), 
PCC (79 mg, 370 µmol), and dichloromethane (2.0 mL). The mixture was stirred for 18 
hours until full conversion was achieved. The reaction was transferred onto a silica pad and 
flushed with diethyl ether (20 mL). The eluent was concentrated to a colorless oil (52.4 
mg), of which 28.9 mg of the crude material was transferred to a 2-5 mL microwave vial. 
(R)-5-bromo-2,3-dihydro-1H-inden-1-amine (15.5 mg, 73 µmol), methanol (1 mL), acetic 
acid (5 µL, 73 µL), and molecular sieves were added. The reaction was allowed to stir for 
30 minutes, then NaBH3CN (14 mg, 220 µmol) was added and stirred at room temperature 
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for 18 hours. After completion, the reaction was quenched by the addition of water (2 mL) 
and diethyl ether (2 mL). The layers were separated and the aqueous layer was extracted 
with diethyl ether. The combined organic layers were dried, filtered, and concentrated. The 
product was purified by flash column chromatography (SiO2, 30% ethyl acetate, 1% Et3N 
in hexanes) to yield an oil (25.9 mg, 60%, 2 steps, 3:1 dr). [a]  +10.7 (c 0.65, CHCl3, 2.30 
equiv TFA added); Rf = 0.39 (1% Et3N/EtOAc); IR (film) 3340, 2960, 2876, 1643, 1525, 
1465, 1378, 1281, 1174, 1137 cm-1; 1H NMR (600 MHz, DMSO-d6) 8.54 (t, J = 5.7 Hz, 1H), 
7.96 (br s, 1H), 7.94 (br s, 2H), 7.39 (br s, 1H), 7.27 (br d, J = 7.7 Hz, 1H), 7.12 (br d, J 
= 7.6 Hz, 1H), 4.49 (dd, J = 10.4, 5.8 Hz, 1H), 4.41 (dd, J = 10.4, 5.6 Hz, 1H), 4.04 (br s, 
1H), 3.18 (br dddd, J = 6.8, 6.8, 6.1, 6.1 Hz, 1H), 2.90-2.86 (m, 1H), 2.70 (ddd, J = 16.0, 
7.7, 7.7 Hz, 1H), 2.32-2.27 (m, 1H), 2.11 (br ddd, J = 11.9, 7.1, 4.0 Hz, 1H), 2.01 (sept, J 
= 6.7 Hz, 1H), 1.86 (d, J = 6.3 Hz, 2H), 1.83-1.78 (m, 1H), 1.68-1.63 (m, 1H), 1.51-1.46 (m, 
1H), 1.34-1.28 (m, 1H), 0.79 (d, J = 6.7 Hz, 3H), 0.76 (d, J = 6.7 Hz, 3H); 13C NMR (125 
MHz, DMSO-d6) ppm 177.4, 146.0, 144.1 (2C), 130.0 (q, 2JCF = 27.2 Hz), 128.6, 127.9, 
127.3, 125.9, 123.4 (q, 1JCF = 272 Hz), 120.3 (dq, 3JCF = 3.4, 3.4 Hz), 60.4, 56.8, 56.4, 41.8, 
34.2, 32.7, 30.2, 29.7, 29.0, 18.4, 17.9; HRMS (EI): Exact mass calcd for C27H30N2O1BrF6 
[M+H]+ 591.1440, found 591.1440. MTK-6-195, 200, and 201. 
 
 
(1S,3R)-N-(3,5-Bis(trifluoromethyl)benzyl)-3-(((S)-5-bromo-2,3-dihydro-1H-
inden-1-yl)amino)-1-isopropylcyclopentane-1-carboxamide (epi-148) 
To a 10 mL round bottomed flask with stir bar was added alcohol (35 mg, 90 µmol), 
PCC (38 mg, 180 µmol), and dichloromethane (2.0 mL). The mixture was stirred for 18 
hours until full conversion was achieved. The reaction was transferred onto a silica pad and 
flushed with diethyl ether (10 mL). The eluent was concentrated to a colorless oil (33 mg), 
which was transferred to a 2-5 mL microwave vial. (S)-5-bromo-2,3-dihydro-1H-inden-1-
amine (18 mg, 80 µmol), methanol (1 mL), acetic acid (5 µL, 80 µL), and molecular sieves 
were added. The reaction was allowed to stir for 30 minutes, then NaBH3CN (16 mg, 250 
µmol) was added and stirred at room temperature for 18 hours. After completion, the 
reaction was quenched by the addition of water (2 mL) and diethyl ether (2 mL). The layers 
were separated and the aqueous layer was extracted with diethyl ether. The combined 
organic layers were dried, filtered, and concentrated. The product was purified by flash 
column chromatography (SiO2, 30% ethyl acetate, 1% Et3N in hexanes) to yield an oil (45.0 
mg, 92%, 2 steps, 2:1 dr). [a]  -19.2 (c 0.76, CHCl3, 2.75 equiv TFA added); Rf = 0.39 (1% 
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Et3N/EtOAc); IR (film) 3341, 2925, 2858, 1643, 1525, 1462, 1377, 1280 cm-1; 1H NMR (600 
MHz, DMSO-d6) 8.54 (t, J = 5.9 Hz, 1H), 7.94 (s, 2H), 7.92 (d, J = 7.4 Hz, 1H), 7.39 (br 
s, 1H), 7.24 (br d, J = 7.8 Hz, 1H), 7.10 (br d, J = 7.9 Hz, 1H), 4.51 (dd, J = 15.8, 5.9 Hz, 
1H), 4.42 (dd, J = 15.8, 5.9 Hz, 1H), 4.05 (br s, 1H), 3.19 (br dddd, J = 6.8, 6.8, 5.9, 5.9 
Hz, 1H), 2.88 (dddd, J = 15.4, 12.1, 8.1, 3.7 Hz, 1H), 2.70 (ddd, J = 16.1, 7.9, 7.9 Hz, 1H), 
2.32-2.27 (m, 1H), 2.15-2.11 (m, 1H), 2.00 (sept, J = 6.7 Hz, 1H), 1.97-1.92 (m, 1H), 1.83-
1.76 (m, 2H), 1.68-1.62 (m, 1H), 1.49 (dt, J  = 13.2, 8.5 Hz), 1.31-1.27 (m, 1H), 0.79 (d, J 
= 6.9 Hz, 3H), 0.76 (d, J = 6.8 Hz, 3H); 13C NMR (125 MHz, DMSO-d6) ppm 177.4, 145.9, 
144.1 (2C), 130.0 (q, 2JCF = 27.2 Hz), 128.7, 127.9, 127.3, 126.0, 123.4 (q, 1JCF = 226 Hz), 
120.3 (dq, 3JCF = 3.4, 3.4 Hz), 60.5, 56.7, 56.4, 41.8, 34.4, 33.6, 30.5, 29.7, 29.0, 18.4, 17.9; 
HRMS (EI): Exact mass calcd for C27H30N2O1BrF6 [M+H]+ 591.1440, found 591.1443. MTK-
6-184. 
 
 
 
Methyl((S)-2-(4-(benzyloxy)phenyl)-2-((tert-butoxycarbonyl)amino)acetyl)-L-
phenylalaninate (167). 
A three-necked (24/40, 29/42, and 24/40 joints), dimpled 1-L round bottom flasked 
was equipped with an overhead mechanical stirrer in the central neck and placed into a 
temperature controlled isopropanol bath. A thermometer adapter and thermometer were 
placed in a 24/40 neck. Bromonitroalkane (8.90 g, 19.7 mmol, 1.0 equiv, 92/95% ee), L-
phenylalanine methyl ester (4.24 g, 23.7 mmol, 1.2 equiv), and cesium carbonate (14.14 g, 
43.4 mmol, 2.2 equiv) were loaded into the flask. Deionized water (35 mL) and 2-Me-THF 
(200 mL) were poured into the vessel. A septum and oxygen balloon were then placed in 
the open neck, and the mixture was stirred in the 0 °C isopropanol bath until the internal 
reaction temperature reached 0 °C. N-iodosuccinimide (4.44 g, 19.7 mmol, 1.0 equiv) was 
then added in one portion through the neck bearing a septum. The reaction mixture was 
stirred for 9 d refilling the oxygen balloon as needed, until full consumption of starting 
material was observed by 1H NMR. To quench the reaction, satd aq Na2S2O3 (50 mL) was 
poured into the stirring reaction, and the mixture was then gradually warmed to room 
temperature by turning off the cold finger and continuing stirring. The mixture was then 
poured into a 1-L separatory funnel, using ethyl acetate (50 mL) to rinse the remaining 
mixture into the funnel. The organic and aqueous layers were separated, and the latter was 
extracted with ethyl acetate (2 x 50 mL). The combined organic layers were dried over 
MgSO4 (25 g), filtered, and concentrated to a red oil in a 1-L round-bottomed flask by 
rotary evaporation (25 °C, 23 mm Hg). The oil was transferred onto a pad of silica (8 cm 
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tall by 7 cm wide), using 10 mL of dichloromethane to retrieve the residual oil. The silica 
was then flushed with 50% ethyl acetate and hexanes (600 mL) into a 1-L round bottom 
flask and was concentrated to a red solid by rotary evaporation (25 °C, 23 mm Hg). The 
material was subjected to high vacuum (0.01 mm Hg) for 1 h. To the crude solid was added 
50 mL of 60% toluene/cyclohexane and stirred in a warm water bath (70 °C) until all solids 
dissolved. The flask was then removed from the water bath, capped with a plastic stopper, 
and allowed to cool to room temperature (25 °C) for 6 h. The suspension was vacuum 
filtered through a Büchner funnel (7 cm diameter), fitted with filter paper. Cyclohexane (2 
x 25 mL) was used to rinse the remaining powder from the round-bottomed flask onto the 
filter cake. The solid was transferred into a tared 100 mL round bottom flask and dried by 
high vacuum (0.1 mm Hg) for 10 h to give an off white solid (5.25 g, 51% yield). Rf = 0.46 
(30% EtOAc/hexanes); mp = 125-127 °C; Rf = 0.47 (50% EtOAc/hexanes); IR (film) 3322, 
3033, 2976, 1669, 1507, 1237, 1170 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.42-7.31 (m, 5H), 
7.28-7.18 (m, 5H), 7.05 (d, J = 7.6 Hz, 2H), 6.90 (d, J = 8.8 Hz, 2H), 6.29 (br d, J = 6.8 
Hz, 1H), 5.60 (br s, 1H), 5.05 (br s, 1H), 5.03 (s, 2H), 4.80 (dd, J = 13.2, 7.2 Hz, 1H), 3.64 
(s, 3H), 3.14 (dd, J = 14.0, 6.0 Hz, 1H), 3.04 (dd, J = 14.0, 6.0 Hz, 1H), 1.41 (s, 9H); 13C 
NMR (125 MHz, CDCl3) ppm 171.5, 170.2, 158.9, 155.2, 136.9, 135.7, 130.1, 129.4, 128.7 
(2C), 128.6, 128.1, 127.6, 127.3 (2C), 115.4, 80.2, 70.1, 53.6, 52.4, 37.8, 28.4; HRMS (EI): 
Exact mass calcd for C30H34N2O6Na [M+Na]+ 541.2315, found 541.2295. 
 
 
 
Benzyl((S)-2-(4-(benzyloxy)phenyl)-2-((tert-butoxycarbonyl)amino)acetyl)-L-
phenylalaninate (169).  
A three-necked (24/40, 29/42, and 24/40 joints), dimpled 1-L round bottom flasked 
was equipped with an overhead mechanical stirrer in the central neck. A septum and plastic 
stopper were placed in the other two necks. Bromonitroalkane (8.90 g, 19.7 mmol, 1.0 equiv, 
92/95% ee), L-phenylalanine benzyl ester hydrochloride (6.90 g, 23.7 mmol, 1.2 equiv), and 
cesium carbonate (20.6 g, 63.1 mmol, 3.2 equiv) were loaded into the flask. Deionized water 
(35 mL) and 2-Me-THF (200 mL) were poured into the vessel. An oxygen balloon was then 
placed in the septum, and the mixture was stirred at room temperature for 5 minutes. N-
Iodosuccinimide (4.44 g, 19.7 mmol, 1.0 equiv) was then added in one portion through the 
neck bearing the plastic stopper. The reaction mixture was stirred for 24 hours. To quench 
the reaction, satd aq Na2S2O3 (50 mL) was poured into the stirring reaction and allowed to 
stir for 1 hour. The mixture was then poured into a 1-L separatory funnel, using ethyl 
acetate (50 mL) to rinse the remaining mixture into the funnel. The organic and aqueous 
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layers were separated, and the latter was extracted with ethyl acetate (2 x 50 mL). The 
combined organic layers were dried over MgSO4 (25 g), filtered, and concentrated to a red 
oil in a 1-L round-bottomed flask by rotary evaporation (25 °C, 23 mm Hg). The oil was 
transferred onto a pad of silica (8 cm tall by 7 cm wide), using 10 mL of dichloromethane 
to retrieve the residual oil. The silica was then flushed with 50% ethyl acetate and hexanes 
(600 mL) into a 1-L round bottom flask and was concentrated to a red solid by rotary 
evaporation (25 °C, 23 mm Hg). The material was subjected to high vacuum (0.01 mm Hg) 
for 1 h. To the crude solid was added 50 mL of 60% toluene/cyclohexane and heated in a 
warm water bath (70 °C) until all solids dissolved. The flask was then removed from the 
water bath, capped with a plastic stopper, and allowed to cool to room temperature (25 °C) 
for 2 h. The flask was cooled to 0 ºC in a freezer for 18 h. The suspension was vacuum 
filtered through a Büchner funnel (7 cm diameter), fitted with filter paper. Cold cyclohexane 
(2 x 25 mL) was used to rinse the remaining powder from the round-bottomed flask onto 
the filter cake. The solid was transferred into a tared 100 mL round bottom flask and dried 
by high vacuum (0.1 mm Hg) for 10 h to give an off-white solid (6.70 g, 57% yield). Rf = 
0.44 (25% EtOAc/hexanes); 99% purity (Q NMR, DMF internal standard); mp = 126-
128 °C; IR (film) 3321, 3034, 2974, 2929, 1668, 1507, 1240, 1172 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.43-7.33 (m, 8H), 7.24-7.16 (m, 7H), 6.97-6.95 (m, 2H), 6.88 (d, J = 8.7 Hz, 2H), 
6.14 (br d, J = 6.9 Hz, 1H), 5.57 (br s, 1H), 5.11-5.03 (br m, 5H), 4.84 (dd, J = 7.6, 5.8 Hz, 
1H), 3.14 (dd, J = 14.0, 5.8 Hz, 1H), 3.06 (dd, J = 14.0, 5.7 Hz, 1H), 1.41 (s, 9H); 13C NMR 
(125 MHz, DMSO-d6) 170.9, 170.2, 157.6, 154.7, 137.1, 136.9, 135.6, 130.8, 129.1, 128.4 (2C), 
128.3, 128.2, 127.9, 127.7 (2C), 127.5, 126.4, 114.3, 78.3, 69.1, 65.9, 56.7, 53.7, 36.5, 28.1 
ppm; HRMS (EI): Exact mass calcd for C36H39N2O6 [M+H]+ 595.2808, found 595.2816. 
 
i Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. 
Organometallics 1996, 15, 1518-1520.  
ii Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953. 
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B Spectral data 
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Figure B 1: 1H NMR (400 MHz, CDCl3) of S1 
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Figure B 2: 13C NMR (100 MHz, CDCl3) of S1  
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Figure B 3: 1H NMR (400 MHz, CDCl3) of S2 
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Figure B 4: 13C NMR (100 MHz, CDCl3) of S2  
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Figure B 5: 1H NMR (400 MHz, d6-DMSO/CDCl3 10:1) of 123c 
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Figure B 6: 13C NMR (125 MHz, d6-DMSO/CDCl3 10:1) of 123c 
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Figure B 7: 1H NMR (400 MHz, d6-DMSO) of 126a 
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Figure B 8: 13C NMR (100 MHz, d6-DMSO) of 126a  
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Figure B 9: 1H NMR (400 MHz, d6-DMSO) of 126d 
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Figure B 10: 13C NMR (100 MHz, d6-DMSO) of 126d  
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Figure B 11: 1H NMR (400 MHz, d6-DMSO) of 14i 
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Figure B 12: 13C NMR (100 MHz, d6-DMSO) of 14i  
  
N
N
H
N
t B
u
P
h
P
h
N
H
N
N
t B
u
 146 
Figure B 13: 1H NMR (400 MHz, CDCl3) of 107b 
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Figure B 14: 13C NMR (100 MHz, CDCl3) of 107b  
C
O
2H
 148 
Figure B 15: 1H NMR (400 MHz, CDCl3) of S3 
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Figure B 16: 13C NMR (100 MHz, CDCl3) of S3  
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Figure B 17: 1H NMR (400 MHz, CDCl3) of 107c 
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Figure B 18: 13C NMR (100 MHz, CDCl3) of 107c  
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Figure B 19: 1H NMR (400 MHz, CDCl3) of 107d 
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Figure B 20: 13C NMR (100 MHz, CDCl3) of 107d  
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Figure B 21: 1H NMR (400 MHz, CDCl3) of 107e 
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Figure B 22: 13C NMR (100 MHz, CDCl3) of 107e  
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Figure B 23: 1H NMR (400 MHz, CDCl3) of 107f 
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Figure B 24: 13C NMR (100 MHz, CDCl3) of 107f  
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Figure B 25 1H NMR (400 MHz, CDCl3) of 107g 
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Figure B 26: 13C NMR (100 MHz, CDCl3) of 107g   
C
O
2H
O
2N
 160 
Figure B 27: 1H NMR (400 MHz, CDCl3) of 107h 
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Figure B 28: 13C NMR (100 MHz, CDCl3) of 107h  
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Figure B 29: 1H NMR (400 MHz, CDCl3) of S5 
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Figure B 30: 13C NMR (100 MHz, CDCl3) of S5  
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Figure B 31: 1H NMR (400 MHz, CDCl3) of 107i 
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Figure B 33: 1H NMR (400 MHz, CDCl3) of 128 
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Figure B 34: 13C NMR (100 MHz, CDCl3) of 128  
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Figure B 35: 1H NMR (400 MHz, CDCl3) of 107j 
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Figure B 36: 13C NMR (100 MHz, CDCl3) of 107j  
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Figure B 37: 1H NMR (400 MHz, CDCl3) of 107k 
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Figure B 39: 1H NMR (400 MHz, CDCl3) of S6 
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Figure B 40: 13C NMR (100 MHz, CDCl3) of S6 
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Figure B 41: 1H NMR (400 MHz, CDCl3) of 107n 
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Figure B 43: 1H NMR (500 MHz, CDCl3) of 109a 
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Figure B 47: Proton-proton couplings of 109a 
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Figure B 48: 1H NMR (400 MHz, CDCl3) of 109b 
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Figure B 49: 13C NMR (100 MHz, CDCl3) of 109b  
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Figure B 50: 1H NMR (400 MHz, CDCl3) of 109c 
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Figure B 56: 1H NMR (400 MHz, CDCl3) of 109f 
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Figure B 64: 1H NMR (400 MHz, CDCl3) of 109j 
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Figure B 65: 13C NMR (100 MHz, CDCl3) of 109j  
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Figure B 66: 1H NMR (400 MHz, CDCl3) of 109k 
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O O
I M
e
 202 
Figure B 69: 13C NMR (100 MHz, CDCl3) of 109l  
O O
I M
e
 203 
Figure B 70: 1H NMR (400 MHz, CDCl3) of 109m 
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I
O
B
nO
 208 
Figure B 75: 13C NMR (100 MHz, CDCl3) of 134  
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Figure B 90: 1H NMR (400 MHz, CDCl3) of 152 
O O
i P
r
ne
at
, µ
W
I
A
IB
N
, n
B
u 3
S
nH
C
6H
6, 
80
 ºC
H
2N
C
F 3
C
F 3
1)
2)
N H
O i P
r
H
O
C
F 3
C
F 3
-9
5%
 e
e
 224 
Figure B 91: 13C NMR (100 MHz, CDCl3) of 152  
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Figure B 92: 1H NMR (600 MHz, DMSO-d6) of 148 
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Figure B 93: 13C NMR (125 MHz, DMSO-d6) of 148  
  
N H
O i P
r
H N
C
F 3
C
F 3
N
H
2
B
r1)
 P
C
C
2)
N
aH
B
(O
A
c)
3
N H
O i P
r
H
O
C
F 3
C
F 3
B
r
 227 
Figure B 94: 1D selective ROESY (600 MHz, DMSO-d6) of 148 
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Figure B 95: 1D selective ROESY (600 MHz, DMSO-d6) of 148  
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Figure B 96: 1H NMR (600 MHz, DMSO-d6) of epi-148 
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Figure B 97: 13C NMR (125 MHz, DMSO-d6) of epi-148  
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Figure B 98: 1D selective ROESY (600 MHz, DMSO-d6) of epi-148 
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Figure B 99: 1D selective ROESY (600 MHz, DMSO-d6) of epi-148  
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Figure B 100: 1H NMR (400 MHz, CDCl3) of 167 
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Figure B 101: 13C NMR (100 MHz, CDCl3) of 167  
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Figure B 102: 1H NMR (400 MHz, CDCl3) of 169 
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Figure B 103: 13C NMR (125 MHz, CDCl3) of 169  
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C HPLC traces 
Figure C 1: HPLC trace of 109a 
  
Signal: MWD1 B, Sig=254,16 Ref=360,100
11.863 BB 0.2361 1635.6903 104.7975 97.3878
7.510 BB 0.1384 43.8737 4.9008 2.6122
Sum 1679.5640
RT [min] Type Width [min] Area Height Area% Name
Signal: MWD1 B, Sig=254,16 Ref=360,100
12.430 VB 0.2453 3024.8416 188.3916 45.4820
7.176 VV 0.1327 3625.7966 428.5378 54.5180
Sum 6650.6382
RT [min] Type Width [min] Area Height Area% Name
O
O
I
 238 
Signal: MWD1 B, Sig=254,16 Ref=360,100
12.202 MM 0.2593 2035.0994 130.7970 54.1354
11.167 MM 0.2303 1724.1740 124.7827 45.8646
Sum 3759.2733
RT [min] Type Width [min] Area Height Area% Name
Figure C 2: HPLC trace of 109b 
  
Signal: MWD1 B, Sig=254,16 Ref=360,100
12.241 BB 0.2418 11673.7402 757.5051 95.3186
11.080 BB 0.2134 573.3398 41.9578 4.6814
Sum 12247.0801
RT [min] Type Width [min] Area Height Area% Name
O
O
I
 239 
Figure C 3: HPLC trace of 109c 
 
 
  
Signal: MWD1 D, Sig=230,16 Ref=360,100
10.810 BB 0.2130 3012.2837 220.9678 48.6270
9.234 BB 0.1850 3182.3850 267.1710 51.3730
Sum 6194.6687
RT [min] Type Width [min] Area Height Area% Name
Signal: MWD1 D, Sig=230,16 Ref=360,100
10.667 MM 0.2383 16128.9902 1127.9482 82.0260
9.180 MM 0.1920 3534.2861 306.7835 17.9740
Sum 19663.2764
RT [min] Type Width [min] Area Height Area% Name
O
O
I
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Figure C 4: HPLC trace of 109d 
  
Signal: MWD1 B, Sig=254,16 Ref=360,100
11.020 MM 0.2361 3171.8628 223.9151 53.4889
8.073 MM 0.1613 2758.0833 285.0321 46.5111
Sum 5929.9460
RT [min] Type Width [min] Area Height Area% Name
Signal: MWD1 B, Sig=254,16 Ref=360,100
11.257 BB 0.2105 460.8923 33.9166 94.6429
8.137 BB 0.1464 26.0882 2.7575 5.3571
Sum 486.9806
RT [min] Type Width [min] Area Height Area% Name
O
O
I
Cl
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Figure C 5: HPLC trace of 109e 
  
Signal: MWD1 D, Sig=230,16 Ref=360,100
12.993 VB 0.2666 4873.4849 283.3961 45.3035
9.627 MM 0.2011 5883.9355 487.6227 54.6965
Sum 10757.4204
RT [min] Type Width [min] Area Height Area% Name
Signal: MWD1 D, Sig=230,16 Ref=360,100
13.115 MM 0.2952 9378.2842 529.5397 94.8556
9.687 MM 0.2061 508.6172 41.1241 5.1444
Sum 9886.9014
RT [min] Type Width [min] Area Height Area% Name
O
O
I
Br
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Figure C 6: HPLC trace of 109f 
  
Signal: MWD1 D, Sig=230,16 Ref=360,100
13.602 BB 0.2371 2059.5540 134.1978 49.9551
11.931 VB 0.2038 2063.2578 156.5276 50.0449
Sum 4122.8118
RT [min] Type Width [min] Area Height Area% Name
Signal: MWD1 B, Sig=254,16 Ref=360,100
13.349 BB 0.2643 2003.8063 117.8705 95.5476
11.864 BB 0.2232 93.3749 6.5168 4.4524
Sum 2097.1812
RT [min] Type Width [min] Area Height Area% Name
O
O
I
MeO
 243 
Signal: MWD1 B, Sig=254,16 Ref=off
18.271 MM 0.4442 14443.8447 541.9376 53.0766
12.060 MM 0.2810 12769.3418 757.4849 46.9234
Sum 27213.1865
RT [min] Type Width [min] Area Height Area% Name
Figure C 7: HPLC trace of 109g 
  
Signal: MWD1 B, Sig=254,16 Ref=off
18.447 BB 0.4067 6353.5059 241.7000 92.8740
12.129 BB 0.2553 487.4927 29.7299 7.1260
Sum 6840.9986
RT [min] Type Width [min] Area Height Area% Name
O
O
I
O2N
 244 
Figure C 8: HPLC trace of 109h 
  
Signal: MWD1 B, Sig=254,16 Ref=360,100
15.611 MM 0.3701 10931.5391 492.2958 44.0964
12.819 MM 0.2986 13858.5752 773.4414 55.9036
Sum 24790.1143
RT [min] Type Width [min] Area Height Area% Name
Signal: MWD1 B, Sig=254,16 Ref=360,100
14.918 BB 0.3133 11726.1328 566.9210 97.0071
12.511 BB 0.2526 361.7747 22.1391 2.9929
Sum 12087.9075
RT [min] Type Width [min] Area Height Area% Name
O
O
I
Ph
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Figure C 9: HPLC trace of 109i 
  
Signal: MWD1 B, Sig=254,16 Ref=360,100
12.495 VB 0.2479 4046.3152 248.5837 45.5591
7.153 VB 0.1325 4835.1460 572.4946 54.4409
Sum 8881.4612
RT [min] Type Width [min] Area Height Area% Name
Signal: MWD1 B, Sig=254,16 Ref=360,100
12.257 BB 0.2324 2908.7844 196.8011 95.8350
7.705 VB 0.1394 126.4164 13.9976 4.1650
Sum 3035.2008
RT [min] Type Width [min] Area Height Area% Name
O
O
I
S
 246 
Signal: MWD1 B, Sig=254,16 Ref=360,100
6.597 MM 0.1262 623.5004 82.3372 50.1655
4.925 MM 0.0899 619.3856 114.8271 49.8345
Sum 1242.8859
RT [min] Type Width [min] Area Height Area% Name
Figure C 10: HPLC trace of 109j 
  
Signal: MWD1 B, Sig=254,16 Ref=360,100
6.679 BV 0.1206 281.0329 36.1773 93.6582
4.947 MM 0.0885 19.0293 3.5837 6.3418
Sum 300.0623
RT [min] Type Width [min] Area Height Area% Name
O
O
I
Me
Me
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Figure C 11: HPLC trace of 109k 
  
Signal: MWD1 B, Sig=254,16 Ref=360,100
14.298 BB 0.2755 129.3422 7.2710 50.2356
9.518 BB 0.1751 128.1288 11.4057 49.7644
Sum 257.4710
RT [min] Type Width [min] Area Height Area% Name
Signal: MWD1 B, Sig=254,16 Ref=360,100
14.545 BB 0.2704 435.2518 25.0936 93.5079
10.064 BB 0.1747 30.2189 2.6970 6.4921
Sum 465.4707
RT [min] Type Width [min] Area Height Area% Name
O
O
I
Ph
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Figure C 12: HPLC trace of 109l 
  
Signal: MWD1 B, Sig=254,16 Ref=360,100
8.562 MM 0.1706 158.6190 15.5002 48.4162
5.607 BB 0.0952 168.9962 27.6781 51.5838
Sum 327.6152
RT [min] Type Width [min] Area Height Area% Name
Signal: MWD1 B, Sig=254,16 Ref=360,100
9.077 BV 0.1600 326.9082 31.7891 93.2203
5.807 BB 0.1000 23.7754 3.7470 6.7797
Sum 350.6836
RT [min] Type Width [min] Area Height Area% Name
O
O
I
Me
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Figure C 13: HPLC trace of 109m 
  
Signal: MWD1 B, Sig=254,16 Ref=360,100
8.066 VB 0.0844 267.7996 50.0367 46.9685
7.847 VV 0.0855 302.3685 57.3134 53.0315
Sum 570.1681
RT [min] Type Width [min] Area Height Area% Name
Signal: MWD1 B, Sig=254,16 Ref=360,100
8.117 VB 0.0781 308.1693 61.8659 82.0108
7.832 BV 0.1876 67.5972 5.4923 17.9892
Sum 375.7665
RT [min] Type Width [min] Area Height Area% Name
O
O
I
O
O
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Figure C 14: HPLC trace of 109n 
  
Signal: MWD1 B, Sig=254,16 Ref=360,100
8.310 BB 0.1492 1786.0481 184.1522 46.5759
7.250 BB 0.1287 2048.6560 247.1414 53.4241
Sum 3834.7041
RT [min] Type Width [min] Area Height Area% Name
Signal: MWD1 B, Sig=254,16 Ref=360,100
8.855 BB 0.1673 766.0233 71.3417 86.8987
7.623 BB 0.1383 115.4892 12.9238 13.1013
Sum 881.5125
RT [min] Type Width [min] Area Height Area% Name
O
O
I
S
O
 251 
Figure C 15: HPLC trace of 137 
  
Signal: MWD1 B, Sig=254,16 Ref=360,100
12.027 BB 0.2714 285.3990 16.3683 57.5302
9.211 VB 0.1953 210.6861 16.9173 42.4698
Sum 496.0850
RT [min] Type Width [min] Area Height Area% Name
Signal: MWD1 B, Sig=254,16 Ref=360,100
11.904 BB 0.2756 1173.5099 65.3102 97.7281
9.244 MM 0.3058 27.2807 1.4869 2.2719
Sum 1200.7906
RT [min] Type Width [min] Area Height Area% Name
O
OPh
I
LAH
THF
-78 ºC
Ph
OH
OH
I
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Figure C 16: HPLC trace of 138 
  
Signal: MWD1 C, Sig=210,16 Ref=360,100
8.122 FM 0.1729 2339.6848 225.4895 46.9193
7.437 MF 0.1558 2646.9331 283.1826 53.0807
Sum 4986.6179
RT [min] Type Width [min] Area Height Area% Name
Signal: MWD1 C, Sig=210,16 Ref=360,100
8.134 FM 0.2139 263.6217 20.5368 2.7466
7.429 MF 0.1552 9334.4229 1002.3060 97.2534
Sum 9598.0446
RT [min] Type Width [min] Area Height Area% Name
O
OPh
I
LAH
THF
0 ºC
O
Ph
OH
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Figure C 17: HPLC trace of 139 
  
Signal: MWD1 C, Sig=210,16 Ref=360,100
14.832 FM 0.3115 13322.1143 712.7924 50.3497
14.012 MF 0.2851 13137.0547 768.0323 49.6503
Sum 26459.1689
RT [min] Type Width [min] Area Height Area% Name
Signal: MWD1 C, Sig=210,16 Ref=360,100
14.780 VB 0.3780 55111.0156 2329.8367 95.4866
14.075 VV 0.2574 2604.9226 158.7713 4.5134
Sum 57715.9382
RT [min] Type Width [min] Area Height Area% Name
O
O
I
Ph
O
OPh
AIBN
HSnBu3
C6H6
80 ºC
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D Isothermal titration calorimetry 
 
Figure D 1: Ph substrate titrated into StilbPBAM (14) 
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Figure D 2:Ph substrate titrated into StilbAnBAM (126d) 
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Figure D 3: 2-Naphthyl substrate titrated into StilbAnBAM (126d) 
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Figure D 4: Bn substrate titrated into StilbAnBAM (126d). 
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Figure D 5: CO2tBu substrate titrated into StilbAnBAM (126d). 
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Figure D 6: 1-Naphthyl substrate titrated into StilbAnBAM (126d). 
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E X-Ray Crystallography of cocrystal structures 
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E 1: X-ray structure of 109a.  
The sample was submitted by Matthew Knowe (research group of Jeff Johnston, Department of Chemistry, 
Vanderbilt University). A colorless crystal (approximate dimensions 0.31 × 0.14 × 0.05 mm3) was placed onto the tip 
of a 0.05 mm diameter glass capillary and mounted on a Bruker APEX II Kappa Duo diffractometer equipped with an 
APEX II detector at 150(2) K. 
 
 
 
Data collection 
 
The data collection was carried out using Mo Kα radiation (graphite monochromator) with a frame time of 20 
seconds and a detector distance of 40 mm. A collection strategy was calculated and complete data to a resolution of 0.50 Å 
with a redundancy of 4 were collected. Eight major sections of frames were collected with 0.50º ω and φ scans. The total 
exposure time was 17.59 hours. The frames were integrated with the Bruker SAINT software package1 using a narrow-
frame algorithm. The integration of the data using a monoclinic unit cell yielded a total of 26319 reflections to a maximum 
θ angle of 30.13° (0.71 Å resolution), of which 6227 were independent (average redundancy 4.227, completeness = 99.6%, 
Rint = 2.56%, Rsig = 2.45%) and 5978 (96.00%) were greater than 2σ(F2). The final cell constants of a = 12.2856(8) Å, b 
= 6.1896(4) Å, c = 15.4428(11) Å, β = 103.702(4)°, volume = 1140.90(13) Å3, are based upon the refinement of the XYZ-
centroids of 9859 reflections above 20 σ(I) with 4.838° < 2θ < 60.02°. Data were corrected for absorption effects using the 
multi-scan method (SADABS).2 The ratio of minimum to maximum apparent transmission was 0.765. The calculated 
minimum and maximum transmission coefficients (based on crystal size) are 0.4790 and 0.8730. Please refer to Table 1 for 
additional crystal and refinement information. 
 
 
 
Structure solution and refinement 
 
The space group P21 was determined based on intensity statistics and systematic absences. The structure was 
solved and refined using the SHELX suite of programs.3 An intrinsic-methods solution was calculated, which provided 
most non-hydrogen atoms from the E-map. Full-matrix least squares / difference Fourier cycles were performed, which 
located the remaining non-hydrogen atoms. All non-hydrogen atoms were refined with anisotropic displacement 
parameters. The hydrogen atoms were placed in ideal positions and refined as riding atoms with relative isotropic 
displacement parameters. The final anisotropic full-matrix least-squares refinement on F2 with 271 variables 
converged at R1 = 1.86%, for the observed data and wR2 = 4.34% for all data. The goodness-of-fit was 1.056. The 
largest peak in the final difference electron density synthesis was 0.638 e-/Å3 and the largest hole was -0.833 e -/Å3 
with an RMS deviation of 0.067 e-/Å3. On the basis of the final model, the calculated density was 1.829 g/cm3 and 
F(000), 608 e-. The absolute configuration was determined for anomalous dispersion effects. 
 
 
 
 
 
 
 
 
_________________ 
 
1 SAINT, Bruker Analytical X-Ray Systems, Madison, WI, current version.  
2 SADABS, Bruker Analytical X-Ray Systems, Madison, WI, current version.  
3 A short history of SHELX, G. M. Sheldrick, Acta Cryst. A64, 112 - 122 (2008). 
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Bulk material.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asymmetric unit (two independent molecules). 
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Asymmetric unit (two independent molecules).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Formula unit. 
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Cell plot, view along a.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell plot, view along b. 
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Cell plot, view along c. 
 267 
 
Table 1. Crystal data and structure refinement for 16042. 
 
Empirical formula  C12 H11 I O2  
Formula weight  314.11  
Crystal color, shape, size  colorless plate, 0.31 × 0.14 × 0.05 mm3 
Temperature  150(2) K  
Wavelength  0.71073 Å  
Crystal system, space group  Monoclinic, P21  
Unit cell dimensions  a = 12.2856(8) Å α= 90°. 
  b = 6.1896(4) Å β= 103.702(4)°. 
  c = 15.4428(11) Å γ = 90°. 
Volume  1140.89(13) Å3  
Z  4  
Density (calculated)  1.829 Mg/m3  
Absorption coefficient  2.784 mm-1  
F(000)  608  
Data collection    
Diffractometer  APEX II Kappa Duo, Bruker  
Theta range for data collection  1.357 to 30.130°.  
Index ranges  -17<=h<=17, -8<=k<=6, -21<=l<=21 
Reflections collected  26319  
Independent reflections  6227 [Rint = 0.0256]  
Observed Reflections  5978  
Completeness to theta = 25.242° 100.0 %  
Solution and Refinement    
Absorption correction  Semi-empirical from equivalents 
Max. and min. transmission  0.7460 and 0.5707  
Solution  Intrinsic methods  
Refinement method  Full-matrix least-squares on F2  
Weighting scheme  w = [σ2Fo2+ AP2+ BP]-1, with  
  P = (Fo2+ 2 Fc2)/3, A = 0.0198, B = 0.2503 
Data / restraints / parameters  6227 / 1 / 271  
Goodness-of-fit on F2  1.056  
Final R indices [I>2sigma(I)]  R1 = 0.0186, wR2 = 0.0427  
R indices (all data)  R1 = 0.0201, wR2 = 0.0434  
Absolute structure parameter  0.002(7)  
Largest diff. peak and hole  0.638 and -0.833 e.Å-3  
_______________________________________________________  
Goodness-of-fit = [Σ[w(Fo2 − Fc2)2]/Nobservns − Nparams)]1/2, all data.  
R1 = Σ(|Fo| − |Fc|) / Σ |Fo|. wR2 = [Σ[w(Fo2 − Fc2)2] / Σ [w(Fo2)2]]1/2.  
 268 
 
Table 2. Atomic coordinates (× 104) and equivalent isotropic displacement parameters (Å2 × 103) 
for 16042. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.  
________________________________________________________________________________  
x y z U(eq)  
________________________________________________________________________________  
I1A 3024(1) 5258(1) 3649(1) 30(1) 
O1A 1804(2) 969(4) 1410(1) 28(1) 
O2A 2609(2) -2062(4) 1065(2) 29(1) 
C1A 3758(2) 1040(5) 1790(2) 18(1) 
C2A 2713(2) -281(5) 1375(2) 22(1) 
C3A 2257(2) 3012(5) 1846(2) 25(1) 
C4A 2701(2) 2411(5) 2823(2) 24(1) 
C5A 3777(2) 1106(5) 2808(2) 24(1) 
C6A 3307(2) 3302(5) 1499(2) 23(1) 
C7A 4813(2) 230(5) 1562(2) 20(1) 
C8A 5289(2) 1341(5) 961(2) 25(1) 
C9A 6240(2) 523(6) 726(2) 31(1) 
C10A 6708(2) -1410(6) 1080(2) 34(1) 
C11A 6243(2) -2517(6) 1684(2) 33(1) 
C12A 5302(2) -1705(5) 1928(2) 27(1) 
I1B 3704(1) 9641(1) 5459(1) 34(1) 
O1B 902(2) 5627(4) 5708(1) 30(1) 
C1B 1214(2) 8433(5) 6746(2) 19(1) 
O2B -607(2) 6556(5) 6205(2) 40(1) 
C2B 359(2) 6828(5) 6221(2) 26(1) 
C3B 2072(2) 6374(5) 5914(2) 24(1) 
C4B 2030(2) 8560(5) 5454(2) 23(1) 
C5B 1453(2) 10023(5) 6025(2) 25(1) 
C6B 2258(2) 6951(5) 6898(2) 24(1) 
C7B 899(2) 9487(6) 7526(2) 24(1) 
C8B 340(3) 11464(6) 7427(2) 32(1) 
C9B 71(3) 12473(7) 8158(3) 44(1) 
C10B 350(3) 11494(8) 8988(3) 49(1) 
C11B 883(2) 9524(8) 9089(2) 43(1) 
C12B 1157(2) 8495(6) 8363(2) 31(1)  
________________________________________________________________________________ 
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Table 3. Bond lengths [Å] and angles [°] for 16042.  
_____________________________________________________________________________________________  
I1A-C4A 2.156(3) O1A-C2A 1.370(3) 
O1A-C3A 1.478(4) O2A-C2A 1.197(4) 
C1A-C7A 1.507(3) C1A-C2A 1.530(4) 
C1A-C6A 1.534(4) C1A-C5A 1.567(4) 
C3A-C6A 1.520(4) C3A-C4A 1.524(4) 
C3A-H3A 1.0000 C4A-C5A 1.554(4) 
C4A-H4A 1.0000 C5A-H5A 0.9900 
C5A-H5B 0.9900 C6A-H6A 0.9900 
C6A-H6B 0.9900 C7A-C8A 1.390(4) 
C7A-C12A 1.398(4) C8A-C9A 1.399(4) 
C8A-H8A 0.9500 C9A-C10A 1.383(5) 
C9A-H9A 0.9500 C10A-C11A 1.384(5) 
C10A-H10A 0.9500 C11A-C12A 1.392(4) 
C11A-H11A 0.9500 C12A-H12A 0.9500 
I1B-C4B 2.161(3) O1B-C2B 1.369(4) 
O1B-C3B 1.472(3) C1B-C7B 1.499(4) 
C1B-C2B 1.531(4) C1B-C6B 1.549(4) 
C1B-C5B 1.565(4) O2B-C2B 1.193(4) 
C3B-C4B 1.524(4) C3B-C6B 1.525(4) 
C3B-H3B 1.0000 C4B-C5B 1.548(4) 
C4B-H4B 1.0000 C5B-H5C 0.9900 
C5B-H5D 0.9900 C6B-H6C 0.9900 
C6B-H6D 0.9900 C7B-C8B 1.393(5) 
C7B-C12B 1.398(4) C8B-C9B 1.397(5) 
C8B-H8B 0.9500 C9B-C10B 1.385(7) 
C9B-H9B 0.9500 C10B-C11B 1.375(6) 
C10B-H10B 0.9500 C11B-C12B 1.398(4) 
C11B-H11B 0.9500 C12B-H12B 0.9500 
C2A-O1A-C3A 106.2(2) C7A-C1A-C2A 114.1(2) 
C7A-C1A-C6A 120.4(2) C2A-C1A-C6A 99.0(2) 
C7A-C1A-C5A 115.7(2) C2A-C1A-C5A 104.2(2) 
C6A-C1A-C5A 100.9(2) O2A-C2A-O1A 121.7(2) 
O2A-C2A-C1A 131.2(2) O1A-C2A-C1A 107.0(2) 
O1A-C3A-C6A 101.6(2) O1A-C3A-C4A 104.5(2) 
C6A-C3A-C4A 104.1(2) O1A-C3A-H3A 115.0 
C6A-C3A-H3A 115.0 C4A-C3A-H3A 115.0 
C3A-C4A-C5A 102.6(2) C3A-C4A-I1A 111.06(19) 
C5A-C4A-I1A 113.32(18) C3A-C4A-H4A 109.9 
C5A-C4A-H4A 109.9 I1A-C4A-H4A 109.9 
C4A-C5A-C1A 102.6(2) C4A-C5A-H5A 111.3 
 270 
 
C1A-C5A-H5A 111.3 C4A-C5A-H5B 111.3 
C1A-C5A-H5B 111.3 H5A-C5A-H5B 109.2 
C3A-C6A-C1A 93.8(2) C3A-C6A-H6A 113.0 
C1A-C6A-H6A 113.0 C3A-C6A-H6B 113.0 
C1A-C6A-H6B 113.0 H6A-C6A-H6B 110.4 
C8A-C7A-C12A 119.0(2) C8A-C7A-C1A 120.8(3) 
C12A-C7A-C1A 120.1(2) C7A-C8A-C9A 120.3(3) 
C7A-C8A-H8A 119.9 C9A-C8A-H8A 119.9 
C10A-C9A-C8A 120.3(3) C10A-C9A-H9A 119.9 
C8A-C9A-H9A 119.9 C9A-C10A-C11A 119.7(3) 
C9A-C10A-H10A 120.1 C11A-C10A-H10A 120.1 
C10A-C11A-C12A 120.4(3) C10A-C11A-H11A 119.8 
C12A-C11A-H11A 119.8 C11A-C12A-C7A 120.3(3) 
C11A-C12A-H12A 119.8 C7A-C12A-H12A 119.8 
C2B-O1B-C3B 106.8(2) C7B-C1B-C2B 115.6(2) 
C7B-C1B-C6B 119.9(2) C2B-C1B-C6B 97.8(2) 
C7B-C1B-C5B 115.2(2) C2B-C1B-C5B 104.6(2) 
C6B-C1B-C5B 101.1(2) O2B-C2B-O1B 122.0(3) 
O2B-C2B-C1B 131.1(3) O1B-C2B-C1B 107.0(2) 
O1B-C3B-C4B 104.7(2) O1B-C3B-C6B 101.4(2) 
C4B-C3B-C6B 103.8(2) O1B-C3B-H3B 115.1 
C4B-C3B-H3B 115.1 C6B-C3B-H3B 115.1 
C3B-C4B-C5B 102.9(2) C3B-C4B-I1B 110.21(18) 
C5B-C4B-I1B 112.4(2) C3B-C4B-H4B 110.4 
C5B-C4B-H4B 110.4 I1B-C4B-H4B 110.4 
C4B-C5B-C1B 103.1(2) C4B-C5B-H5C 111.2 
C1B-C5B-H5C 111.2 C4B-C5B-H5D 111.2 
C1B-C5B-H5D 111.2 H5C-C5B-H5D 109.1 
C3B-C6B-C1B 93.7(2) C3B-C6B-H6C 113.0 
C1B-C6B-H6C 113.0 C3B-C6B-H6D 113.0 
C1B-C6B-H6D 113.0 H6C-C6B-H6D 110.4 
C8B-C7B-C12B 119.0(3) C8B-C7B-C1B 120.6(3) 
C12B-C7B-C1B 120.4(3) C7B-C8B-C9B 120.6(4) 
C7B-C8B-H8B 119.7 C9B-C8B-H8B 119.7 
C10B-C9B-C8B 119.9(4) C10B-C9B-H9B 120.1 
C8B-C9B-H9B 120.1 C11B-C10B-C9B 120.0(3) 
C11B-C10B-H10B 120.0 C9B-C10B-H10B 120.0 
C10B-C11B-C12B 120.7(4) C10B-C11B-H11B 119.6 
C12B-C11B-H11B 119.6 C11B-C12B-C7B 119.8(4) 
C11B-C12B-H12B 120.1 C7B-C12B-H12B 120.1  
_____________________________________________________________________________________________ 
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Table 4. Anisotropic displacement parameters (Å2 × 10 3) for 16042. The anisotropic 
displacement factor exponent takes the form: -2π2[ h2 a*2U11 + ... + 2 h k a* b* U12 ]  
______________________________________________________________________________ 
U11 U22 U33 U23 U13 U12  
______________________________________________________________________________  
I1A 33(1) 26(1) 35(1) -9(1) 16(1) 0(1) 
O1A 18(1) 31(1) 37(1) -7(1) 7(1) 0(1) 
O2A 27(1) 22(1) 36(1) -7(1) 5(1) -2(1) 
C1A 18(1) 15(1) 23(1) 0(1) 7(1) -1(1) 
C2A 20(1) 22(2) 25(1) -1(1) 6(1) -1(1) 
C3A 22(1) 22(2) 33(1) -3(1) 10(1) 3(1) 
C4A 25(1) 21(2) 30(1) -5(1) 13(1) -2(1) 
C5A 28(1) 21(1) 24(1) -1(1) 9(1) 3(1) 
C6A 26(1) 18(1) 27(1) 4(1) 10(1) 4(1) 
C7A 16(1) 19(1) 23(1) -4(1) 4(1) 0(1) 
C8A 22(1) 31(2) 22(1) -1(1) 6(1) 0(1) 
C9A 22(1) 49(2) 25(1) -7(1) 9(1) -2(1) 
C10A 18(1) 46(2) 36(2) -19(1) 5(1) 4(1) 
C11A 23(1) 29(2) 44(2) -10(1) -1(1) 7(1) 
C12A 22(1) 21(2) 36(2) -1(1) 4(1) 1(1) 
I1B 32(1) 38(1) 38(1) -4(1) 17(1) -7(1) 
O1B 31(1) 30(1) 33(1) -13(1) 15(1) -7(1) 
C1B 19(1) 22(1) 16(1) -1(1) 2(1) 2(1) 
O2B 27(1) 55(2) 42(1) -21(1) 13(1) -14(1) 
C2B 27(1) 29(2) 24(1) -7(1) 7(1) -2(1) 
C3B 25(1) 23(2) 25(1) -2(1) 8(1) 3(1) 
C4B 23(1) 28(2) 20(1) 2(1) 6(1) 4(1) 
C5B 27(1) 24(2) 24(1) 3(1) 6(1) 6(1) 
C6B 24(1) 25(2) 22(1) 3(1) 6(1) 8(1) 
C7B 16(1) 32(2) 24(1) -7(1) 5(1) -3(1) 
C8B 26(1) 32(2) 40(2) -11(1) 13(1) 3(1) 
C9B 31(2) 44(2) 63(2) -27(2) 23(2) -2(1) 
C10B 29(2) 75(3) 48(2) -37(2) 22(2) -18(2) 
C11B 28(1) 78(3) 25(1) -14(2) 11(1) -11(2) 
C12B 25(1) 48(2) 22(1) -4(1) 7(1) -1(1)  
______________________________________________________________________________ 
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Table 5. Hydrogen coordinates ( × 104) and isotropic displacement parameters (Å2 × 103) for 16042. 
________________________________________________________________________________  
x y z U(eq)  
________________________________________________________________________________ 
 
H3A 1726 4260 1736 30 
H4A 2149 1462 3024 29 
H5A 3744 -368 3050 28 
H5B 4456 1847 3154 28 
H6A 3799 4473 1806 27 
H6B 3143 3510 845 27 
H8A 4966 2661 709 30 
H9A 6566 1299 320 38 
H10A 7345 -1976 910 41 
H11A 6567 -3838 1932 40 
H12A 4991 -2470 2346 32 
H3B 2622 5323 5771 29 
H4B 1564 8468 4829 28 
H5C 749 10643 5662 30 
H5D 1954 11213 6303 30 
H6C 2968 7738 7133 28 
H6D 2205 5686 7279 28 
H8B 141 12132 6857 39 
H9B -303 13828 8086 53 
H10B 174 12184 9487 58 
H11B 1066 8854 9659 52 
H12B 1518 7128 8439 38  
________________________________________________________________________________ 
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Table 6. Torsion angles [°] for 16042.  
_____________________________________________________________________________________________  
C3A-O1A-C2A-O2A 179.0(3) C3A-O1A-C2A-C1A -0.8(3) 
C7A-C1A-C2A-O2A 17.9(4) C6A-C1A-C2A-O2A 147.1(3) 
C5A-C1A-C2A-O2A -109.2(3) C7A-C1A-C2A-O1A -162.3(2) 
C6A-C1A-C2A-O1A -33.1(3) C5A-C1A-C2A-O1A 70.6(3) 
C2A-O1A-C3A-C6A 35.1(3) C2A-O1A-C3A-C4A -73.0(3) 
O1A-C3A-C4A-C5A 73.0(2) C6A-C3A-C4A-C5A -33.2(3) 
O1A-C3A-C4A-I1A -165.59(15) C6A-C3A-C4A-I1A 88.2(2) 
C3A-C4A-C5A-C1A -3.0(3) I1A-C4A-C5A-C1A -122.80(19) 
C7A-C1A-C5A-C4A 169.1(2) C2A-C1A-C5A-C4A -64.9(3) 
C6A-C1A-C5A-C4A 37.4(3) O1A-C3A-C6A-C1A -52.9(2) 
C4A-C3A-C6A-C1A 55.4(2) C7A-C1A-C6A-C3A 175.5(2) 
C2A-C1A-C6A-C3A 50.7(2) C5A-C1A-C6A-C3A -55.8(2) 
C2A-C1A-C7A-C8A 106.3(3) C6A-C1A-C7A-C8A -11.1(4) 
C5A-C1A-C7A-C8A -132.9(3) C2A-C1A-C7A-C12A -71.1(3) 
C6A-C1A-C7A-C12A 171.5(2) C5A-C1A-C7A-C12A 49.7(3) 
C12A-C7A-C8A-C9A 0.2(4) C1A-C7A-C8A-C9A -177.2(2) 
C7A-C8A-C9A-C10A 0.8(4) C8A-C9A-C10A-C11A -1.2(4) 
C9A-C10A-C11A-C12A 0.6(5) C10A-C11A-C12A-C7A 0.4(4) 
C8A-C7A-C12A-C11A -0.8(4) C1A-C7A-C12A-C11A 176.6(3) 
C3B-O1B-C2B-O2B -178.9(3) C3B-O1B-C2B-C1B 1.8(3) 
C7B-C1B-C2B-O2B 16.8(5) C6B-C1B-C2B-O2B 145.4(4) 
C5B-C1B-C2B-O2B -110.9(4) C7B-C1B-C2B-O1B -164.0(3) 
C6B-C1B-C2B-O1B -35.4(3) C5B-C1B-C2B-O1B 68.3(3) 
C2B-O1B-C3B-C4B -74.2(3) C2B-O1B-C3B-C6B 33.5(3) 
O1B-C3B-C4B-C5B 71.1(2) C6B-C3B-C4B-C5B -34.8(3) 
O1B-C3B-C4B-I1B -168.89(16) C6B-C3B-C4B-I1B 85.2(2) 
C3B-C4B-C5B-C1B -1.0(3) I1B-C4B-C5B-C1B -119.56(19) 
C7B-C1B-C5B-C4B 166.3(2) C2B-C1B-C5B-C4B -65.6(2) 
C6B-C1B-C5B-C4B 35.5(2) O1B-C3B-C6B-C1B -52.8(2) 
C4B-C3B-C6B-C1B 55.6(2) C7B-C1B-C6B-C3B 177.4(3) 
C2B-C1B-C6B-C3B 51.9(2) C5B-C1B-C6B-C3B -54.7(2) 
C2B-C1B-C7B-C8B -92.5(3) C6B-C1B-C7B-C8B 150.8(3) 
C5B-C1B-C7B-C8B 29.8(3) C2B-C1B-C7B-C12B 87.3(3) 
C6B-C1B-C7B-C12B -29.4(4) C5B-C1B-C7B-C12B -150.4(3) 
C12B-C7B-C8B-C9B 1.8(4) C1B-C7B-C8B-C9B -178.4(3) 
C7B-C8B-C9B-C10B -0.6(5) C8B-C9B-C10B-C11B -0.6(5) 
C9B-C10B-C11B-C12B 0.6(5) C10B-C11B-C12B-C7B 0.6(5) 
C8B-C7B-C12B-C11B -1.8(4) C1B-C7B-C12B-C11B 178.4(3)  
_____________________________________________________________________________________________ 
 274 
 
Table 7. Hydrogen bonds for 16042 [Å and °]. 
______________________________________________________________________
______ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)  
____________________________________________________________________________  
C4A-H4A...O2B#1 1.00 2.47 3.314(4) 142.2 
C5A-H5A...I1A#2 0.99 3.06 4.027(3) 166.0 
C5A-H5B...I1B#3 0.99 3.22 4.195(3) 167.2 
C4B-H4B...O2B#4 1.00 2.59 3.307(4) 128.7 
C5B-H5C...O1B#4 0.99 2.56 3.464(3) 151.8  
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x,y-1/2,-z+1 #2 x,y-1,z #3 -x+1,y-1/2,-z+1 #4 -x,y+1/2,-z+1 
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E 2: X-ray cocrystal structure of 14•107a. 
 
The sample was submitted by Matthew Knowe (research group of Jeffrey Johnston, Department of 
Chemistry, Vanderbilt University). A colorless crystal (approximate dimensions 0.24 × 0.13 × 0.05 mm3) 
was placed onto the tip of a 0.05 mm diameter glass capillary and mounted on a Bruker APEX II Kappa 
Duo diffractometer equipped with an APEX II detector at 150(2) K. 
 
Data collection  
The data collection was carried out using Mo Kα radiation (graphite monochromator) with a frame time of 
20 seconds and a detector distance of 40 mm. A collection strategy was calculated and complete data to a 
resolution of 0.70 Å with a redundancy of 4 were collected. Five major sections of frames were collected 
with 0.50º ω and φ scans.  
Axis 2θ/° ω/° φ/° χ/° Frames Time/s 
Omega -30.50 -134.05 -231.31 41.78 220 20.00 
Omega -23.00 -28.39 -73.14 -58.65 157 20.00 
Phi -30.50 182.00 -144.08 99.23 373 20.00 
Phi 14.50 -31.53 24.82 30.74 130 20.00 
Omega 22.00 129.45 -129.95 -99.10 113 20.00  
A total of 993 frames were collected. The total exposure time was 5.52 hours. The frames were integrated with the 
Bruker SAINT software package1 using a narrow-frame algorithm. The integration of the data using a monoclinic unit 
cell yielded a total of 20962 reflections to a maximum θ angle of 27.53° (0.77 Å resolution), of which 9504 were 
independent (average redundancy 2.206, completeness = 99.2%, Rint = 3.58%, Rsig = 5.71%) and 7401 (77.87%) 
were greater than 2σ(F2). The final cell constants of a = 11.0401(7) Å, b = 15.2838(11) Å, c = 13.7571(9) Å, β =  
99.998(4)°, volume = 2286.0(3) Å3, are based upon the refinement of the XYZ-centroids of 6280 reflections 
above 20 σ(I) with 4.597° < 2θ < 54.07°. Data were corrected for absorption effects using the multi-scan 
method (SADABS2). The ratio of minimum to maximum apparent transmission was 0.836. The calculated 
minimum and maximum transmission coefficients (based on crystal size) are 0.9740 and 0.9950. Please 
refer to Table 1 for additional crystal and refinement information. 
 
Structure solution and refinement  
The space group P21 was determined based on intensity statistics and systematic absences. The structure was solved 
and refined using the SHELX suite of programs.3 An intrinsic-methods solution was calculated, which provided most 
non-hydrogen atoms from the E-map. Full-matrix least squares / difference Fourier cycles were performed, which 
located the remaining non-hydrogen atoms. All non-hydrogen atoms were refined with anisotropic displacement 
parameters with exception of the partially occupied solvent molecule (DCM). The hydrogen atoms were placed in ideal 
positions and refined as riding atoms with relative isotropic displacement parameters. The final anisotropic full-matrix 
least-squares refinement on F2 with 566 variables converged at R1 = 5.57%, for the observed data and wR2 = 14.35% 
for all data. The goodness-of-fit was 1.043. The largest peak in the final difference electron density synthesis was 0.814 
e-/Å3 and the largest hole was -0.464 e-/Å3 with an RMS deviation of 0.049 e-/Å3. On the basis of the final model, the 
calculated density was 1.191 g/cm3 and F(000), 871 e-. 
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4 SAINT, Bruker Analytical X-Ray Systems, Madison, WI, current 
version.   
5 SADABS, Bruker Analytical X-Ray Systems, Madison, WI, current 
version.   
6 A short history of SHELX, G. M. Sheldrick, Acta Cryst. A64, 112 - 122 
(2008).  
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Cell plot, view along a. 
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Cell plot, view along b. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell plot, view along c. 
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Table 1.  Crystal data and structure refinement for 15113.  
Empirical formula C52.31 H52.63 Cl0.64 N6 O2  
Formula weight 819.93  
Crystal color, shape, size colorless plate, 0.24 × 0.13 × 0.05 mm3 
Temperature 150(2) K  
Wavelength 0.71073 Å  
Crystal system, space group Monoclinic, P21  
Unit cell dimensions a = 11.0401(7) Å α= 90°. 
 b = 15.2838(11) Å β= 99.998(4)°. 
 c = 13.7571(9) Å γ = 90°. 
Volume 2286.0(3) Å3  
Z 2  
Density (calculated) 1.191 Mg/m3  
Absorption coefficient 0.109 mm-1  
F(000) 871  
Data collection   
Diffractometer APEX II Kappa Duo, Bruker  
Theta range for data collection 1.873 to 27.530°.  
Index ranges -14<=h<=13, -19<=k<=19, -17<=l<=15 
Reflections collected 20962  
Independent reflections 9504 [Rint = 0.0358]  
Observed Reflections 7401  
Completeness to theta = 25.242° 99.8 %  
Solution and Refinement   
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.6236  
Solution Intrinsic methods  
Refinement method Full-matrix least-squares on F2  
Weighting scheme w = [σ2Fo2+ AP2+ BP]-1, with  
 P = (Fo2+ 2 Fc2)/3, A = 0.0707, B = 0.5367 
Data / restraints / parameters 9504 / 2 / 566  
Goodness-of-fit on F2 1.043  
Final R indices [I>2σ(I)] R1 = 0.0557, wR2 = 0.1321  
R indices (all data) R1 = 0.0769, wR2 = 0.1435  
Absolute structure parameter 0.06(11)  
Largest diff. peak and hole 0.814 and -0.464 e.Å-3  
_______________________________________________________  
Goodness-of-fit = [Σ[w(Fo2 − Fc2)2]/Nobservns − Nparams)]1/2, all data.  
R1 = Σ(|Fo| − |Fc|) / Σ |Fo|. wR2 = [Σ[w(Fo2 − Fc2)2] / Σ [w(Fo2)2]]1/2.  
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Table 2. Atomic coordinates ( × 104) and equivalent isotropic displacement parameters (Å2 × 
103) for 15113. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.  
________________________________________________________________________________  
x y z U(eq)  
________________________________________________________________________________  
O1 7151(2) 5568(2) 2463(2) 33(1) 
O2 5561(2) 6371(2) 1763(2) 37(1) 
N1 8407(2) 4508(2) 4081(2) 23(1) 
N2 9949(3) 3594(2) 4877(2) 24(1) 
N3 12175(3) 4369(2) 2811(2) 24(1) 
N4 5887(3) 5153(2) 4009(2) 25(1) 
N5 4409(2) 6101(2) 3271(2) 23(1) 
N6 2414(3) 5768(2) 5541(2) 27(1) 
C1 7453(3) 4005(2) 4437(3) 22(1) 
C2 9585(3) 4171(2) 4174(3) 20(1) 
C3 11168(3) 3353(2) 5007(3) 23(1) 
C4 11610(3) 2837(3) 5846(3) 29(1) 
C5 12833(3) 2626(3) 6096(3) 31(1) 
C6 13663(3) 2908(3) 5501(3) 29(1) 
C7 13259(3) 3387(2) 4666(3) 25(1) 
C8 12003(3) 3617(2) 4382(3) 23(1) 
C9 11513(3) 4154(2) 3540(3) 21(1) 
C10 10324(3) 4475(2) 3490(3) 22(1) 
C11 11600(3) 4911(3) 1972(3) 28(1) 
C12 12505(4) 4872(3) 1256(3) 36(1) 
C13 13006(4) 3950(3) 1412(3) 40(1) 
C14 13160(3) 3822(3) 2523(3) 30(1) 
C15 6790(3) 3361(2) 3671(3) 24(1) 
C16 6855(4) 3390(3) 2678(3) 36(1) 
C17 6189(4) 2798(3) 2022(3) 47(1) 
C18 5445(4) 2180(3) 2349(3) 38(1) 
C19 5365(3) 2144(3) 3337(3) 31(1) 
C20 6039(3) 2726(2) 3988(3) 26(1) 
C21 6497(3) 4603(2) 4811(3) 22(1) 
C22 4828(3) 5580(2) 4040(3) 22(1) 
C23 3356(3) 6593(2) 3240(3) 24(1) 
C24 3056(3) 7170(3) 2435(3) 28(1) 
C25 2069(3) 7729(3) 2401(3) 33(1) 
C26 1385(3) 7719(3) 3156(3) 34(1) 
C27 1652(3) 7139(3) 3928(3) 29(1) 
C28 2634(3) 6538(2) 3989(3) 24(1) 
C29 3028(3) 5921(2) 4800(3) 22(1) 
C30 4158(3) 5491(2) 4804(3) 23(1) 
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C31 1155(3) 6043(3) 5634(3) 37(1) 
C32 827(4) 5412(4) 6416(4) 49(1) 
C33 2028(4) 5262(3) 7081(3) 45(1) 
C34 2935(3) 5197(3) 6370(3) 31(1) 
C35 6990(3) 5111(2) 5738(3) 24(1) 
C36 6811(4) 4790(3) 6654(3) 36(1) 
C37 7210(4) 5262(3) 7501(3) 44(1) 
C38 7779(4) 6060(3) 7474(3) 43(1) 
C39 7970(4) 6383(3) 6569(3) 38(1) 
C40 7571(3) 5913(3) 5707(3) 30(1) 
C41 7080(3) 6013(3) 768(3) 28(1) 
C42 8486(4) 5985(4) 996(3) 55(1) 
C43 8787(6) 6958(5) 1136(4) 83(2) 
C44 7880(6) 7443(4) 741(4) 68(2) 
C45 6805(4) 6909(3) 275(3) 38(1) 
C46 6561(3) 5989(3) 1753(3) 26(1) 
C47 7082(6) 4442(3) 144(4) 60(2) 
C48 6528(10) 3747(4) -388(5) 89(3) 
C49 5374(11) 3813(5) -891(6) 99(3) 
C50 4710(7) 4578(6) -875(4) 87(2) 
C51 5282(5) 5311(4) -333(3) 52(1) 
C52 6476(4) 5243(3) 171(3) 37(1) 
Cl1S 107(9) 7857(7) 8530(7) 151(4) 
C1S 820(30) 6966(18) 8650(20) 131(11) 
Cl2S 1759(6) 6614(5) 9582(5) 103(3)  
________________________________________________________________________________ 
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Table 3.  Bond lengths [Å] and angles [°] for 15113.  
_____________________________________________________________________________________________  
O1-C46 1.254(4) O2-C46 1.251(4) 
N1-C2 1.383(4) N1-C1 1.456(4) 
N1-H1N 0.89(4) N2-C2 1.320(4) 
N2-C3 1.376(4) N3-C9 1.379(4) 
N3-C11 1.472(5) N3-C14 1.479(5) 
N4-C22 1.346(4) N4-C21 1.455(4) 
N4-H4N 0.85(4) N5-C22 1.341(5) 
N5-C23 1.379(4) N5-H5N 0.94(4) 
N6-C29 1.339(5) N6-C34 1.473(5) 
N6-C31 1.479(4) C1-C15 1.532(5) 
C1-C21 1.550(5) C1-H1 1.0000 
C2-C10 1.426(5) C3-C4 1.413(5) 
C3-C8 1.423(5) C4-C5 1.373(5) 
C4-H4 0.9500 C5-C6 1.399(5) 
C5-H5 0.9500 C6-C7 1.370(5) 
C6-H6 0.9500 C7-C8 1.418(5) 
C7-H7 0.9500 C8-C9 1.446(5) 
C9-C10 1.392(5) C10-H10 0.9500 
C11-C12 1.522(5) C11-H11A 0.9900 
C11-H11B 0.9900 C12-C13 1.515(6) 
C12-H12A 0.9900 C12-H12B 0.9900 
C13-C14 1.522(5) C13-H13A 0.9900 
C13-H13B 0.9900 C14-H14A 0.9900 
C14-H14B 0.9900 C15-C16 1.382(5) 
C15-C20 1.395(5) C16-C17 1.394(6) 
C16-H16 0.9500 C17-C18 1.378(6) 
C17-H17 0.9500 C18-C19 1.378(6) 
C18-H18 0.9500 C19-C20 1.384(5) 
C19-H19 0.9500 C20-H20 0.9500 
C21-C35 1.511(5) C21-H21 1.0000 
C22-C30 1.393(5) C23-C24 1.409(5) 
C23-C28 1.411(5) C24-C25 1.379(5) 
C24-H24 0.9500 C25-C26 1.387(6) 
C25-H25A 0.9500 C26-C27 1.374(6) 
C26-H26 0.9500 C27-C28 1.413(5) 
C27-H27 0.9500 C28-C29 1.468(5) 
C29-C30 1.409(5) C30-H30 0.9500 
C31-C32 1.534(6) C31-H31A 0.9900 
C31-H31B 0.9900 C32-C33 1.492(7) 
C32-H32A 0.9900 C32-H32B 0.9900 
C33-C34 1.520(5) C33-H33A 0.9900 
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C33-H33B 0.9900 
C34-H34B 0.9900 
C35-C36 1.397(5) 
C36-H36 0.9500 
C37-H37A 0.9500 
C38-H38 0.9500 
C39-H39 0.9500 
C41-C52 1.522(6) 
C41-C45 1.535(6) 
C42-C43 1.528(9) 
C42-H42B 0.9900 
C43-H43 0.9500 
C44-H44 0.9500 
C45-H45B 0.9900 
C47-C52 1.399(7) 
C48-C49 1.344(11) 
C49-C50 1.383(12) 
C50-C51 1.431(9) 
C51-C52 1.382(7) 
Cl1S-C1S 1.57(2) 
C1S-H1S1 0.9900 
C2-N1-C1 119.8(3) 
C1-N1-H1N 117(2) 
C9-N3-C11 119.6(3) 
C11-N3-C14 110.2(3) 
C22-N4-H4N 119(2) 
C22-N5-C23 121.5(3) 
C23-N5-H5N 118(2) 
C29-N6-C31 128.7(3) 
N1-C1-C15 113.3(3) 
C15-C1-C21 109.6(3) 
C15-C1-H1 107.2 
N2-C2-N1 118.6(3) 
N1-C2-C10 117.1(3) 
N2-C3-C8 124.6(3) 
C5-C4-C3 121.4(3) 
C3-C4-H4 119.3 
C4-C5-H5 120.1 
C7-C6-C5 120.3(3) 
C5-C6-H6 119.9 
C6-C7-H7 119.2 
C7-C8-C3 118.0(3) 
  
C34-H34A 0.9900 
C35-C40 1.387(5) 
C36-C37 1.376(6) 
C37-C38 1.375(7) 
C38-C39 1.389(6) 
C39-C40 1.391(6) 
C40-H40 0.9500 
C41-C42 1.531(5) 
C41-C46 1.560(5) 
C42-H42A 0.9900 
C43-C44 1.287(9) 
C44-C45 1.491(7) 
C45-H45A 0.9900 
C47-C48 1.372(9) 
C47-H47 0.9500 
C48-H48 0.9500 
C49-H49 0.9500 
C50-H50 0.9500 
C51-H51 0.9500 
C1S-Cl2S 1.592(19) 
C1S-H1S2 0.9900 
C2-N1-H1N 119(2) 
C2-N2-C3 116.1(3) 
C9-N3-C14 124.5(3) 
C22-N4-C21 123.1(3) 
C21-N4-H4N 117(2) 
C22-N5-H5N 121(2) 
C29-N6-C34 120.8(3) 
C34-N6-C31 110.3(3) 
N1-C1-C21 112.1(3) 
N1-C1-H1 107.2 
C21-C1-H1 107.2 
N2-C2-C10 124.4(3) 
N2-C3-C4 116.5(3) 
C4-C3-C8 118.9(3) 
C5-C4-H4 119.3 
C4-C5-C6 119.8(3) 
C6-C5-H5 120.1 
C7-C6-H6 119.9 
C6-C7-C8 121.6(3) 
C8-C7-H7 119.2 
C7-C8-C9 124.9(3) 
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C3-C8-C9 116.9(3) 
N3-C9-C8 123.1(3) 
C9-C10-C2 119.7(3) 
C2-C10-H10 120.1 
N3-C11-H11A 110.9 
N3-C11-H11B 110.9 
H11A-C11-H11B 109.0 
C13-C12-H12A 111.3 
C13-C12-H12B 111.3 
H12A-C12-H12B 109.2 
C12-C13-H13A 111.0 
C12-C13-H13B 111.0 
H13A-C13-H13B 109.0 
N3-C14-H14A 111.0 
N3-C14-H14B 111.0 
H14A-C14-H14B 109.0 
C16-C15-C1 124.0(3) 
C15-C16-C17 120.5(4) 
C17-C16-H16 119.7 
C18-C17-H17 119.6 
C17-C18-C19 119.5(4) 
C19-C18-H18 120.3 
C18-C19-H19 120.2 
C19-C20-C15 121.7(3) 
C15-C20-H20 119.1 
N4-C21-C1 109.9(3) 
N4-C21-H21 106.1 
C1-C21-H21 106.1 
N5-C22-C30 119.8(3) 
N5-C23-C24 116.6(3) 
C24-C23-C28 121.7(3) 
C25-C24-H24 120.3 
C24-C25-C26 119.9(4) 
C26-C25-H25A 120.1 
C27-C26-H26 119.5 
C26-C27-C28 121.7(4) 
C28-C27-H27 119.2 
C23-C28-C29 117.6(3) 
N6-C29-C30 118.7(3) 
C30-C29-C28 116.6(3) 
C22-C30-H30 118.8 
N6-C31-C32 102.9(3) 
C32-C31-H31A 111.2 
  
N3-C9-C10 119.6(3) 
C10-C9-C8 117.2(3) 
C9-C10-H10 120.1 
N3-C11-C12 104.1(3) 
C12-C11-H11A 110.9 
C12-C11-H11B 110.9 
C13-C12-C11 102.1(3) 
C11-C12-H12A 111.3 
C11-C12-H12B 111.3 
C12-C13-C14 103.6(3) 
C14-C13-H13A 111.0 
C14-C13-H13B 111.0 
N3-C14-C13 103.8(3) 
C13-C14-H14A 111.0 
C13-C14-H14B 111.0 
C16-C15-C20 117.8(3) 
C20-C15-C1 118.1(3) 
C15-C16-H16 119.7 
C18-C17-C16 120.8(4) 
C16-C17-H17 119.6 
C17-C18-H18 120.3 
C18-C19-C20 119.6(4) 
C20-C19-H19 120.2 
C19-C20-H20 119.1 
N4-C21-C35 113.2(3) 
C35-C21-C1 114.6(3) 
C35-C21-H21 106.1 
N5-C22-N4 116.5(3) 
N4-C22-C30 123.7(3) 
N5-C23-C28 121.6(3) 
C25-C24-C23 119.4(4) 
C23-C24-H24 120.3 
C24-C25-H25A 120.1 
C27-C26-C25 120.9(3) 
C25-C26-H26 119.5 
C26-C27-H27 119.2 
C23-C28-C27 116.3(3) 
C27-C28-C29 125.9(3) 
N6-C29-C28 124.6(3) 
C22-C30-C29 122.5(3) 
C29-C30-H30 118.8 
N6-C31-H31A 111.2 
N6-C31-H31B 111.2 
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C32-C31-H31B 111.2 
C33-C32-C31 103.5(4) 
C31-C32-H32A 111.1 
C31-C32-H32B 111.1 
C32-C33-C34 103.3(3) 
C34-C33-H33A 111.1 
C34-C33-H33B 111.1 
N6-C34-C33 104.3(3) 
C33-C34-H34A 110.9 
C33-C34-H34B 110.9 
C40-C35-C36 118.5(4) 
C36-C35-C21 119.6(3) 
C37-C36-H36 119.8 
C38-C37-C36 121.5(4) 
C36-C37-H37A 119.3 
C37-C38-H38 120.6 
C38-C39-C40 120.3(4) 
C40-C39-H39 119.8 
C35-C40-H40 119.7 
C52-C41-C42 115.0(4) 
C42-C41-C45 103.4(3) 
C42-C41-C46 109.5(3) 
C43-C42-C41 100.9(4) 
C41-C42-H42A 111.6 
C41-C42-H42B 111.6 
C44-C43-C42 111.8(4) 
C42-C43-H43 124.1 
C43-C44-H44 124.2 
C44-C45-C41 102.5(4) 
C41-C45-H45A 111.3 
C41-C45-H45B 111.3 
O2-C46-O1 124.9(3) 
O1-C46-C41 118.0(3) 
C48-C47-H47 119.3 
C49-C48-C47 120.7(7) 
C47-C48-H48 119.6 
C48-C49-H49 119.6 
C49-C50-C51 118.9(7) 
C51-C50-H50 120.6 
C52-C51-H51 120.0 
C51-C52-C47 118.1(5) 
C47-C52-C41 121.7(4) 
Cl1S-C1S-H1S1 105.1 
  
H31A-C31-H31B 109.1 
C33-C32-H32A 111.1 
C33-C32-H32B 111.1 
H32A-C32-H32B 109.0 
C32-C33-H33A 111.1 
C32-C33-H33B 111.1 
H33A-C33-H33B 109.1 
N6-C34-H34A 110.9 
N6-C34-H34B 110.9 
H34A-C34-H34B 108.9 
C40-C35-C21 121.9(3) 
C37-C36-C35 120.3(4) 
C35-C36-H36 119.8 
C38-C37-H37A 119.3 
C37-C38-C39 118.7(4) 
C39-C38-H38 120.6 
C38-C39-H39 119.8 
C35-C40-C39 120.6(4) 
C39-C40-H40 119.7 
C52-C41-C45 114.6(3) 
C52-C41-C46 105.0(3) 
C45-C41-C46 109.3(3) 
C43-C42-H42A 111.6 
C43-C42-H42B 111.6 
H42A-C42-H42B 109.4 
C44-C43-H43 124.1 
C43-C44-C45 111.7(5) 
C45-C44-H44 124.2 
C44-C45-H45A 111.3 
C44-C45-H45B 111.3 
H45A-C45-H45B 109.2 
O2-C46-C41 117.2(3) 
C48-C47-C52 121.4(6) 
C52-C47-H47 119.3 
C49-C48-H48 119.6 
C48-C49-C50 120.9(7) 
C50-C49-H49 119.6 
C49-C50-H50 120.6 
C52-C51-C50 119.9(6) 
C50-C51-H51 120.0 
C51-C52-C41 120.2(4) 
Cl1S-C1S-Cl2S 129(2) 
Cl2S-C1S-H1S1 105.1 
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Cl1S-C1S-H1S2 105.1 Cl2S-C1S-H1S2 105.1 
H1S1-C1S-H1S2 105.9    
_____________________________________________________________________________________________ 
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Table 4. Anisotropic displacement parameters (Å2 × 103) for 15113. The anisotropic 
displacement factor exponent takes the form: -2π2[ h2 a*2U11 + ... + 2 h k a* b* U12 ]  
______________________________________________________________________________ 
U11 U22 U33 U23 U13 U12  
______________________________________________________________________________  
O1 34(1) 42(2) 25(1) 11(1) 9(1) 9(1) 
O2 37(1) 52(2) 27(1) 8(1) 15(1) 18(1) 
N1 20(1) 24(2) 26(2) 7(1) 9(1) 5(1) 
N2 20(1) 27(2) 28(2) 5(1) 8(1) 2(1) 
N3 21(1) 30(2) 24(2) 4(1) 9(1) 2(1) 
N4 22(1) 34(2) 22(2) 4(1) 12(1) 7(1) 
N5 21(1) 27(2) 22(2) -1(1) 7(1) 5(1) 
N6 24(1) 28(2) 29(2) -4(1) 9(1) 2(1) 
C1 17(2) 26(2) 24(2) 4(2) 8(1) 6(1) 
C2 18(1) 18(2) 24(2) -1(1) 5(1) 0(1) 
C3 22(2) 20(2) 28(2) 0(2) 7(1) 1(1) 
C4 25(2) 29(2) 35(2) 7(2) 13(2) 2(2) 
C5 31(2) 31(2) 32(2) 9(2) 6(2) 6(2) 
C6 21(2) 29(2) 37(2) 6(2) 4(2) 6(1) 
C7 20(2) 25(2) 31(2) 1(2) 10(1) 0(1) 
C8 22(2) 19(2) 27(2) 1(2) 6(1) 0(1) 
C9 22(2) 18(2) 23(2) 0(1) 5(1) 1(1) 
C10 21(2) 22(2) 24(2) 4(2) 5(1) 2(1) 
C11 28(2) 35(2) 23(2) 5(2) 6(1) -2(2) 
C12 36(2) 47(3) 27(2) 3(2) 13(2) 1(2) 
C13 38(2) 55(3) 32(2) -5(2) 18(2) 5(2) 
C14 30(2) 34(2) 29(2) 0(2) 13(2) 2(2) 
C15 19(2) 25(2) 29(2) 2(2) 9(1) 7(1) 
C16 50(2) 30(2) 34(2) -3(2) 20(2) -6(2) 
C17 64(3) 47(3) 33(2) -1(2) 17(2) -2(2) 
C18 42(2) 32(2) 38(2) -6(2) 3(2) 0(2) 
C19 24(2) 26(2) 42(2) 6(2) 3(2) 2(1) 
C20 23(2) 28(2) 27(2) 4(2) 7(1) 6(1) 
C21 18(2) 26(2) 25(2) 6(2) 8(1) 4(1) 
C22 20(2) 24(2) 22(2) -4(2) 3(1) 3(1) 
C23 20(2) 24(2) 27(2) -6(2) 4(1) 3(1) 
C24 25(2) 33(2) 26(2) 0(2) 7(1) 5(1) 
C25 33(2) 30(2) 34(2) 5(2) 3(2) 6(2) 
C26 28(2) 30(2) 45(2) -2(2) 5(2) 10(2) 
C27 21(2) 31(2) 37(2) -5(2) 8(2) 5(1) 
C28 20(2) 24(2) 28(2) -9(2) 2(1) 1(1) 
C29 20(2) 24(2) 23(2) -8(2) 5(1) -1(1) 
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C30 23(2) 26(2) 20(2) -1(2) 6(1) 4(1) 
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C31 25(2) 51(3) 38(2) -3(2) 15(2) 8(2) 
C32 38(2) 68(4) 48(3) 0(2) 24(2) 4(2) 
C33 45(2) 58(3) 37(2) 3(2) 23(2) 4(2) 
C34 31(2) 35(2) 29(2) 0(2) 11(2) 0(2) 
C35 22(2) 27(2) 25(2) 4(2) 6(1) 9(1) 
C36 44(2) 37(2) 30(2) 5(2) 15(2) 1(2) 
C37 57(3) 51(3) 25(2) 1(2) 10(2) 2(2) 
C38 46(2) 47(3) 35(2) -14(2) 6(2) 12(2) 
C39 37(2) 31(2) 47(3) -2(2) 8(2) 5(2) 
C40 29(2) 30(2) 31(2) 4(2) 4(2) 6(2) 
C41 28(2) 37(2) 21(2) 3(2) 10(1) 5(2) 
C42 30(2) 100(4) 36(2) 19(3) 10(2) 5(2) 
C43 64(4) 138(7) 41(3) 14(4) -3(3) -55(4) 
C44 99(4) 63(4) 37(3) 5(3) 2(3) -46(3) 
C45 50(2) 38(3) 27(2) 9(2) 10(2) 0(2) 
C46 26(2) 34(2) 18(2) 2(2) 6(1) 2(2) 
C47 114(5) 41(3) 33(3) 8(2) 33(3) 16(3) 
C48 195(9) 39(4) 48(4) -6(3) 61(5) -5(5) 
C49 184(9) 65(5) 58(4) -11(4) 50(5) -55(6) 
C50 102(5) 121(7) 39(3) -2(4) 13(3) -59(5) 
C51 55(3) 65(3) 36(2) 2(2) 9(2) -22(2) 
C52 54(2) 41(3) 21(2) 3(2) 18(2) 2(2)  
______________________________________________________________________________ 
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Table 5.  Hydrogen coordinates ( × 104) and isotropic displacement parameters ( Å2 × 10 3) for 15113.  
________________________________________________________________________________  
x y z U(eq)  
________________________________________________________________________________ 
 
H1N 8160(30) 4900(20) 3610(30) 16(9) 
H4N 6300(30) 5290(20) 3570(30) 10(8) 
H5N 4860(40) 6180(30) 2760(30) 30(11) 
H1 7864 3653 5013 26 
H4 11049 2633 6247 35 
H5 13114 2289 6671 37 
H6 14511 2767 5677 35 
H7 13834 3569 4267 30 
H10 10006 4895 3003 26 
H11A 11489 5521 2184 34 
H11B 10791 4671 1668 34 
H12A 12085 4962 567 43 
H12B 13166 5313 1422 43 
H13A 13805 3894 1183 48 
H13B 12422 3518 1057 48 
H14A 13053 3200 2689 36 
H14B 13981 4022 2856 36 
H16 7357 3817 2440 43 
H17 6248 2822 1342 57 
H18 4990 1781 1896 45 
H19 4851 1723 3569 37 
H20 5988 2692 4670 31 
H21 5849 4205 4986 27 
H24 3530 7174 1921 33 
H25A 1859 8120 1861 39 
H26 723 8119 3140 41 
H27 1164 7144 4432 35 
H30 4475 5127 5349 27 
H31A 581 5978 5000 44 
H31B 1142 6658 5858 44 
H32A 221 5678 6780 59 
H32B 487 4858 6111 59 
H33A 2012 4714 7463 54 
H33B 2236 5756 7545 54 
H34A 3760 5403 6685 37 
H34B 3002 4586 6145 37 
H36 6412 4243 6692 43 
H37A 7089 5031 8118 53 
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H38 8036 6384 8063 51 
H39 8374 6929 6538 46 
H40 7699 6142 5091 36 
H42A 8788 5647 1604 66 
H42B 8834 5735 440 66 
H43 9550 7178 1473 99 
H44 7895 8064 746 81 
H45A 6760 6870 -449 46 
H45B 6024 7154 417 46 
H47 7894 4378 501 73 
H48 6965 3212 -401 107 
H49 5010 3327 -1263 119 
H50 3887 4617 -1219 105 
H51 4842 5844 -319 62 
H1S1 1277 6942 8096 157 
H1S2 175 6510 8518 157  
________________________________________________________________________________ 
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Table 6.  Torsion angles [°] for 15113.  
_____________________________________________________________________________________________  
C2-N1-C1-C15 -86.9(4) C2-N1-C1-C21 148.5(3) 
C3-N2-C2-N1 -173.1(3) C3-N2-C2-C10 7.1(5) 
C1-N1-C2-N2 -25.2(5) C1-N1-C2-C10 154.6(3) 
C2-N2-C3-C4 171.0(3) C2-N2-C3-C8 -6.3(5) 
N2-C3-C4-C5 -174.1(4) C8-C3-C4-C5 3.3(6) 
C3-C4-C5-C6 -1.3(6) C4-C5-C6-C7 -0.7(6) 
C5-C6-C7-C8 0.6(6) C6-C7-C8-C3 1.5(5) 
C6-C7-C8-C9 176.9(4) N2-C3-C8-C7 173.9(3) 
C4-C3-C8-C7 -3.3(5) N2-C3-C8-C9 -1.9(5) 
C4-C3-C8-C9 -179.1(3) C11-N3-C9-C10 -2.0(5) 
C14-N3-C9-C10 -152.7(3) C11-N3-C9-C8 179.3(3) 
C14-N3-C9-C8 28.5(5) C7-C8-C9-N3 12.6(5) 
C3-C8-C9-N3 -172.0(3) C7-C8-C9-C10 -166.2(3) 
C3-C8-C9-C10 9.3(5) N3-C9-C10-C2 172.4(3) 
C8-C9-C10-C2 -8.7(5) N2-C2-C10-C9 0.4(5) 
N1-C2-C10-C9 -179.4(3) C9-N3-C11-C12 -170.4(3) 
C14-N3-C11-C12 -15.8(4) N3-C11-C12-C13 34.4(4) 
C11-C12-C13-C14 -40.3(4) C9-N3-C14-C13 143.9(3) 
C11-N3-C14-C13 -9.2(4) C12-C13-C14-N3 30.8(4) 
N1-C1-C15-C16 -15.2(5) C21-C1-C15-C16 110.8(4) 
N1-C1-C15-C20 167.3(3) C21-C1-C15-C20 -66.8(4) 
C20-C15-C16-C17 -0.2(6) C1-C15-C16-C17 -177.7(4) 
C15-C16-C17-C18 0.6(7) C16-C17-C18-C19 -0.3(7) 
C17-C18-C19-C20 -0.4(6) C18-C19-C20-C15 0.9(5) 
C16-C15-C20-C19 -0.6(5) C1-C15-C20-C19 177.1(3) 
C22-N4-C21-C35 -66.8(4) C22-N4-C21-C1 163.6(3) 
N1-C1-C21-N4 61.1(4) C15-C1-C21-N4 -65.5(4) 
N1-C1-C21-C35 -67.7(4) C15-C1-C21-C35 165.6(3) 
C23-N5-C22-N4 -177.7(3) C23-N5-C22-C30 3.6(5) 
C21-N4-C22-N5 176.4(3) C21-N4-C22-C30 -4.9(5) 
C22-N5-C23-C24 175.0(3) C22-N5-C23-C28 -3.5(5) 
N5-C23-C24-C25 -175.0(3) C28-C23-C24-C25 3.4(5) 
C23-C24-C25-C26 0.1(6) C24-C25-C26-C27 -2.1(6) 
C25-C26-C27-C28 0.5(6) N5-C23-C28-C27 173.6(3) 
C24-C23-C28-C27 -4.8(5) N5-C23-C28-C29 -1.1(5) 
C24-C23-C28-C29 -179.5(3) C26-C27-C28-C23 2.8(5) 
C26-C27-C28-C29 177.1(3) C34-N6-C29-C30 3.0(5) 
C31-N6-C29-C30 -171.1(4) C34-N6-C29-C28 -174.5(3) 
C31-N6-C29-C28 11.3(6) C23-C28-C29-N6 -177.1(3) 
C27-C28-C29-N6 8.7(5) C23-C28-C29-C30 5.3(4) 
C27-C28-C29-C30 -168.9(3) N5-C22-C30-C29 1.0(5) 
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N4-C22-C30-C29 -177.6(3) N6-C29-C30-C22 176.8(3) 
C28-C29-C30-C22 -5.4(5) C29-N6-C31-C32 160.3(4) 
C34-N6-C31-C32 -14.4(4) N6-C31-C32-C33 33.5(4) 
C31-C32-C33-C34 -39.9(5) C29-N6-C34-C33 175.0(3) 
C31-N6-C34-C33 -9.9(4) C32-C33-C34-N6 30.9(5) 
N4-C21-C35-C40 -41.2(4) C1-C21-C35-C40 85.9(4) 
N4-C21-C35-C36 135.7(3) C1-C21-C35-C36 -97.1(4) 
C40-C35-C36-C37 -0.3(6) C21-C35-C36-C37 -177.3(4) 
C35-C36-C37-C38 0.7(6) C36-C37-C38-C39 -1.1(7) 
C37-C38-C39-C40 1.1(6) C36-C35-C40-C39 0.2(5) 
C21-C35-C40-C39 177.2(3) C38-C39-C40-C35 -0.7(6) 
C52-C41-C42-C43 154.9(4) C45-C41-C42-C43 29.2(4) 
C46-C41-C42-C43 -87.3(4) C41-C42-C43-C44 -19.5(6) 
C42-C43-C44-C45 0.5(7) C43-C44-C45-C41 18.7(6) 
C52-C41-C45-C44 -155.4(4) C42-C41-C45-C44 -29.5(5) 
C46-C41-C45-C44 87.1(4) C52-C41-C46-O2 -86.3(4) 
C42-C41-C46-O2 149.7(4) C45-C41-C46-O2 37.1(5) 
C52-C41-C46-O1 91.5(4) C42-C41-C46-O1 -32.4(5) 
C45-C41-C46-O1 -145.1(3) C52-C47-C48-C49 -0.9(8) 
C47-C48-C49-C50 -0.9(10) C48-C49-C50-C51 1.6(10) 
C49-C50-C51-C52 -0.6(8) C50-C51-C52-C47 -1.1(6) 
C50-C51-C52-C41 -178.6(4) C48-C47-C52-C51 1.8(7) 
C48-C47-C52-C41 179.3(4) C42-C41-C52-C51 -160.3(4) 
C45-C41-C52-C51 -40.7(5) C46-C41-C52-C51 79.3(4) 
C42-C41-C52-C47 22.3(5) C45-C41-C52-C47 141.9(4) 
C46-C41-C52-C47 -98.1(4)    
_____________________________________________________________________________________________ 
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Table 7.  Hydrogen bonds for 15113 [Å and °].  
___________________________________________________________________________
_  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
N1-H1N...O1 0.89(4) 2.04(4) 2.905(4) 163(3) 
N4-H4N...O1 0.85(4) 1.97(4) 2.812(4) 175(3) 
N5-H5N...O2 0.94(4) 1.71(4) 2.647(4) 174(4) 
C11-H11B...Cl1S#1 0.99 2.94 3.665(11) 130.9 
C12-H12A...Cl2S#2 0.99 2.86 3.523(8) 125.2 
C24-H24...O2 0.95 2.60 3.298(4) 130.8 
C32-H32B...N2#3 0.99 2.57 3.526(6) 161.7 
____________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms: #1 -x+1,y-1/2,-z+1 #2 x+1,y,z-1#3 x-1,y,z  
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E 3: X-ray cocrystal structure of 126d•107a. 
 
The sample was submitted by Matthew Knowe (research group of J. Johnston, Department of Chemistry, Vanderbilt 
University). A colorless crystal (approximate dimensions 0.19 ´ 0.15 ´ 0.12 mm3) was placed onto the tip of a 0.05 
mm diameter glass capillary and mounted on a Bruker APEX II Kappa Duo diffractometer equipped with an APEX 
II detector at 150(2) K. 
 
 
 
Data collection 
 
The data collection was carried out using Mo Ka radiation (graphite monochromator) with a frame time of 20 seconds 
and a detector distance of 4.00 cm. A collection strategy was calculated and complete data to a resolution of 0.70 Å 
with a redundancy of 4 were collected. Six major sections of frames were collected with 0.50º w and f scans. The 
total exposure time was 11.18 hours. The frames were integrated with the Bruker SAINT software package1 using a 
narrow-frame algorithm. The integration of the data using an orthorhombic unit cell yielded a total of 139860 
reflections to a maximum θ angle of 30.09° (0.71 Å resolution), of which 20232 were independent (average 
redundancy 6.913, completeness = 99.8%, Rint = 4.99%, Rsig = 3.34%) and 16070 (79.43%) were greater than 2σ(F2). 
The final cell constants of a = 18.4334(12) Å, b = 18.4544(11) Å, c = 20.2984(14) Å, volume = 6905.1(8) Å3, are 
based upon the refinement of the XYZ-centroids of 9926 reflections above 20 σ(I) with 4.581° < 2θ < 54.54°. Data 
were corrected for absorption effects using the multi-scan method (SADABS).2 The ratio of minimum to maximum 
apparent transmission was 0.890. The calculated minimum and maximum transmission coefficients (based on crystal 
size) are 0.6640 and 0.7460. 
 
 
 
Structure solution and refinement 
 
The space group P212121 was determined based on intensity statistics and systematic absences. The structure was 
solved and refined using the SHELX suite of programs.3 An intrinsic-methods solution was calculated, which provided 
most non-hydrogen atoms from the E-map. Full-matrix least squares / difference Fourier cycles were performed, which 
located the remaining non-hydrogen atoms. All non-hydrogen atoms were refined with anisotropic displacement 
parameters. Disorder was refined for co-crystallized solvent (heptane). The final anisotropic full-matrix least-squares 
refinement on F2 with 861 variables converged at R1 = 6.01%, for the observed data and wR2 = 18.17% for all data. 
The goodness-of-fit was 1.020. The largest peak in the final difference electron density synthesis was 0.549 e-/Å3 and 
the largest hole was -0.352 e-/Å3 with an RMS deviation of 0.053 e-/Å3. On the basis of the final model, the calculated 
density was 1.134 g/cm3 and F(000), 2556 e-. 
 
 
 
 
 
 
7 SAINT, Bruker Analytical X-Ray Systems, Madison, WI, current version.   
8 SADABS, Bruker Analytical X-Ray Systems, Madison, WI, current version.   
9 A short history of SHELX, G. M. Sheldrick, Acta Cryst. A64, 112 - 122 (2008).  
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Bulk material. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Formula unit, solvent omitted. 
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Formula unit, solvent omitted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell plot, view along a. 
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Cell plot, view along b. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell plot, view along c. 
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Table 1.  Crystal data and structure refinement for 16066. 
 
Empirical formula C80 H101 N6 O2  
Formula weight 1178.66  
Crystal color, shape, size colorless block, 0.19 × 0.15 × 0.12 mm3 
Temperature 150(2) K  
Wavelength 0.71073 Å  
Crystal system, space group Orthorhombic, P212121  
Unit cell dimensions a = 18.4334(12) Å a= 90°. 
 b = 18.4544(11) Å b= 90°. 
 c = 20.2984(14) Å g = 90°. 
Volume 6905.1(8) Å3  
Z 4  
Density (calculated) 1.134 Mg/m3  
Absorption coefficient 0.068 mm-1  
F(000) 2556  
Data collection   
Diffractometer APEX II Kappa Duo, Bruker  
Theta range for data collection 1.491 to 30.091°.  
Index ranges -25<=h<=25, -26<=k<=25, -28<=l<=28 
Reflections collected 139860  
Independent reflections 20232 [Rint = 0.0499]  
Observed Reflections 16070  
Completeness to theta = 25.242° 100.0 %  
Solution and Refinement   
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7460 and 0.6640  
Solution Intrinsic methods  
Refinement method Full-matrix least-squares on F2  
Weighting scheme w = [s2Fo 2+ AP2+ BP]-1, with  
 P = (Fo2+ 2 Fc2)/3, A = 0.1128, B = 1.3497 
Data / restraints / parameters 20232 / 278 / 861  
Goodness-of-fit on F2 1.020  
Final R indices [I>2sigma(I)] R1 = 0.0601, wR2 = 0.1642  
R indices (all data) R1 = 0.0808, wR2 = 0.1817  
Absolute structure parameter 0.3(3)  
Largest diff. peak and hole 0.549 and -0.352 e.Å-3  
_______________________________________________________  
Goodness-of-fit = [S[w(Fo2 - Fc2)2]/Nobservns - Nparams)]1/2, all data. 
R1 = S(|Fo| - |Fc|) / S |Fo|. wR2 = [S[w(Fo2 - Fc2)2] / S [w(Fo2)2]]1/2. 
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Table 2. Atomic coordinates ( × 104) and equivalent isotropic displacement parameters (Å2 × 103) 
for 16066. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
x y z U(eq)  
________________________________________________________________________________  
N1 4693(1) 6597(1) 6510(1) 27(1) 
N2 5178(1) 5653(1) 5928(1) 25(1) 
N3 6095(1) 4737(1) 7595(1) 27(1) 
N4 3662(1) 7818(1) 6456(1) 26(1) 
N5 2865(1) 8516(1) 7086(1) 22(1) 
N6 1505(1) 8702(1) 5415(1) 29(1) 
C1 4380(1) 6916(1) 7104(1) 28(1) 
C2 5065(1) 5969(1) 6517(1) 23(1) 
C3 5574(1) 5024(1) 5866(1) 24(1) 
C4 5670(2) 4728(2) 5238(1) 32(1) 
C5 6050(2) 4098(2) 5159(1) 36(1) 
C6 6355(1) 3728(1) 5702(1) 28(1) 
C7 6259(1) 4025(1) 6323(1) 24(1) 
C8 5872(1) 4678(1) 6419(1) 22(1) 
C9 5770(1) 5023(1) 7055(1) 22(1) 
C10 5351(1) 5648(1) 7092(1) 24(1) 
C11 3751(2) 6468(2) 7359(2) 37(1) 
C12 3750(2) 6247(2) 8017(2) 50(1) 
C13 3188(3) 5830(2) 8269(2) 70(1) 
C14 2620(3) 5631(2) 7862(3) 83(2) 
C15 2619(2) 5837(3) 7209(3) 82(2) 
C16 3186(2) 6254(2) 6954(2) 56(1) 
C17 6736(2) 2999(2) 5589(2) 39(1) 
C18 7170(4) 2993(3) 4964(3) 94(2) 
C19 6127(3) 2425(2) 5512(4) 97(2) 
C20 7192(2) 2761(2) 6168(2) 59(1) 
C21 6046(2) 5004(1) 8249(1) 32(1) 
C22 6685(2) 5121(2) 8600(2) 43(1) 
C23 6655(3) 5332(2) 9257(2) 60(1) 
C24 6004(3) 5445(2) 9565(2) 68(1) 
C25 5365(3) 5338(2) 9209(2) 63(1) 
C26 5377(2) 5105(2) 8557(2) 43(1) 
C27 5962(5) 5683(4) 10284(2) 117(3) 
C28 4187(1) 7729(1) 6985(1) 26(1) 
C29 3040(1) 8220(1) 6511(1) 22(1) 
C30 2215(1) 8887(1) 7110(1) 21(1) 
C31 2012(1) 9224(1) 7706(1) 26(1) 
C32 1395(1) 9644(2) 7746(1) 29(1) 
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C33 939(1) 9766(1) 7198(1) 28(1) 
C34 1122(1) 9418(1) 6620(1) 25(1) 
C35 1744(1) 8970(1) 6566(1) 22(1) 
C36 1959(1) 8638(1) 5952(1) 23(1) 
C37 2607(1) 8274(1) 5935(1) 23(1) 
C38 4875(1) 8168(1) 6884(1) 30(1) 
C39 5246(2) 8438(2) 7434(2) 42(1) 
C40 5893(2) 8815(2) 7364(2) 56(1) 
C41 6186(2) 8927(2) 6743(2) 55(1) 
C42 5824(2) 8673(2) 6192(2) 46(1) 
C43 5171(2) 8302(2) 6266(2) 36(1) 
C44 285(2) 10276(2) 7265(1) 37(1) 
C45 -97(2) 10400(2) 6608(2) 48(1) 
C46 -262(2) 9942(3) 7746(2) 54(1) 
C47 539(2) 11004(2) 7537(2) 61(1) 
C48 1739(1) 8607(1) 4750(1) 26(1) 
C49 2269(2) 9063(2) 4494(1) 32(1) 
C50 2442(2) 9024(2) 3827(1) 35(1) 
C51 2101(2) 8539(2) 3411(1) 34(1) 
C52 1575(2) 8083(2) 3675(1) 34(1) 
C53 1398(1) 8110(2) 4344(1) 30(1) 
C54 2296(2) 8495(2) 2690(2) 51(1) 
O1 4165(1) 7041(1) 5289(1) 44(1) 
O2 4906(1) 6294(1) 4757(1) 32(1) 
C55 4340(2) 7245(2) 4127(1) 44(1) 
C56 4373(2) 6728(2) 3528(1) 46(1) 
C57 3610(2) 6469(3) 3454(2) 64(1) 
C58 3162(2) 6913(3) 3766(2) 77(1) 
C59 3546(2) 7514(3) 4095(2) 70(1) 
C60 4470(2) 6816(2) 4778(1) 32(1) 
C61 4912(3) 7834(2) 4131(2) 57(1) 
C62 5594(3) 7721(2) 3850(2) 59(1) 
C63 6140(4) 8243(3) 3881(3) 86(2) 
C64 5997(6) 8899(3) 4188(3) 114(3) 
C65 5337(6) 9021(3) 4455(3) 112(3) 
C66 4782(4) 8498(2) 4438(2) 82(2) 
C1S 8707(16) 2209(18) 7077(13) 69(3) 
C2S 9156(5) 2426(5) 6504(5) 86(2) 
C3S 9855(5) 2817(6) 6638(4) 89(2) 
C4S 10351(5) 2889(7) 6070(6) 108(3) 
C5S 10993(5) 3375(6) 6155(4) 98(2) 
C6S 11519(5) 3087(8) 6673(5) 109(3) 
C7S 12169(12) 3574(13) 6758(12) 155(9) 
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C1D 8720(30) 2250(30) 7160(30) 69(3) 
C2D 9300(9) 2758(9) 6991(8) 86(2) 
C3D 9682(10) 2665(11) 6328(8) 89(2) 
C4D 10284(8) 3198(11) 6321(11) 108(3) 
C5D 11005(9) 3078(11) 6564(8) 98(2) 
C6D 11569(9) 3640(14) 6387(9) 109(3) 
C7D 12140(20) 3960(30) 6770(20) 155(9) 
C8S 9027(7) 2733(6) 3805(7) 157(5) 
C9S 9088(15) 2372(12) 4402(11) 278(9) 
C10S 9055(11) 1580(11) 4331(11) 240(8) 
C11S 8667(11) 1189(11) 4799(13) 268(10) 
C12S 8628(12) 422(13) 4737(14) 294(10) 
C13S 8110(20) 140(20) 5240(17) 366(15) 
C14S 7798(14) -512(15) 5006(14) 289(10) 
C8D 10010(30) 1770(30) 4250(30) 157(5) 
C9D 9280(40) 2040(60) 4330(50) 278(9) 
C10D 8970(40) 1780(40) 4970(40) 240(8) 
C11D 9010(30) 990(40) 5050(50) 268(10) 
C12D 8300(40) 690(50) 5230(60) 294(10) 
C13D 8100(70) 10(90) 4850(80) 366(15) 
C14D 7400(50) -240(60) 5110(60) 289(10)  
________________________________________________________________________________ 
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Table 3.  Bond lengths [Å] and angles [°] for 16066.  
_____________________________________________________________________________________________  
N1-C2 1.347(3) N1-C1 1.459(3) 
N1-H1N 0.97(3) N2-C2 1.345(3) 
N2-C3 1.377(3) N2-H2N 0.96(4) 
N3-C9 1.357(3) N3-C21 1.418(3) 
N3-H3N 0.90(3) N4-C29 1.371(3) 
N4-C28 1.456(3) N4-H4N 0.90(3) 
N5-C29 1.329(3) N5-C30 1.381(3) 
N6-C36 1.379(3) N6-C48 1.427(3) 
C1-C11 1.515(4) C1-C28 1.561(3) 
C1-H1 1.0000 C2-C10 1.411(3) 
C3-C4 1.398(3) C3-C8 1.403(3) 
C4-C5 1.367(4) C4-H4 0.9500 
C5-C6 1.413(4) C5-H5 0.9500 
C6-C7 1.386(3) C6-C17 1.534(4) 
C7-C8 1.414(3) C7-H7 0.9500 
C8-C9 1.452(3) C9-C10 1.389(3) 
C10-H10 0.9500 C11-C16 1.385(5) 
C11-C12 1.397(4) C12-C13 1.388(6) 
C12-H12 0.9500 C13-C14 1.383(8) 
C13-H13 0.9500 C14-C15 1.380(9) 
C14-H14 0.9500 C15-C16 1.397(6) 
C15-H15 0.9500 C16-H16 0.9500 
C17-C18 1.501(5) C17-C20 1.510(5) 
C17-C19 1.553(6) C18-H18A 0.9800 
C18-H18B 0.9800 C18-H18C 0.9800 
C19-H19A 0.9800 C19-H19B 0.9800 
C19-H19C 0.9800 C20-H20A 0.9800 
C20-H20B 0.9800 C20-H20C 0.9800 
C21-C22 1.394(4) C21-C26 1.395(4) 
C22-C23 1.390(4) C22-H22 0.9500 
C23-C24 1.367(8) C23-H23 0.9500 
C24-C25 1.397(8) C24-C27 1.526(5) 
C25-C26 1.390(5) C25-H25 0.9500 
C26-H26 0.9500 C27-H27A 0.9800 
C27-H27B 0.9800 C27-H27C 0.9800 
C28-C38 1.520(4) C28-H28 1.0000 
C29-C37 1.420(3) C30-C31 1.411(3) 
C30-C35 1.413(3) C31-C32 1.378(3) 
C31-H31 0.9500 C32-C33 1.412(3) 
C32-H32 0.9500 C33-C34 1.379(3) 
C33-C44 1.535(3) C34-C35 1.418(3) 
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C34-H34 0.9500 
C36-C37 1.371(3) 
C38-C43 1.389(4) 
C39-C40 1.388(5) 
C40-C41 1.387(6) 
C41-C42 1.385(5) 
C42-C43 1.393(4) 
C43-H43 0.9500 
C44-C47 1.527(5) 
C45-H45A 0.9800 
C45-H45C 0.9800 
C46-H46B 0.9800 
C47-H47A 0.9800 
C47-H47C 0.9800 
C48-C49 1.391(4) 
C49-H49 0.9500 
C50-H50 0.9500 
C51-C54 1.508(4) 
C52-H52 0.9500 
C54-H54A 0.9800 
C54-H54C 0.9800 
O2-C60 1.254(3) 
C55-C56 1.546(4) 
C55-C60 1.560(4) 
C56-H56A 0.9900 
C57-C58 1.324(7) 
C57-H57B 0.9900 
C58-H58A 0.9900 
C59-H59A 0.9900 
C61-C66 1.396(5) 
C62-C63 1.393(7) 
C63-C64 1.387(10) 
C64-C65 1.351(12) 
C65-C66 1.407(11) 
C66-H66 0.9500 
C1S-H1S1 0.9800 
C1S-H1S3 0.9800 
C2S-H2S1 0.9900 
C3S-C4S 1.477(12) 
C3S-H3S2 0.9900 
C4S-H4S1 0.9900 
C5S-C6S 1.527(12) 
C5S-H5S2 0.9900 
  
C35-C36 1.445(3) 
C37-H37 0.9500 
C38-C39 1.401(4) 
C39-H39 0.9500 
C40-H40 0.9500 
C41-H41 0.9500 
C42-H42 0.9500 
C44-C45 1.526(4) 
C44-C46 1.532(5) 
C45-H45B 0.9800 
C46-H46A 0.9800 
C46-H46C 0.9800 
C47-H47B 0.9800 
C48-C53 1.384(4) 
C49-C50 1.393(4) 
C50-C51 1.383(4) 
C51-C52 1.390(4) 
C52-C53 1.397(4) 
C53-H53 0.9500 
C54-H54B 0.9800 
O1-C60 1.252(3) 
C55-C61 1.514(6) 
C55-C59 1.546(5) 
C56-C57 1.494(6) 
C56-H56B 0.9900 
C57-H57A 0.9900 
C58-C59 1.476(8) 
C58-H58B 0.9900 
C59-H59B 0.9900 
C61-C62 1.396(6) 
C62-H62 0.9500 
C63-H63 0.9500 
C64-H64 0.9500 
C65-H65 0.9500 
C1S-C2S 1.483(16) 
C1S-H1S2 0.9800 
C2S-C3S 1.502(11) 
C2S-H2S2 0.9900 
C3S-H3S1 0.9900 
C4S-C5S 1.495(12) 
C4S-H4S2 0.9900 
C5S-H5S1 0.9900 
C6S-C7S 1.507(15) 
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C6S-H6S1 0.9900 
C7S-H7S1 0.9800 
C7S-H7S3 0.9800 
C1D-H1D1 0.9800 
C1D-H1D3 0.9800 
C2D-H2D1 0.9900 
C3D-C4D 1.483(17) 
C3D-H3D2 0.9900 
C4D-H4D1 0.9900 
C5D-C6D 1.511(18) 
C5D-H5D2 0.9900 
C6D-H6D1 0.9900 
C7D-H7D1 0.9800 
C7D-H7D3 0.9800 
C8S-H8S1 0.9800 
C8S-H8S3 0.9800 
C9S-H9S1 0.9900 
C10S-C11S 1.391(17) 
C10S-H10B 0.9900 
C11S-H11A 0.9900 
C12S-C13S 1.488(19) 
C12S-H12B 0.9900 
C13S-H13A 0.9900 
C14S-H14A 0.9800 
C14S-H14C 0.9800 
C8D-H8D1 0.9800 
C8D-H8D3 0.9800 
C9D-H9D1 0.9900 
C10D-C11D 1.48(2) 
C10D-H10D 0.9900 
C11D-H11C 0.9900 
C12D-C13D 1.51(2) 
C12D-H12D 0.9900 
C13D-H13C 0.9900 
C14D-H14D 0.9800 
C14D-H14F 0.9800 
C2-N1-C1 122.7(2) 
C1-N1-H1N 123(2) 
C2-N2-H2N 118(3) 
C9-N3-C21 126.4(2) 
C21-N3-H3N 109(2) 
C29-N4-H4N 112(2) 
  
C6S-H6S2 0.9900 
C7S-H7S2 0.9800 
C1D-C2D 1.46(2) 
C1D-H1D2 0.9800 
C2D-C3D 1.529(17) 
C2D-H2D2 0.9900 
C3D-H3D1 0.9900 
C4D-C5D 1.435(18) 
C4D-H4D2 0.9900 
C5D-H5D1 0.9900 
C6D-C7D 1.43(2) 
C6D-H6D2 0.9900 
C7D-H7D2 0.9800 
C8S-C9S 1.388(18) 
C8S-H8S2 0.9800 
C9S-C10S 1.469(18) 
C9S-H9S2 0.9900 
C10S-H10A 0.9900 
C11S-C12S 1.422(18) 
C11S-H11B 0.9900 
C12S-H12A 0.9900 
C13S-C14S 1.42(2) 
C13S-H13B 0.9900 
C14S-H14B 0.9800 
C8D-C9D 1.45(2) 
C8D-H8D2 0.9800 
C9D-C10D 1.50(2) 
C9D-H9D2 0.9900 
C10D-H10C 0.9900 
C11D-C12D 1.45(2) 
C11D-H11D 0.9900 
C12D-H12C 0.9900 
C13D-C14D 1.46(2) 
C13D-H13D 0.9900 
C14D-H14E 0.9800 
C2-N1-H1N 112(2) 
C2-N2-C3 121.9(2) 
C3-N2-H2N 120(3) 
C9-N3-H3N 124(2) 
C29-N4-C28 123.8(2) 
C28-N4-H4N 124(2) 
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C29-N5-C30 116.42(19) 
N1-C1-C11 111.4(2) 
C11-C1-C28 113.7(2) 
C11-C1-H1 107.0 
N2-C2-N1 116.3(2) 
N1-C2-C10 124.0(2) 
N2-C3-C8 121.2(2) 
C5-C4-C3 120.2(2) 
C3-C4-H4 119.9 
C4-C5-H5 119.2 
C7-C6-C5 117.9(2) 
C5-C6-C17 119.4(2) 
C6-C7-H7 119.1 
C3-C8-C7 118.4(2) 
C7-C8-C9 124.2(2) 
N3-C9-C8 119.3(2) 
C9-C10-C2 120.7(2) 
C2-C10-H10 119.6 
C16-C11-C1 121.9(3) 
C13-C12-C11 121.1(4) 
C11-C12-H12 119.5 
C14-C13-H13 120.3 
C15-C14-C13 120.2(4) 
C13-C14-H14 119.9 
C14-C15-H15 119.8 
C11-C16-C15 120.1(4) 
C15-C16-H16 120.0 
C18-C17-C6 112.1(3) 
C18-C17-C19 107.2(4) 
C6-C17-C19 106.4(3) 
C17-C18-H18B 109.5 
C17-C18-H18C 109.5 
H18B-C18-H18C 109.5 
C17-C19-H19B 109.5 
C17-C19-H19C 109.5 
H19B-C19-H19C 109.5 
C17-C20-H20B 109.5 
C17-C20-H20C 109.5 
H20B-C20-H20C 109.5 
C22-C21-N3 118.6(3) 
C23-C22-C21 120.1(4) 
C21-C22-H22 120.0 
C24-C23-H23 119.5 
  
C36-N6-C48 123.6(2) 
N1-C1-C28 110.51(19) 
N1-C1-H1 107.0 
C28-C1-H1 107.0 
N2-C2-C10 119.7(2) 
N2-C3-C4 118.6(2) 
C4-C3-C8 120.1(2) 
C5-C4-H4 119.9 
C4-C5-C6 121.6(2) 
C6-C5-H5 119.2 
C7-C6-C17 122.7(2) 
C6-C7-C8 121.7(2) 
C8-C7-H7 119.1 
C3-C8-C9 117.38(19) 
N3-C9-C10 121.6(2) 
C10-C9-C8 119.0(2) 
C9-C10-H10 119.6 
C16-C11-C12 118.9(3) 
C12-C11-C1 119.2(3) 
C13-C12-H12 119.5 
C14-C13-C12 119.5(4) 
C12-C13-H13 120.3 
C15-C14-H14 119.9 
C14-C15-C16 120.4(5) 
C16-C15-H15 119.8 
C11-C16-H16 120.0 
C18-C17-C20 111.1(3) 
C20-C17-C6 113.2(2) 
C20-C17-C19 106.4(3) 
C17-C18-H18A 109.5 
H18A-C18-H18B 109.5 
H18A-C18-H18C 109.5 
C17-C19-H19A 109.5 
H19A-C19-H19B 109.5 
H19A-C19-H19C 109.5 
C17-C20-H20A 109.5 
H20A-C20-H20B 109.5 
H20A-C20-H20C 109.5 
C22-C21-C26 119.7(3) 
C26-C21-N3 121.5(3) 
C23-C22-H22 120.0 
C24-C23-C22 121.0(4) 
C22-C23-H23 119.5 
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C23-C24-C25 118.8(3) 
C25-C24-C27 119.5(6) 
C26-C25-H25 119.3 
C25-C26-C21 118.9(4) 
C21-C26-H26 120.6 
C24-C27-H27B 109.5 
C24-C27-H27C 109.5 
H27B-C27-H27C 109.5 
N4-C28-C1 112.0(2) 
N4-C28-H28 107.1 
C1-C28-H28 107.1 
N5-C29-C37 124.0(2) 
N5-C30-C31 118.6(2) 
C31-C30-C35 117.3(2) 
C32-C31-H31 119.5 
C31-C32-C33 122.3(2) 
C33-C32-H32 118.8 
C34-C33-C44 123.5(2) 
C33-C34-C35 122.3(2) 
C35-C34-H34 118.9 
C30-C35-C36 117.4(2) 
C37-C36-N6 123.4(2) 
N6-C36-C35 118.7(2) 
C36-C37-H37 119.9 
C43-C38-C39 117.7(3) 
C39-C38-C28 119.3(3) 
C40-C39-H39 119.5 
C41-C40-C39 120.2(3) 
C39-C40-H40 119.9 
C42-C41-H41 120.1 
C41-C42-C43 119.7(3) 
C43-C42-H42 120.1 
C38-C43-H43 119.2 
C45-C44-C47 109.0(3) 
C47-C44-C46 109.0(3) 
C47-C44-C33 109.3(2) 
C44-C45-H45A 109.5 
H45A-C45-H45B 109.5 
H45A-C45-H45C 109.5 
C44-C46-H46A 109.5 
H46A-C46-H46B 109.5 
H46A-C46-H46C 109.5 
C44-C47-H47A 109.5 
  
C23-C24-C27 121.7(6) 
C26-C25-C24 121.5(4) 
C24-C25-H25 119.3 
C25-C26-H26 120.6 
C24-C27-H27A 109.5 
H27A-C27-H27B 109.5 
H27A-C27-H27C 109.5 
N4-C28-C38 113.2(2) 
C38-C28-C1 110.0(2) 
C38-C28-H28 107.1 
N5-C29-N4 119.8(2) 
N4-C29-C37 116.1(2) 
N5-C30-C35 124.04(19) 
C32-C31-C30 121.1(2) 
C30-C31-H31 119.5 
C31-C32-H32 118.8 
C34-C33-C32 116.8(2) 
C32-C33-C44 119.7(2) 
C33-C34-H34 118.9 
C30-C35-C34 120.0(2) 
C34-C35-C36 122.4(2) 
C37-C36-C35 117.9(2) 
C36-C37-C29 120.2(2) 
C29-C37-H37 119.9 
C43-C38-C28 123.0(2) 
C40-C39-C38 121.1(3) 
C38-C39-H39 119.5 
C41-C40-H40 119.9 
C42-C41-C40 119.7(3) 
C40-C41-H41 120.1 
C41-C42-H42 120.1 
C38-C43-C42 121.6(3) 
C42-C43-H43 119.2 
C45-C44-C46 108.3(3) 
C45-C44-C33 112.1(2) 
C46-C44-C33 109.1(3) 
C44-C45-H45B 109.5 
C44-C45-H45C 109.5 
H45B-C45-H45C 109.5 
C44-C46-H46B 109.5 
C44-C46-H46C 109.5 
H46B-C46-H46C 109.5 
C44-C47-H47B 109.5 
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H47A-C47-H47B 109.5 
H47A-C47-H47C 109.5 
C53-C48-C49 119.8(2) 
C49-C48-N6 119.4(2) 
C48-C49-H49 120.2 
C51-C50-C49 121.5(3) 
C49-C50-H50 119.2 
C50-C51-C54 121.3(3) 
C51-C52-C53 121.0(3) 
C53-C52-H52 119.5 
C48-C53-H53 120.1 
C51-C54-H54A 109.5 
H54A-C54-H54B 109.5 
H54A-C54-H54C 109.5 
C61-C55-C56 114.8(3) 
C56-C55-C59 101.7(3) 
C56-C55-C60 110.3(3) 
C57-C56-C55 103.8(3) 
C55-C56-H56A 111.0 
C55-C56-H56B 111.0 
C58-C57-C56 110.0(4) 
C56-C57-H57A 109.7 
C56-C57-H57B 109.7 
C57-C58-C59 112.5(4) 
C59-C58-H58A 109.1 
C59-C58-H58B 109.1 
C58-C59-C55 103.4(3) 
C55-C59-H59A 111.1 
C55-C59-H59B 111.1 
O1-C60-O2 124.8(2) 
O2-C60-C55 117.4(2) 
C66-C61-C55 120.9(5) 
C63-C62-C61 122.0(5) 
C61-C62-H62 119.0 
C64-C63-H63 120.5 
C65-C64-C63 119.8(7) 
C63-C64-H64 120.1 
C64-C65-H65 119.0 
C61-C66-C65 119.3(6) 
C65-C66-H66 120.4 
C2S-C1S-H1S2 109.6 
C2S-C1S-H1S3 109.5 
H1S2-C1S-H1S3 109.5 
  
C44-C47-H47C 109.5 
H47B-C47-H47C 109.5 
C53-C48-N6 120.5(2) 
C48-C49-C50 119.5(3) 
C50-C49-H49 120.2 
C51-C50-H50 119.2 
C50-C51-C52 118.3(2) 
C52-C51-C54 120.4(3) 
C51-C52-H52 119.5 
C48-C53-C52 119.8(3) 
C52-C53-H53 120.1 
C51-C54-H54B 109.5 
C51-C54-H54C 109.5 
H54B-C54-H54C 109.5 
C61-C55-C59 115.4(3) 
C61-C55-C60 104.6(2) 
C59-C55-C60 110.1(3) 
C57-C56-H56A 111.0 
C57-C56-H56B 111.0 
H56A-C56-H56B 109.0 
C58-C57-H57A 109.7 
C58-C57-H57B 109.7 
H57A-C57-H57B 108.2 
C57-C58-H58A 109.1 
C57-C58-H58B 109.1 
H58A-C58-H58B 107.8 
C58-C59-H59A 111.1 
C58-C59-H59B 111.1 
H59A-C59-H59B 109.0 
O1-C60-C55 117.7(2) 
C66-C61-C62 117.8(5) 
C62-C61-C55 121.3(3) 
C63-C62-H62 119.0 
C64-C63-C62 119.0(7) 
C62-C63-H63 120.5 
C65-C64-H64 120.1 
C64-C65-C66 122.0(6) 
C66-C65-H65 119.0 
C61-C66-H66 120.4 
C2S-C1S-H1S1 109.3 
H1S1-C1S-H1S2 109.5 
H1S1-C1S-H1S3 109.5 
C1S-C2S-C3S 117.8(13) 
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C1S-C2S-H2S1 107.9 C3S-C2S-H2S1 107.9 
C1S-C2S-H2S2 107.9 C3S-C2S-H2S2 107.9 
H2S1-C2S-H2S2 107.2 C4S-C3S-C2S 115.6(8) 
C4S-C3S-H3S1 108.4 C2S-C3S-H3S1 108.4 
C4S-C3S-H3S2 108.4 C2S-C3S-H3S2 108.4 
H3S1-C3S-H3S2 107.4 C3S-C4S-C5S 117.0(9) 
C3S-C4S-H4S1 108.0 C5S-C4S-H4S1 108.0 
C3S-C4S-H4S2 108.0 C5S-C4S-H4S2 108.0 
H4S1-C4S-H4S2 107.3 C4S-C5S-C6S 112.0(10) 
C4S-C5S-H5S1 109.2 C6S-C5S-H5S1 109.2 
C4S-C5S-H5S2 109.2 C6S-C5S-H5S2 109.2 
H5S1-C5S-H5S2 107.9 C7S-C6S-C5S 112.1(12) 
C7S-C6S-H6S1 109.2 C5S-C6S-H6S1 109.2 
C7S-C6S-H6S2 109.2 C5S-C6S-H6S2 109.2 
H6S1-C6S-H6S2 107.9 C6S-C7S-H7S1 109.4 
C6S-C7S-H7S2 109.6 H7S1-C7S-H7S2 109.5 
C6S-C7S-H7S3 109.5 H7S1-C7S-H7S3 109.5 
H7S2-C7S-H7S3 109.5 C2D-C1D-H1D1 109.4 
C2D-C1D-H1D2 109.4 H1D1-C1D-H1D2 109.5 
C2D-C1D-H1D3 109.6 H1D1-C1D-H1D3 109.5 
H1D2-C1D-H1D3 109.5 C1D-C2D-C3D 118(2) 
C1D-C2D-H2D1 107.7 C3D-C2D-H2D1 107.7 
C1D-C2D-H2D2 107.7 C3D-C2D-H2D2 107.7 
H2D1-C2D-H2D2 107.1 C4D-C3D-C2D 106.2(14) 
C4D-C3D-H3D1 110.5 C2D-C3D-H3D1 110.5 
C4D-C3D-H3D2 110.5 C2D-C3D-H3D2 110.5 
H3D1-C3D-H3D2 108.7 C5D-C4D-C3D 126.0(19) 
C5D-C4D-H4D1 105.8 C3D-C4D-H4D1 105.8 
C5D-C4D-H4D2 105.8 C3D-C4D-H4D2 105.8 
H4D1-C4D-H4D2 106.2 C4D-C5D-C6D 116.7(17) 
C4D-C5D-H5D1 108.1 C6D-C5D-H5D1 108.1 
C4D-C5D-H5D2 108.1 C6D-C5D-H5D2 108.1 
H5D1-C5D-H5D2 107.3 C7D-C6D-C5D 131(2) 
C7D-C6D-H6D1 104.4 C5D-C6D-H6D1 104.4 
C7D-C6D-H6D2 104.4 C5D-C6D-H6D2 104.4 
H6D1-C6D-H6D2 105.6 C6D-C7D-H7D1 109.5 
C6D-C7D-H7D2 109.5 H7D1-C7D-H7D2 109.5 
C6D-C7D-H7D3 109.3 H7D1-C7D-H7D3 109.5 
H7D2-C7D-H7D3 109.5 C9S-C8S-H8S1 109.9 
C9S-C8S-H8S2 109.3 H8S1-C8S-H8S2 109.5 
C9S-C8S-H8S3 109.2 H8S1-C8S-H8S3 109.5 
H8S2-C8S-H8S3 109.5 C8S-C9S-C10S 112.8(19) 
C8S-C9S-H9S1 109.0 C10S-C9S-H9S1 109.0 
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C8S-C9S-H9S2 109.0 C10S-C9S-H9S2 109.0 
H9S1-C9S-H9S2 107.8 C11S-C10S-C9S 118.1(18) 
C11S-C10S-H10A 107.8 C9S-C10S-H10A 107.8 
C11S-C10S-H10B 107.8 C9S-C10S-H10B 107.8 
H10A-C10S-H10B 107.1 C10S-C11S-C12S 118.9(17) 
C10S-C11S-H11A 107.6 C12S-C11S-H11A 107.6 
C10S-C11S-H11B 107.6 C12S-C11S-H11B 107.6 
H11A-C11S-H11B 107.0 C11S-C12S-C13S 108.5(19) 
C11S-C12S-H12A 110.0 C13S-C12S-H12A 110.0 
C11S-C12S-H12B 110.0 C13S-C12S-H12B 110.0 
H12A-C12S-H12B 108.4 C14S-C13S-C12S 109(2) 
C14S-C13S-H13A 109.9 C12S-C13S-H13A 109.9 
C14S-C13S-H13B 109.9 C12S-C13S-H13B 109.9 
H13A-C13S-H13B 108.3 C13S-C14S-H14A 109.5 
C13S-C14S-H14B 109.7 H14A-C14S-H14B 109.5 
C13S-C14S-H14C 109.3 H14A-C14S-H14C 109.5 
H14B-C14S-H14C 109.5 C9D-C8D-H8D1 109.1 
C9D-C8D-H8D2 108.2 H8D1-C8D-H8D2 109.5 
C9D-C8D-H8D3 111.1 H8D1-C8D-H8D3 109.5 
H8D2-C8D-H8D3 109.5 C8D-C9D-C10D 110(3) 
C8D-C9D-H9D1 109.6 C10D-C9D-H9D1 109.6 
C8D-C9D-H9D2 109.6 C10D-C9D-H9D2 109.6 
H9D1-C9D-H9D2 108.2 C11D-C10D-C9D 113(3) 
C11D-C10D-H10C 109.0 C9D-C10D-H10C 109.0 
C11D-C10D-H10D 109.0 C9D-C10D-H10D 109.0 
H10C-C10D-H10D 107.8 C12D-C11D-C10D 111(3) 
C12D-C11D-H11C 109.4 C10D-C11D-H11C 109.4 
C12D-C11D-H11D 109.4 C10D-C11D-H11D 109.4 
H11C-C11D-H11D 108.0 C11D-C12D-C13D 114(3) 
C11D-C12D-H12C 108.6 C13D-C12D-H12C 108.6 
C11D-C12D-H12D 108.6 C13D-C12D-H12D 108.6 
H12C-C12D-H12D 107.6 C14D-C13D-C12D 108(3) 
C14D-C13D-H13C 110.1 C12D-C13D-H13C 110.1 
C14D-C13D-H13D 110.1 C12D-C13D-H13D 110.1 
H13C-C13D-H13D 108.4 C13D-C14D-H14D 111.1 
C13D-C14D-H14E 110.6 H14D-C14D-H14E 109.5 
C13D-C14D-H14F 106.7 H14D-C14D-H14F 109.5 
H14E-C14D-H14F 109.5    
_____________________________________________________________________________________________ 
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Table 4. Anisotropic displacement parameters (Å2 × 103) for 16066. The anisotropic 
displacement factor exponent takes the form: -2p2[ h2 a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
U11 U22 U33 U23 U13 U12  
______________________________________________________________________________  
N1 31(1) 27(1) 23(1) 2(1) 0(1) 10(1) 
N2 28(1) 25(1) 22(1) 1(1) 0(1) 6(1) 
N3 36(1) 23(1) 23(1) 1(1) -4(1) 8(1) 
N4 28(1) 30(1) 21(1) -3(1) -2(1) 10(1) 
N5 22(1) 24(1) 21(1) -2(1) -2(1) 1(1) 
N6 24(1) 42(1) 20(1) -4(1) -2(1) 3(1) 
C1 31(1) 27(1) 24(1) 1(1) 1(1) 8(1) 
C2 22(1) 23(1) 25(1) 2(1) 1(1) 3(1) 
C3 24(1) 23(1) 23(1) 0(1) 1(1) 2(1) 
C4 42(1) 31(1) 22(1) 1(1) -2(1) 8(1) 
C5 49(2) 33(1) 25(1) -5(1) 3(1) 9(1) 
C6 30(1) 25(1) 30(1) -3(1) 4(1) 3(1) 
C7 24(1) 21(1) 27(1) 1(1) -1(1) 2(1) 
C8 21(1) 22(1) 23(1) 1(1) 0(1) 1(1) 
C9 23(1) 21(1) 22(1) 2(1) 0(1) 0(1) 
C10 27(1) 23(1) 22(1) 1(1) 0(1) 3(1) 
C11 39(1) 30(1) 43(2) 6(1) 12(1) 11(1) 
C12 75(2) 33(2) 42(2) 4(1) 22(2) 7(2) 
C13 98(3) 44(2) 70(3) 14(2) 43(3) 8(2) 
C14 70(3) 47(2) 132(5) 28(3) 47(3) 6(2) 
C15 48(2) 63(3) 134(5) 27(3) 2(3) -8(2) 
C16 43(2) 54(2) 72(2) 17(2) -3(2) -8(2) 
C17 48(2) 30(1) 38(1) -4(1) 4(1) 14(1) 
C18 119(4) 87(3) 75(3) 17(3) 44(3) 62(3) 
C19 88(3) 32(2) 170(6) -8(3) -51(4) 7(2) 
C20 76(3) 42(2) 58(2) -13(2) -18(2) 30(2) 
C21 52(2) 21(1) 22(1) 2(1) -4(1) 6(1) 
C22 63(2) 29(1) 36(1) -7(1) -16(1) 15(1) 
C23 105(3) 39(2) 36(2) -9(1) -28(2) 19(2) 
C24 126(4) 49(2) 29(2) -4(1) -1(2) 8(2) 
C25 101(3) 53(2) 34(2) 2(1) 24(2) 5(2) 
C26 62(2) 35(1) 32(1) 6(1) 10(1) 0(1) 
C27 207(8) 110(4) 32(2) -21(2) -1(3) 9(5) 
C28 28(1) 28(1) 24(1) -2(1) -3(1) 9(1) 
C29 21(1) 19(1) 25(1) 1(1) -1(1) 0(1) 
C30 21(1) 22(1) 21(1) -2(1) -1(1) 0(1) 
C31 26(1) 31(1) 20(1) -4(1) -3(1) 2(1) 
C32 28(1) 36(1) 24(1) -9(1) 0(1) 4(1) 
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C33 22(1) 33(1) 29(1) -5(1) 0(1) 5(1) 
C34 22(1) 28(1) 25(1) -4(1) -2(1) 2(1) 
C35 21(1) 24(1) 21(1) -1(1) -1(1) 0(1) 
C36 22(1) 24(1) 21(1) -2(1) -2(1) -2(1) 
C37 25(1) 25(1) 20(1) -4(1) 0(1) 2(1) 
C38 29(1) 25(1) 36(1) -2(1) -6(1) 7(1) 
C39 42(2) 42(2) 42(2) -7(1) -12(1) 6(1) 
C40 46(2) 47(2) 75(3) -14(2) -21(2) -2(2) 
C41 38(2) 40(2) 86(3) -4(2) -6(2) -5(1) 
C42 43(2) 38(2) 58(2) 5(1) 5(1) 1(1) 
C43 37(1) 31(1) 39(1) -1(1) -1(1) 2(1) 
C44 30(1) 43(2) 38(1) -11(1) -4(1) 14(1) 
C45 40(2) 53(2) 50(2) -10(1) -8(1) 24(1) 
C46 32(2) 87(3) 44(2) -10(2) 7(1) 14(2) 
C47 56(2) 45(2) 83(3) -27(2) -13(2) 22(2) 
C48 23(1) 33(1) 21(1) -2(1) -3(1) 6(1) 
C49 31(1) 36(1) 30(1) -3(1) 0(1) -2(1) 
C50 35(1) 39(1) 31(1) 8(1) 5(1) 1(1) 
C51 34(1) 45(2) 23(1) 4(1) 0(1) 11(1) 
C52 34(1) 42(2) 26(1) -8(1) -4(1) 3(1) 
C53 28(1) 36(1) 26(1) -4(1) 0(1) -1(1) 
C54 56(2) 73(2) 24(1) 3(1) 6(1) 9(2) 
O1 51(1) 55(1) 24(1) -1(1) 1(1) 25(1) 
O2 32(1) 37(1) 26(1) 4(1) -1(1) 12(1) 
C55 59(2) 53(2) 21(1) 1(1) -4(1) 30(2) 
C56 53(2) 59(2) 24(1) -6(1) -5(1) 18(2) 
C57 60(2) 88(3) 45(2) 1(2) -11(2) 13(2) 
C58 52(2) 123(4) 55(2) 12(3) -10(2) 30(3) 
C59 72(3) 98(3) 39(2) 4(2) -5(2) 59(3) 
C60 33(1) 41(1) 22(1) -1(1) -3(1) 14(1) 
C61 102(3) 40(2) 28(1) 8(1) -13(2) 18(2) 
C62 80(3) 45(2) 52(2) 16(2) -9(2) 3(2) 
C63 112(4) 71(3) 74(3) 28(3) -20(3) -21(3) 
C64 213(9) 67(3) 63(3) 11(3) -26(5) -42(5) 
C65 242(10) 43(2) 50(3) 0(2) -20(4) -16(4) 
C66 161(5) 47(2) 38(2) -2(2) 5(2) 22(3) 
C1S 59(2) 67(4) 81(7) 0(5) -17(4) 27(2) 
C2S 85(4) 87(5) 86(4) -1(3) -13(3) 15(3) 
C3S 102(5) 100(5) 65(4) -2(4) -13(4) -16(4) 
C4S 97(4) 112(7) 115(7) -38(5) 15(4) 11(5) 
C5S 110(5) 124(6) 60(4) -16(4) 18(4) 5(4) 
C6S 87(5) 174(9) 66(5) 2(4) 10(4) 0(5) 
C7S 109(6) 250(30) 104(6) 12(13) 11(5) -51(14) 
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C1D 59(2) 67(4) 81(7) 0(5) -17(4) 27(2) 
C2D 85(4) 87(5) 86(4) -1(3) -13(3) 15(3) 
C3D 102(5) 100(5) 65(4) -2(4) -13(4) -16(4) 
C4D 97(4) 112(7) 115(7) -38(5) 15(4) 11(5) 
C5D 110(5) 124(6) 60(4) -16(4) 18(4) 5(4) 
C6D 87(5) 174(9) 66(5) 2(4) 10(4) 0(5) 
C7D 109(6) 250(30) 104(6) 12(13) 11(5) -51(14) 
C8S 177(9) 115(7) 180(10) -90(7) 24(8) 21(7) 
C9S 238(13) 337(18) 259(14) -37(12) 54(12) 93(13) 
C10S 182(12) 321(16) 218(14) -28(11) 32(11) 103(12) 
C11S 186(14) 350(17) 268(19) -37(12) 106(14) 114(12) 
C12S 209(14) 349(18) 320(20) 27(14) 68(13) 120(13) 
C13S 340(20) 440(20) 320(30) -1(19) 95(19) 10(18) 
C14S 278(19) 370(20) 219(17) 123(16) -40(15) 71(17) 
C8D 177(9) 115(7) 180(10) -90(7) 24(8) 21(7) 
C9D 238(13) 337(18) 259(14) -37(12) 54(12) 93(13) 
C10D 182(12) 321(16) 218(14) -28(11) 32(11) 103(12) 
C11D 186(14) 350(17) 268(19) -37(12) 106(14) 114(12) 
C12D 209(14) 349(18) 320(20) 27(14) 68(13) 120(13) 
C13D 340(20) 440(20) 320(30) -1(19) 95(19) 10(18) 
C14D 278(19) 370(20) 219(17) 123(16) -40(15) 71(17)  
______________________________________________________________________________ 
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Table 5.  Hydrogen coordinates ( × 104) and isotropic displacement parameters ( Å2 × 10 3) for 16066. 
________________________________________________________________________________  
x y z U(eq)  
________________________________________________________________________________ 
 
H1N 4532(18) 6721(18) 6070(17) 33(8) 
H2N 5020(20) 5900(20) 5540(20) 55(12) 
H3N 6412(18) 4368(19) 7583(16) 29(8) 
H4N 3728(16) 7659(17) 6043(16) 26(7) 
H1 4766 6904 7450 33 
H4 5470 4966 4865 38 
H5 6111 3905 4729 43 
H7 6459 3783 6694 29 
H10 5257 5862 7509 29 
H12 4140 6385 8297 60 
H13 3194 5682 8717 85 
H14 2230 5352 8033 99 
H15 2230 5695 6930 98 
H16 3184 6391 6503 67 
H18A 7559 3354 4993 140 
H18B 6853 3111 4591 140 
H18C 7382 2512 4898 140 
H19A 6344 1949 5426 145 
H19B 5811 2559 5143 145 
H19C 5840 2403 5918 145 
H20A 7579 3115 6244 88 
H20B 7406 2286 6074 88 
H20C 6886 2727 6562 88 
H22 7141 5057 8391 51 
H23 7093 5399 9496 72 
H25 4911 5426 9416 75 
H26 4938 5017 8326 52 
H27A 5490 5546 10467 175 
H27B 6021 6210 10311 175 
H27C 6349 5446 10536 175 
H28 3953 7911 7398 32 
H31 2305 9161 8087 31 
H32 1272 9859 8156 35 
H34 820 9481 6244 30 
H37 2766 8056 5536 28 
H39 5051 8362 7862 50 
H40 6135 8997 7742 67 
H41 6633 9177 6696 66 
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H42 6020 8751 5765 55 
H43 4921 8137 5885 43 
H45A -498 10741 6669 71 
H45B -286 9938 6442 71 
H45C 249 10601 6289 71 
H46A -686 10260 7783 81 
H46B -35 9886 8179 81 
H46C -415 9466 7582 81 
H47A 122 11328 7586 92 
H47B 890 11220 7232 92 
H47C 769 10930 7967 92 
H49 2512 9399 4773 39 
H50 2803 9339 3654 42 
H52 1333 7748 3396 41 
H53 1045 7789 4519 36 
H54A 2530 8028 2600 77 
H54B 2630 8890 2579 77 
H54C 1855 8538 2424 77 
H56A 4535 6989 3128 55 
H56B 4707 6319 3613 55 
H57A 3480 6449 2981 77 
H57B 3565 5975 3639 77 
H58A 2885 6635 4099 92 
H58B 2810 7115 3446 92 
H59A 3349 7600 4542 84 
H59B 3508 7966 3835 84 
H62 5690 7276 3632 71 
H63 6603 8150 3693 103 
H64 6362 9261 4211 137 
H65 5244 9474 4660 134 
H66 4324 8595 4633 98 
H1S1 8877 1741 7245 104 
H1S2 8198 2166 6941 104 
H1S3 8748 2576 7424 104 
H2S1 8855 2739 6217 103 
H2S2 9272 1983 6249 103 
H3S1 9739 3308 6803 107 
H3S2 10114 2558 6994 107 
H4S1 10065 3068 5690 130 
H4S2 10530 2400 5954 130 
H5S1 10825 3863 6286 117 
H5S2 11250 3420 5728 117 
H6S1 11263 3043 7100 131 
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H6S2 11685 2598 6543 131 
H7S1 12568 3396 6483 232 
H7S2 12320 3574 7221 232 
H7S3 12042 4068 6624 232 
H1D1 8587 1972 6770 104 
H1D2 8297 2527 7316 104 
H1D3 8886 1926 7509 104 
H2D1 9674 2728 7341 103 
H2D2 9097 3254 7006 103 
H3D1 9872 2166 6282 107 
H3D2 9341 2761 5961 107 
H4D1 10342 3347 5855 130 
H4D2 10101 3629 6559 130 
H5D1 11175 2603 6397 117 
H5D2 10981 3043 7050 117 
H6D1 11815 3439 5994 131 
H6D2 11283 4059 6226 131 
H7D1 12062 4482 6801 232 
H7D2 12607 3866 6552 232 
H7D3 12143 3744 7209 232 
H8S1 9509 2794 3608 236 
H8S2 8807 3209 3879 236 
H8S3 8720 2449 3507 236 
H9S1 8692 2532 4698 334 
H9S2 9554 2505 4612 334 
H10A 8844 1472 3893 288 
H10B 9559 1395 4329 288 
H11A 8164 1377 4801 321 
H11B 8879 1299 5235 321 
H12A 9114 207 4806 353 
H12B 8459 290 4290 353 
H13A 8371 52 5659 439 
H13B 7727 506 5323 439 
H14A 7780 -502 4523 434 
H14B 7306 -562 5182 434 
H14C 8095 -922 5151 434 
H8D1 10290 1872 4653 236 
H8D2 10236 2019 3878 236 
H8D3 10016 1244 4170 236 
H9D1 8973 1857 3963 334 
H9D2 9280 2571 4317 334 
H10C 9240 2015 5337 288 
H10D 8457 1939 5003 288 
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H11C 9175 763 4637 321 
H11D 9360 865 5403 321 
H12C 7926 1063 5146 353 
H12D 8297 578 5703 353 
H13C 8053 120 4376 439 
H13D 8472 -365 4912 439 
H14D 7178 -594 4806 434 
H14E 7069 163 5179 434 
H14F 7503 -481 5530 434  
________________________________________________________________________________ 
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Table 6.  Torsion angles [°] for 16066.  
_____________________________________________________________________________________________  
C2-N1-C1-C11 -69.1(3) C2-N1-C1-C28 163.5(2) 
C3-N2-C2-N1 177.5(2) C3-N2-C2-C10 -0.6(3) 
C1-N1-C2-N2 165.3(2) C1-N1-C2-C10 -16.7(4) 
C2-N2-C3-C4 -179.9(2) C2-N2-C3-C8 0.7(4) 
N2-C3-C4-C5 -179.0(3) C8-C3-C4-C5 0.4(4) 
C3-C4-C5-C6 0.1(5) C4-C5-C6-C7 -0.2(4) 
C4-C5-C6-C17 176.3(3) C5-C6-C7-C8 -0.2(4) 
C17-C6-C7-C8 -176.6(2) N2-C3-C8-C7 178.6(2) 
C4-C3-C8-C7 -0.8(3) N2-C3-C8-C9 -2.2(3) 
C4-C3-C8-C9 178.4(2) C6-C7-C8-C3 0.7(3) 
C6-C7-C8-C9 -178.5(2) C21-N3-C9-C10 1.7(4) 
C21-N3-C9-C8 -179.5(2) C3-C8-C9-N3 -175.1(2) 
C7-C8-C9-N3 4.0(3) C3-C8-C9-C10 3.7(3) 
C7-C8-C9-C10 -177.1(2) N3-C9-C10-C2 175.1(2) 
C8-C9-C10-C2 -3.7(3) N2-C2-C10-C9 2.2(4) 
N1-C2-C10-C9 -175.8(2) N1-C1-C11-C16 -50.6(4) 
C28-C1-C11-C16 75.0(4) N1-C1-C11-C12 127.5(3) 
C28-C1-C11-C12 -106.9(3) C16-C11-C12-C13 -1.1(5) 
C1-C11-C12-C13 -179.3(3) C11-C12-C13-C14 -0.1(6) 
C12-C13-C14-C15 1.0(7) C13-C14-C15-C16 -0.7(7) 
C12-C11-C16-C15 1.4(6) C1-C11-C16-C15 179.6(4) 
C14-C15-C16-C11 -0.6(7) C7-C6-C17-C18 -144.8(4) 
C5-C6-C17-C18 38.9(5) C7-C6-C17-C20 -18.1(4) 
C5-C6-C17-C20 165.6(3) C7-C6-C17-C19 98.4(4) 
C5-C6-C17-C19 -77.9(4) C9-N3-C21-C22 -128.7(3) 
C9-N3-C21-C26 55.5(4) C26-C21-C22-C23 0.6(4) 
N3-C21-C22-C23 -175.3(3) C21-C22-C23-C24 -1.6(5) 
C22-C23-C24-C25 0.5(6) C22-C23-C24-C27 -179.5(4) 
C23-C24-C25-C26 1.5(6) C27-C24-C25-C26 -178.5(4) 
C24-C25-C26-C21 -2.4(5) C22-C21-C26-C25 1.4(4) 
N3-C21-C26-C25 177.2(3) C29-N4-C28-C38 -105.3(3) 
C29-N4-C28-C1 129.6(2) N1-C1-C28-N4 60.0(3) 
C11-C1-C28-N4 -66.0(3) N1-C1-C28-C38 -66.8(3) 
C11-C1-C28-C38 167.1(2) C30-N5-C29-N4 -177.3(2) 
C30-N5-C29-C37 0.6(3) C28-N4-C29-N5 -4.6(4) 
C28-N4-C29-C37 177.3(2) C29-N5-C30-C31 -178.6(2) 
C29-N5-C30-C35 -0.4(3) N5-C30-C31-C32 175.4(2) 
C35-C30-C31-C32 -2.9(4) C30-C31-C32-C33 -0.6(4) 
C31-C32-C33-C34 2.8(4) C31-C32-C33-C44 -176.4(3) 
C32-C33-C34-C35 -1.3(4) C44-C33-C34-C35 177.8(2) 
N5-C30-C35-C34 -174.0(2) C31-C30-C35-C34 4.2(3) 
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N5-C30-C35-C36 0.5(3)  
C33-C34-C35-C30 -2.2(4)  
C48-N6-C36-C37 -20.4(4)  
C30-C35-C36-C37 -0.8(3)  
C30-C35-C36-N6 179.2(2)  
N6-C36-C37-C29 -178.9(2)  
N5-C29-C37-C36 -1.0(4)  
N4-C28-C38-C43 -33.6(3)  
N4-C28-C38-C39 148.0(2)  
C43-C38-C39-C40 -1.2(4)  
C38-C39-C40-C41 -0.4(5)  
C40-C41-C42-C43 -0.5(5)  
C28-C38-C43-C42 -176.5(3)  
C34-C33-C44-C45 -4.9(4)  
C34-C33-C44-C47 -125.8(3)  
C34-C33-C44-C46 115.1(3)  
C36-N6-C48-C53 124.8(3)  
C53-C48-C49-C50 1.1(4)  
C48-C49-C50-C51 -0.2(4)  
C49-C50-C51-C54 -179.4(3)  
C54-C51-C52-C53 178.9(3)  
N6-C48-C53-C52 172.4(2)  
C61-C55-C56-C57 -153.1(3)  
C60-C55-C56-C57 89.0(3)  
C56-C57-C58-C59 -0.8(5)  
C61-C55-C59-C58 152.1(3)  
C60-C55-C59-C58 -89.7(4)  
C56-C55-C60-O1 -149.2(3)  
C61-C55-C60-O2 -89.2(3)  
C59-C55-C60-O2 146.1(3)  
C59-C55-C61-C66 33.6(4)  
C56-C55-C61-C62 -31.0(4)  
C60-C55-C61-C62 90.0(3)  
C55-C61-C62-C63 -176.5(3)  
C62-C63-C64-C65 0.3(8)  
C62-C61-C66-C65 -0.2(6)  
C64-C65-C66-C61 -0.7(8) C2S-C3S-C4S-C5S 170.4(9) C4S-C5S-C6S-C7S 179.8(15) C2D-C3D-C4D-C5D 88(2) 
C4D-C5D-C6D-C7D 139(4) C9S-C10S-C11S-C12S 180(2) C11S-C12S-C13S-C14S 152(3) 
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C31-C30-C35-C36 178.7(2)  
C33-C34-C35-C36 -176.4(2)  
C48-N6-C36-C35 159.7(2)  
C34-C35-C36-C37 173.6(2)  
C34-C35-C36-N6 -6.5(3)  
C35-C36-C37-C29 1.0(3)  
N4-C29-C37-C36 177.0(2)  
C1-C28-C38-C43 92.5(3)  
C1-C28-C38-C39 -85.9(3)  
C28-C38-C39-C40 177.3(3)  
C39-C40-C41-C42 1.2(5)  
C39-C38-C43-C42 2.0(4)  
C41-C42-C43-C38 -1.1(5)  
C32-C33-C44-C45 174.2(3)  
C32-C33-C44-C47 53.3(4)  
C32-C33-C44-C46 -65.8(3)  
C36-N6-C48-C49 -61.1(4)  
N6-C48-C49-C50 -173.0(2)  
C49-C50-C51-C52 -0.1(4)  
C50-C51-C52-C53 -0.4(4)  
C49-C48-C53-C52 -1.6(4)  
C51-C52-C53-C48 1.2(4)  
C59-C55-C56-C57 -27.8(4)  
C55-C56-C57-C58 18.9(5)  
C57-C58-C59-C55 -17.6(5)  
C56-C55-C59-C58 27.2(4)  
C61-C55-C60-O1 86.9(3)  
C59-C55-C60-O1 -37.8(4)  
C56-C55-C60-O2 34.7(4)  
C56-C55-C61-C66 151.5(3)  
C60-C55-C61-C66 -87.6(4)  
C59-C55-C61-C62 -148.8(3)  
C66-C61-C62-C63 1.1(5)  
C61-C62-C63-C64 -1.2(7)  
C63-C64-C65-C66 0.6(9)  
C55-C61-C66-C65 177.4(4) C1S-C2S-C3S-C4S 168.1(19) C3S-C4S-C5S-C6S 65.2(13) C1D-C2D-C3D-C4D -
175(4) C3D-C4D-C5D-C6D 168.4(18) C8S-C9S-C10S-C11S -140(2) C10S-C11S-C12S-C13S -173(3) C8D-C9D-
C10D-C11D -55(10)  
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Table 7.  Hydrogen bonds for 16066 [Å and °]. 
 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)  
____________________________________________________________________________  
N1-H1N...O1 0.97(3) 1.82(4) 2.786(3) 173(3) 
N2-H2N...O2 0.96(4) 1.76(5) 2.703(3) 167(4) 
N3-H3N...N5#1 0.90(3) 2.17(4) 3.029(3) 160(3) 
N4-H4N...O1 0.90(3) 2.07(3) 2.919(3) 157(3)  
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms: #1 -x+1,y-1/2,-z+3/2 
